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Abstract 
 
 
The European Space Agency (ESA) is currently developing its flagship Life Detection 
Mission, ExoMars, which is scheduled to fly to Mars in 2013.  The primary goal of this 
mission is to compliment the Phoenix NASA mission in confirming the presence of organic 
material on Mars, and, for the first time, analyse this organic material to determine the 
presence of organic species indicative of presence of past or present Life.  One of the 
proposed Life detection technologies is the Life Marker Chip (LMC), which uses 
immunoassays with fluorescent readout to detect small organics and proteins in a 
microarray format within microfluidic channel structures.  This PhD thesis encompasses the 
work done by the author on the development of the SMILE LMC during the period prior to, 
and during part of the first phase of, the Life Marker Chip Technology Readiness Level 
Upgrade Study funded by ESA from 2005 to 2007. 
 
The work carried out is split into three key areas.  The first of these is the radiation 
environment and requirements to fly biological materials in space.  The likely radiation and 
sterilisation environments are discussed and a series of experiments carried out to 
determine the effects of such environments on antibodies and fluorescent dyes.  Dry heat 
sterilisation was found to be incompatible with biological immunoassay reagents.  However, 
both antibodies and fluorescent dyes were shown to maintain some activity after exposure 
to several different relevant radiation environments, including in the case of fluorescent 
dyes a sterilisation gamma radiation exposure, thus validating the continued development 
of an antibody-based detection system with fluorescent readout.   
 
The second key area is development of a breadboard instrument platform and assay 
protocols.  A breadboard system representative of the core design for the Life Marker chip 
was assembled and a series of experiments performed towards establishing assay 
protocols, imaging techniques, and functionalisation of surfaces, advancing the 
development of the Life Marker Chip technology and practical knowledge and experience 
within the SMILE consortium.  Although the assay protocol has not been fully optimised, 
this work demonstrates an immunoassay in a microarray format on surfaces representative 
of those currently proposed for the LMC instrument.  
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The final area explored was the likely effects of Martian Regolith salts and sample 
processing reagents on immunoassays.  This research identified the potential problem of 
salts in the Martian samples forming insoluble precipitates by reacting with buffer salts, 
although this reaction appears to be prevented by the addition of an antioxidant 
(ascorbate).  The presence of highly a-polar organic solvents and high concentration of 
Guanidine-HCl in assay buffers was not compatible with immunoassays, however less 
polar solvents e.g. methanol / water mixtures and lower concentrations of Guanidine-HCl 
may be tolerated by the assay.  This knowledge is an important input into the design of the 
LMC sample processing system. 
 
In summary, although the development of the LMC continues beyond the period of this PhD 
thesis, significant progress has been made in three key areas, and this has contributed 
towards the continuing potential inclusion of the SMILE LMC on board the ExoMars 
mission, as well as advancing scientific knowledge in these areas. 
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Chapter 1: Introduction, Aims and Objectives  
 
1.1 Introduction 
 
All of the work reported in this document was carried out in the context of developing 
the Specific Molecular Identification of Life Experiment (SMILE).  SMILE is a Life Marker 
Chip (LMC) which was proposed as a potential instrument on board ExoMars, the 
European Space Agency‟s (ESA) next planned mission to Mars.  ExoMars is one of the 
flagship missions of ESA‟s AURORA programme (the European programme for 
exploration of the solar system), and aims to characterise the potential of the surface 
environment of Mars to support Life, and this includes a surface rover carrying 
astrobiological experiments aiming to determine the presence of Life (Vago et al., 
2003).  Life detection is to be achieved through a specific complementary package of 
instruments in the Pasteur Payload.  The Pasteur Payload is proposed to include a gas-
chromatography mass-spectrometer, which will detect and identify small organic 
molecules, the Urey instrument, which can identify certain types of organic molecules 
and detect differences in the chiral ratios of for example amino acids, and the Life 
Marker Chip (LMC), which would use antibody based assays to detect a range of 
organic molecules e.g. membrane breakdown products and complete proteins (Vago et 
al., 2003, Sims et al., 2005).  The SMILE LMC is being developed by a consortium led 
by the University of Leicester and Cranfield University, which includes European 
partners and input from the MASSE group (Steele et al., 2004). 
 
There are a number of types of evidence supporting the possibility that Life may have 
evolved on Mars, including the fact that Mars was once within the „habitable zone‟ of the 
Solar System (the region of temperatures within which liquid water can exist), the 
similarity of early Mars and early Earth geochemistry, the discovery of dried river 
valleys, seas and sedimentary rocks on the Martian surface, and the discovery of 
structures within Martian meteorites which resemble fossilised terrestrial micro-
organisms.  There are also arguments against such a possibility, including a lack of 
sufficient geological activity on Mars to support life chemistry and other theoretical 
studies.  This area will be discussed in more detail in the literature review (Chapter 2), 
but in summary there is sufficient evidence for the possibility of life to warrant further 
investigation either by analysing samples on the Martian surface or, in the future, to 
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attempt to transport samples from Mars back to Earth for detailed laboratory analysis 
(Vago et al., 2003, Sims et al., 2005). 
 
The SMILE Life Marker Chip proposed for the Pasteur Payoad is to utilise protein chip 
technology within a microfluidic channel, in order that a large number of relevant target 
molecules can be detected simultaneously within a single sample of low volume.   The 
current concept of the SMILE LMC is a multiplexed antibody-based assay for the 
detection of molecular biomarkers.  These biomarkers can be split into two broad 
categories, namely polar biomarkers (of which most are indicators of extant Life), and a-
polar biomarkers (of which most are indicators of preserved, and normally altered, 
biomarkers i.e. extinct Life).  In addition to the detection of biomarkers related to past 
and present Life on the Martian Surface, molecules associated with spacecraft 
contamination and characteristic of organics from meteoritic infall will be considered.  
The assay readout was proposed to utilise fluorescent detection of labelled 
components, since optical fluorescent biosensors can achieve very low limits of 
detection.  To support this fluorescent readout, the assay system will either utilise 
fluorescently labelled analytes or antibodies in a competitive or inhibition assay with pre-
labelled reagents, or include in-situ labelling of the biomarkers in the sample.  The 
fluorescent excitation and readout will be achieved by carrying out the immunoassay on 
an optical waveguide and passing light down the waveguide to generate an evanescent 
field at the surface.  The evanescent field would excite any fluorescent dye on a labelled 
reagent that had bound (specifically by antibody-antigen interaction) to the surface and 
generate fluorescence, which could be detected by a cooled CCD imaging system.  The 
technology being developed for SMILE is also being considered for applications in the 
detection of Life in subglacial Antarctic lakes, specifically Lake Ellsworth, but these 
other applications will not be discussed in this thesis (Vago et al., 2003, Sims et al., 
2005). 
 
In order for the Life Marker Chip instrument to be confirmed for flight on Pasteur 
Payload, a number of factors have to be defined.  These include:  
 the identification of suitable stable molecular targets which may indicate the 
presence of extinct or extant life.  
 the development of specific antibodies to these targets. 
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 ensuring that these antibodies survive the operational conditions required i.e. 
high resistance to gamma and particle radiation, extreme high and low 
temperatures and stability over  long periods of time. 
 determining the effects of radiation on the properties of fluorescent dyes required 
for readout of the proposed SMILE LMC. 
 the development of a multiplexed assay system which can detect low 
concentrations of many target analytes using very low sample volumes. 
 developing a breadboard imaging system to develop the flight instrument design 
concept and demonstrate fluorescent readout of immunoassays in a microarray 
format. 
 establishing any limitations the assay system would impose upon the sample 
extraction and processing system, including investigating the effects of Martian 
regolith salts, and solvents that may be used in the sample processing, on 
representative assays.   
 the development of an extraction system capable of extracting low 
concentrations of target molecules from a variety of mineral rocks. 
 the development of suitable microfluidic devices for transporting small volumes 
of liquid to the sensing area. 
 the identification of areas on the surface of Mars which may be/have been 
suitable for the evolution of life, and within these areas identification of 
appropriate samples to take for analysis. 
 
All of the factors listed above were considered in the same time frame as the work 
reported in this document, although this author was not solely responsible for all of the 
objectives.  The work was carried out initially with a view to securing funding from the 
European Space Agency (ESA) to carry out a 2 year LMC Technology Readiness Level 
(TRL) Upgrade Study.  When this funding was received, the work was continued within 
this TRL upgrade study, developing the design of the instrument and sample processing 
system.  A further phase of work is planned to develop the breadboard system that is to 
be produced as an outcome of the Technology Readiness Level Upgrade Study into a 
flight instrument, and some of the work reported here contributes to the design of the 
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flight instrument in addition to breadboard development (Vago et al., 2003, Sims et al., 
2005). 
1.2 Thesis Objectives and Structure 
 
The work reported here focuses on three key areas of the LMC development.  The first 
of these was testing the resistance of biological recognition elements and fluorescent 
dyes to the environmental conditions encountered during a nominal mission, including 
pre-flight sterilisation and radiation exposure during flight.  The second area involved 
developing the multiplexed assay system and a prototype breadboard system, and the 
third area was a series of studies to determine the effect of Martian regolith salts and 
potential solvents used in sample processing and extraction of biological assays.  While 
these activities were carried out, other aspects of the LMC were being developed by 
partners in the project. 
  
This document, therefore, will be presented in the form of three streams of work carried 
out in these different key areas of work.  The approach adopted throughout the project 
was to establish methodology using reagents and protocols that were available when 
work began, representative of the proposed design for the flight instrument, and allowed 
simple verification of whether a protocol was successful.  As the project became more 
advanced the protocols were refined and new equipment became available through the 
ESA funding, enabling the final experiments to become closely related to the design 
concept at the conclusion of this thesis.  The streams of work were carried out in 
overlapping timescales, but are reported here in distinct sections. 
 
1.2.1 Theme 1: Radiation and Flight Environment conditions 
 
The first priority in terms of the timing of this work was to determine whether there was 
any fundamental reason why antibody-based assays with a fluorescent readout could 
not survive in space.  The processes of spacecraft assembly and flight to Mars involve a 
large number of environmental conditions which biological materials e.g. antibodies and 
fluorescent dyes are not routinely exposed to.  These conditions include long term 
storage at room temperature, exposure to high levels of acoustic energy, exposure to 
particle and gamma radiation from different sources (both solar and galactic cosmic 
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rays, and possibly during spacecraft sterilisation) and of various types (gamma, particle 
radiation and UV), landing shock and vibrations, low atmospheric pressure, and 
temperature cycling in extreme cold on the Martian surface.  Many of these factors had 
not been fully evaluated when proposing the LMC for the Pasteur package (Sims et al., 
2005).  At that time it was considered feasible to overcome engineering issues such as 
withstanding vibration and impact tests, and the biological materials were known to be 
compatible with extremes of cold as this is how they are stored routinely.  The effects of 
radiation on antibodies and fluorescent dyes, however, was unknown and of critical 
importance to the feasibility of the proposed instrument, since both of these types of 
reagent are required for the proposed assay system.  The objectives of this section of 
work, therefore, were to determine any effect of radiation on the properties of 
fluorescent dyes and antibodies in an immunoassay, to test the feasibility of using a 
gamma radiation treatment to sterilise the flight instrument, and determine the effects of 
dry heat sterilisation on antibodies and fluorescent dyes. 
1.2.2 Theme 2: Development of optical breadboard and microarray assay system 
 
After performing a number of radiation and heat sterilisation tests on antibodies and 
fluorescent dyes, and securing funding for the Technology Readiness Level (TRL) 
Upgrade Study, the focus of the project moved to development of the instrumentation 
platform.  The basic components and methods used in the proposed SMILE instrument 
were already well established in the biotechnology sector, but the combination of 
antibody assays and fluorescent readout assays had not been carried out in such a 
small scale as was proposed, and using these assay systems in microfluidic channels 
had rarely been carried out.  In addition, some of the techniques used had not been 
done previously in the laboratories at Cranfield University, where the assay 
development work was carried out, so some work was required to develop suitable 
protocols for microarray spot deposition before attempting to deposit arrays of antibody 
spots.  The key objectives of this section of work were to assemble and test a 
breadboard imaging system representative of the flight LMC design, to develop 
immunoassays in a microarray format using fluorescently labelled reagents, to develop 
and optimise an immunoassay protocol based on a representative biomarker target, to 
establish protocols for in-situ fluorescent labelling of proteins and to demonstrate in-
house functionalisation of surfaces representing those used in the LMC design. 
 
Paul Kerr Wilson     Introduction, Aims and Objectives 
Development of Life Marker Chip Technology for in-situ Life Detection on Mars  Page 6 of 206 
1.2.3 Theme 3: Effects of Mars environment and sample processing reagents on 
antibody-based assays 
 
Part of the work of the TRL upgrade study was to develop a specific sample processing 
and extraction system for the LMC.  An important consideration in this was to determine 
the tolerance of the antibody assay to sample components that may pass through the 
sample processing system, since this is fundamental in the selection of the extraction 
method and solvents used.  For example, if salts were found to present a large problem 
for the assay, a demineralisation step in the sample processing system would have to 
be considered.  Similarly if organic solvents were not tolerated above certain levels, the 
solvents selected may have to be diluted or removed by evaporation or solid phase 
extraction.  To develop this input to the sample processing system design, experiments 
were carried out to determine whether, and how much, antibody assays are affected by 
the presence of salts found to be common on the Martian surface and organic solvents 
that may be present in the sample processing and extraction system.  The objectives of 
this section of work were to determine the effect of Martian regolith salts and solvents 
that may be used in the LMC sample processing system on immunoassays, and to use 
this information to provide input into the design of the LMC sample processing system. 
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Chapter 2: Literature review  
 
The literature review in this document will be divided into four main sections.  The first 
section will review the current state of knowledge of the relevant radiation and pre-flight 
sterilisation requirements and the possible effects on biological materials, and is 
presented in the form of a draft publication which the author of this thesis contributed 
significantly to1.  The second section is a brief review of the targets for the Life Marker 
Chip, and is included to explain the decision to base the LMC instrument on optical 
biosensing technology.  The third section will review the existing optical biosensing 
technologies that may form components of the SMILE LMC instrument, and the final 
section will describe the expected conditions and sample types on the Martian surface, 
and possible effects that regolith materials and sample processing reagents may have 
on the biological assay. 
2.1 The effect of extreme environments on biological materials 
2.1.1 Introduction and space mission environments 
 
One of the key targets for the SMILE LMC is the planet Mars and consequently the 
following sections and discussion concentrate almost exclusively on this environment as 
the example mission environment and in particular on the effects of radiation. Although 
as an aside it should be noted that LMC technology has applications in crewed missions 
in near-Earth orbit e.g. the International Space Station or on missions to other targets 
e.g. Europa, where the radiation environment may differ significantly.  
The review will initially focus on the expected levels of radiation during a Mars mission.  
This will be followed by the likely and measured effects of planetary protection as 
relevant to Life Marker Chips, and then a discussion of the basic effects of radiation on 
biological materials and its possible effects on components within a LMC instrument.  
The measured effects of radiation on biological and biologically based materials will 
then be described. Finally some additional effects and factors will be briefly discussed.  
A summary of the environmental considerations for the LMC will be presented, along 
with the areas where further testing and development were required prior to this work.  
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2.1.1.1 Space mission environments 
 
A key science goal of many space missions and in particular those in astrobiology is 
detection of organic molecules that can be directly associated with present or past Life, 
namely polar and a-polar biomarkers.  Life detection instruments must also detect 
organic targets characteristic of meteoritic organic chemistry and spacecraft 
contamination.  Current target planetary bodies within the Solar System include Mars, 
Europa and Titan.  All have radically different environments, and, in the case of Titan, 
perhaps different potential life chemistries associated with them.  All targets have 
common extreme environment challenges that need to be dealt with, the only difference 
between them being the exact values of the extremes.  These target environmental 
challenges combine with those of the mission itself and are namely 
 Temperature 
 Chemical Environment 
 Radiation including particles radiation, gamma and UV 
 Pressure (or low pressure) 
 Planetary Protection i.e. the need to sterilise and clean the instrument to avoid 
contaminating the target.  This is to be achieved either by thermal sterilisation or 
potentially gamma irradiation 
 
The environmental challenges at all stages of the mission must be considered in any 
space instrument design and development programme, including final assembly, 
integration and testing, pre-launch storage, launch, cruise to the target (Mars), and 
operation in-situ.   
The three key environments, are considered by the author to be, namely, pre-launch 
sterilisation, the flight through inter-planetary space during which the craft will be 
exposed to galactic cosmic radiation and solar radiation including gamma rays, protons 
and heavy ion radiation, and the operational conditions on the planet/moon, which may 
include high radiation dose and extremely cold temperatures.  Temperatures in turn 
could vary considerably on a daily, seasonal, and landing location basis.  
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2.1.1.2 Life Marker Chip instruments 
 
Although a number of instrumentation technologies are highly sensitive in the detection 
of organics, for example gas-chromatography mass-spectrometers (GCMS), there has 
been a move towards confirmation of particular targets by multiple instruments, and 
highly specific molecular detection.  One method of detection involves use of sensors 
based on antibodies or other specific molecular receptors e.g. Molecular Imprinted 
Polymers (MIPs), where high sensitivities and, more importantly, low limits of detection 
can be achieved in small compact instruments.  One such example is the so-called Life 
Marker Chip (LMC) instrument for example the SMILE (Sims et al. 2005), MASSE 
(Steele et al., 2004) or MOBILD (Gómez-Elvira et al., 2004) all of which are based on 
similar concepts. MIPs offer a potentially higher environment robustness, but require 
considerable developments so “first generation” LMC  instruments will utilise antibody 
based detection methods. Such instruments may utilise fluorescence, refractive index or 
electrochemical readout or even a combination to provide information rich and 
confirmatory data. First generation instrumentation will most likely use a fluorescent 
readout as it is relatively simple and well-known technique extensively utilised in 
biotechnology. 
 
Life Marker Chip (LMC) instruments e.g. SMILE, MASSE, MOBILD, although having a 
strong biotechnology heritage, have not been flown in space.  The biological materials 
used in these LMC instrument designs, and their compatibility with the space 
environment and likely ground Assembly, Integration and Verification (AIV) 
requirements are at best poorly known.  One key mission effect is space radiation 
particularly as relatively complex organic molecules i.e. proteins are used within the 
devices. Consequently compatibility with the mission radiation specification is a key test 
to be performed early within any space LMC development. 
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2.1.1.3 The space and planetary radiation environment 
 
Radiation in space and on the surface of another planet consists of the following inputs: 
 
 Electrons 
 Protons 
 Neutrons 
 Ions i.e. Cosmic rays 
 X-rays and Gamma-rays 
 UV radiation 
 
Each radiation type listed is, in principle, capable of producing secondary radiation from 
interaction with the instrument or material surrounding the instrument and modifying the 
radiation spectra seen by any LMC. In addition environmental challenges induced by 
design of the spacecraft need to be taken into account for example in an Radioactive 
Thermal Generator (RTG) powered rover there may be a considerable flux of neutrons 
resulting from the RTG power source, see section 2.1.2.4. 
 
2.1.1.4 Planetary protection 
 
Planetary Protection is a specific term used to describe the international effort to 
prevent terrestrial life being introduced to other planetary bodies by the transfer of living 
biological organisms between worlds through spacecraft contamination.  The 
classifications of spacecraft and the requirements for each type are controlled and 
regulated by the Committee of Space Research (COSPAR), and are described as a 
series of pre-flight and operational requirements for each mission type (DeVincenzi et 
al., 1984).  The regulations state that appropriate sterilisation procedures must be 
carried out on all entities that may come into contact with a planetary surface where 
there is interest in the process of chemical evolution.  The specific requirements and 
procedures to achieve sterilisation are dependent on the type of mission and the 
instrumentation on board.  In the case of landers or other spacecraft which may come 
into contact with planetary surfaces procedures must be carried out to quantify and 
reduce microbial contamination and overall bioload, calculate the probability of 
contamination of the target environment, and document all organics on board and the 
procedures and results of pre-flight sterilisation (Divincenzi et al., 1984).  In the case of 
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Mars missions, this has been further defined such that all Mars landers must be 
sterilised to at least the levels used for the Viking landers i.e. a total spore count of ≤300 
m-2 and a total spore burden not exceeding 3.0x105 (Mahaffy et al., 2004, DeVincenzi et 
al., 1996).  Thus any molecular or biological components of an instrument  must 
therefore survive at least one of the approved procedures used to reach this level of 
sterilisation, namely gamma irradiation, ultraviolet (UV) irradiation, heat sterilisation - a 
minimum of 111.7°C for 30 hours (DeVincenzi et al., 1996), or precision cleaning 
(Mahaffy et al., 2004).   In addition the materials will be exposed to additional 
sterilisation via the electromagnetic and particle radiation encountered during the flight 
to Mars and on the Martian surface. 
 
2.1.1.5 Radiation and its effects on organic and biological materials 
 
It is assumed that the antibodies and other biological type molecule components within 
LMC type instruments will be affected by radiation as per other biological systems. The 
various types of radiation are classified in terms of their effect by the so called biological 
quality factors which are used to derive a biological dose which has the unit of a Sievert 
(see for example Holmes-Seidle and Adams 2002). The relative biological effectiveness 
or quality factors for the various types of radiation are as follows (Table 2.1): 
 
Table 2.1: Types of radiation present in the space environment and their RBE values. 
Type of Radiation Relative Biological Effectiveness (RBE) 
X-ray, UV, Gamma, Beta particles 
(electrons)  
1 
Slow neutrons  5 
Fast neutrons/protons  10 
Alpha particles  20 
High Z particles  20 
 
Consequently the “most” damage is expected by ions as they have the highest RBE 
value. 
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Electrons interact at the atomic level, causing excitation and ionisation that can cause 
them to be scattered and produce Bremmstrahlung radiation.  Protons and heavier ions 
can produce excitation and ionisation but can also react directly with the atomic nucleus 
causing fragmentation of the nucleus and emission of secondary neutrons and protons. 
Neutrons having no charge are difficult to stop but interact strongly with water, which 
can produce an effective shield.  Neutrons can interact directly with the nucleus. 
 
Biological materials are however exposed to radiation treatments for a number of 
reasons, including the sterilisation of food and medical supplies (including diagnostic 
reagents) and for the immobilisation of bioactive materials such as enzymes, (Kume & 
Matsada, 1995, White et al., 1990).  The primary reason for most treatments is to 
achieve inactivation of any bacteria present, although some studies have investigated 
the feasibility of radiation-inactivation of proteins to reduce their antigenicity and 
therefore prevent allergic reactions to specific proteins (Kume & Matsada, 1995).   
 
The effect of radiation on polymers, including biological ones, is the conversion of 
particles into much lower energy radiation and the formation of short-lived intermediate 
compounds, usually free radicals (see for example Yamaguchi et al. 2005).  Radiolytic 
hydrogen gas can be generated from ruptured C-H bonds and any intermediates can 
react with water and oxygen to produce OH radicals that may produce further chemical 
damage. Consequently freeze-drying may be a very effective way to reduce radiation 
damage, (see section 2.1.3.6).  As short-lived intermediate compounds are produced, 
any radiation effects may unfortunately be rate dependant (see section 3.1 regarding 
implications for radiation testing).  In general, for biological and chemical materials, 
radiation causes damage by two methods, producing cross-linking and via scission or 
bond breaking, with the resulting production of new compounds and a consequent 
change in properties. 
 
There are number of commonly used terms in the description of radiation exposure (see 
for example Holmes-Seidle and Adams 2002).  The radiation dose is refined as the 
amount of energy absorbed by the target.  The units used to describe this are the Rad 
(1Rad = 0.00001 Joules of energy absorbed per gram of substance), Grays (Gy - 1 Gy 
= 100Rads), and the Roentgen Equivalent Mean (REM).  The REM is a much more 
complicated unit as it describes the amount of biological damage produced and is 
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dependent on a large number of factors including the type and energy of radiation.  The 
REM is related to the Rad by the following equation: 
 
 REM Dose Equivalent = Relative Biological Effectiveness (RBE) x Rads 
 
where the relative biological effectiveness (RBE) is a proportionality constant as given in 
Table 2.1.  By convention the damage done to a human by a whole body irradiation of 
250keV X-Rays is considered to be equivalent to 1 rad, and the RBE under these 
conditions is unity. Space mission doses are normally quoted in rads. 
 
2.1.1.6 Effects of radiation on the Life Marker Chip and related instruments 
 
One of the major unknown factors in the potential application of biological recognition 
elements e.g. antibodies in an LMC-type experiment is the effect of the different types of 
radiation that would be encountered during the mission.  Since very few experiments 
involving the irradiation of antibodies or other molecular receptors have been carried 
out, particularly those involving freeze-dried antibodies and particle radiation, the 
majority of literature included in the review below is based on the effect of gamma 
radiation on proteins and enzymes in both liquid and freeze dried states, as these 
provide a basis for determining the possible effects of radiation on antibodies and other 
molecular receptors.  Similarly there have been very few experiments on the resistance 
of freeze-dried biological materials to extreme temperatures and temperature cycling.  
 
A variety of different potential damage mechanisms might be expected within an 
instrument, as given below. 
 
 Damage to fluorophore / fluorescent molecules would lead to a change in 
quantum efficiency, peak emission or excitation fluorescent wavelength or even 
complete loss of fluorescence. 
 
 Damage to the antibodies would cause a loss of affinity to their antigen, or 
stronger binding to other (non-target) compounds, i.e. loss of specificity. 
 
 Radiation may damage the binding of materials to surfaces or change the 
surface free energy, therefore affecting the ability to move fluids through a 
system and non-specific binding. 
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As the biologically based elements will be housed inside the instrument it is assumed in 
what follows that UV radiation is not a factor that is likely to affect such instruments, due 
to the effect of shielding offered by the spacecraft and rover structure.  Therefore, UV 
radiation will not be considered in the following sections. 
 
2.1.2 Expected radiation levels during a Mars Mission 
2.1.2.1 Radiation during a Mars mission 
 
During transfer to Mars, a spacecraft will be exposed to a wide range of radiation types 
and energies including gamma rays, protons, neutrons and heavy ions (e.g. Adams 
(1992), Petrov (2004)) at energies ranging from a few MeV to thousands of GeV and 
beyond, peaking at around 1 GeV (see for example Benton and Benton (2001)).   
 
Additional contributions may come from any on-board radio-active sources (Butcher et 
al., 2006) or radio-active heater units or radio-active thermal generators (RTGs). For 
example in the case of the Mars Science Laboratory Mars Rover mission expected to fly 
in 2009 which will carry an Radioactive Power Supply (RPS) based on RTGs the 
radiation dose on the surface of Mars is dominated by the RPS with a expected dose of 
76 Rads compared to 28 Rads of the natural environment. The RPS results in a total 
mission fluence of 3.2 x 1010 equivalent 1 MeV neutron fluence through the analytical 
laboratory during the nominal mission consisting of 300 days cruise to Mars and 670 
Sols (Martian days) (approximately 645 Earth days) on the Martian surface (MSL PIP 
2004).  
 
2.1.2.2 Measured radiation environment at Mars 
 
The Mars Radiation Environment Experiment (MARIE) on board the 2001 Mars 
Odyssey orbiter was designed to record the radiation environment during flight to and in 
orbit around Mars (see http://marie.jsc.nasa.gov/Data/Index.cfm).  This includes data on 
the galactic cosmic ray energy spectra and solar energetic particles, and changes 
occurring during solar events e.g. solar flares.  Solar energetic particle events occur 
sporadically during the 3 year prior to and 4 years following a solar maximum, and lead 
to sharp, short-term increases in radiation dose and dose rate.  MARIE can measure 
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particle energies between 15MeV and 500MeV per nucleon, a range encompassing 
most radiation particles which are harmful to humans and that can damage DNA.   
 
A basic calculation of the expected radiation dose is given by the HZETRN model 
(Wilson et al., 1995), which uses the daily solar deceleration parameter (phi) to 
determine the galactic cosmic radiation spectra. Error! Reference source not found. 
shows a plot of the dose predicted by this model against the actual data recorded by 
MARIE during flight to Mars, and Figure 2.2 shows the same plot for radiation dose at 
Mars orbit. 
 
 
 
Figure 2.1: Provisional data from the MARIE: Absorbed Dose Rate vs HZETRN Model Calculations 
During Flight, as presented on the NASA MARIE website in 2002-3.  NOTE: This provisional figure is no 
longer available, but revised versions that compensate for some calibration issues have been prepared 
and will be published in the near future by the NASA MARIE group (Personal Communication, Cary 
Zeitlin (2006)). 
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Figure 2.2: Provisional figure showing MARIE measurements vs. HZETRN model calculations during 
Martian orbit as presented on the NASA MARIE website in 2002-3.  NOTE: This provisional figure is no 
longer available, but revised versions that compensate for some calibration issues have been prepared 
and will be published in the near future by the NASA MARIE group (Personal Communication, Cary 
Zeitlin (2006)). 
The gaps in data in Figure 2.1 and Figure 2.2 are due to alterations to the instrument 
and downloading of data.  The HZETRN model predicts a basic dose rate of 
~25mRad.day-1 due to galactic cosmic radiation alone in both cases, although in Figure 
2.2  there is some variation due to solar modulation during this period.  Figure 2.1 
includes a large peak in dose rate (nearly 50mrad.day-1) on May 22nd 2002, due to a 
solar particle event (SPE).  There are also some smaller peaks in dose rate in Figure 
2.2, which are also likely to be due to SPEs.  The basic dose rate in Martian orbit 
appears to be slightly below that predicted by the HZETRN model, possibly due to the 
limited range of angles in which radiation is recorded by the MARIE instrument. 
The distribution of charged particles detected by the MARIE instrument is shown in 
Figure 2.3 and Figure 2.4 (http://marie.jsc.nasa.gov/Data/Index.cfm).  These show that 
the vast majority of particle radiation encountered by MARIE has been protons (z = 1) 
and helium nuclei (z = 2).  However, significant numbers of carbon nuclei (Z = 6), 
nitrogen nuclei (Z = 7), and oxygen nuclei (Z = 8) can be clearly seen in Figure 4, and 
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some indications of boron nuclei (Z = 5) and a slight Neon nuclei (Z = 10) peak may 
also be present.   
 
Figure 2.3: Provisional MARIE measurements of the Average Charge of Non-Stopping Particles (low Z) 
as presented on the NASA MARIE website in 2002-3. NOTE: This provisional figure is no longer 
available, but revised versions that compensate for some calibration issues have been prepared and will 
be published in the near future by the NASA MARIE group (Personal Communication, Cary Zeitlin 
(2006)). 
 
Figure 2.4: Provisional MARIE Measurements of Average Charge of Non-Stopping Particles (High Z) as 
presented on the NASA MARIE website in 2002-3.  NOTE: This provisional figure is no longer available, 
but revised versions that compensate for some calibration issues have been prepared and will be 
published in the near future by the NASA MARIE group (Personal Communication, Cary Zeitlin (2006)). 
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Since Mars, unlike Earth, is not protected from radiation by a magnetic shield (NASA 
MARIE) and its atmosphere is less than 1% as thick as Earths, it can be assumed that 
radiation on the planetary surface will be similar to that in orbit around the planet.  This 
gives an indication of the dose that all the biological molecules involved in the Life 
Marker Chip must withstand in order to be suitable for this application. 
 
2.1.2.3 Summary of information about the radiation environment from NASA MARIE 
 
While the MARIE experiment does not give a fixed radiation dose for any given mission 
to Mars (due to the variation in duration, flight path and solar activity between missions), 
the correlation of the measured radiation dose with that predicted by modelling 
techniques (Figure 2.2), within at least an order of magnitude, validates the use of the 
HZETRN model to calculate approximate expected radiation environment for any given 
mission.  The basis of this model and other similar models and predictions of the 
radiation environment for ExoMars will be discussed in section 2.1.2.4. 
 
2.1.2.4 Predictions of the radiation environment and the radiation dose and testing 
problem 
 
It is possible to model the expected radiation environment during a space mission. Such 
tools as the High-charge-and Energy TRaNsport computer program (HZETRN) model 
and SPace ENVironment Information System (SPENVIS) (European Space Agency 
General Support Technologies Programme – see www.spenvis.oma.be) can be used. 
Many mission design specifications however give the integrated radiation dose 
(equivalent to the absorbed by silicon) in rads. There therefore remains a “calibration” 
problem when biological materials are used, unless a standard silicon detector is 
utilized in any tests.  
 
Alternatively using such tools as SPENVIS the fluence vs. energy of a particular 
radiation type can be calculated allowing for the shielding of the spacecraft/probe and 
instrumentation. This fluence can then be used to provide inputs for testing components 
for space flight for a given mission, such as testing LMC components and biological 
materials to determine whether they will survive the mission radiation environment of 
ExoMars.  The radiation is normally described in terms of total ionising dose and total 
non-ionising dose. 
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At the time that the radiation studies reported in this document were performed, the 
minimum radiation environment for instruments on board the ExoMars Mission to 
survive had been calculated to consist of a total ionising radiation dose of 2.5 krad 
(assuming 4mm Aluminum shielding), and a non-ionising energy loss of 5 x 107 
MeV/g(Si) (assuming 4mm Aluminum shielding) (ESA, 2005).  For Mars Science 
Laboratory, a NASA mission comparable to ExoMars in that it will also fly to Mars 
carrying a rover with a payload of instruments for the detection of organics, the 
expected ionising radiation dose is expected to be 3.0krad, and non-ionising dose 
equivalent to 3.2 x 1010 1MeV neutrons for the analytical instruments (MSL PIP, 2004).  
The experiments reported in section 3.1 of this thesis were based on these figures.  
However, more recently, a study has been carried out within the Technology Readiness 
Level Upgrade Study (Alex Hands and David Rodgers, QinetiQ, Personal 
Communication), which indicates that in fact the total ionising radiation dose for 
ExoMars will be 6.6kRads and total non ionising dose of 1.4x108MeV/g.  These slightly 
higher figures do not invalidate the work carried out in section 3.1, due to the large over-
testing philosophy adopted at the time of these experiments, and exposures many 
orders of magnitude greater than the minimum requirement for the mission. 
 
The problem in testing is however that normally either one single energy or a limited 
range of energies of particular radiation types are present and can only be applied at 
higher rates than during the mission. The former has the problem that not all energies 
can be run simultaneously and consequently multiple tests and limited energy range 
tests must be conducted.  The latter has the advantage that tests can be conducted in a 
reasonable and limited time, however its does not allow for any decay-type processes 
that may occur in a real material during a mission e.g. decay of excited states etc. Some 
combined testing is possible with exposures of targets to mixed radiation for example 
via reactors, however undesirable radiation components (from a test point of view) 
cannot be excluded from use of such test apparatus. 
2.1.3 Effects of radiation on whole cells and cellular components  
2.1.3.1 Introduction: viral and bacterial exposure to radiation 
 
The results of exposure of whole cells and cellular components to different types of 
radiation are reviewed below, and the overall results and relevance to the current 
application discussed.  The primary aim of exposing viruses or bacteria to radiation is to 
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achieve sterilisation, either for food or medical products.  The main goal is to achieve 
inactivation of these pathogens, and studies therefore focus on the minimum radiation 
dose required to achieve this. 
 
Gamma photons are by far the most widely used radiation treatment of biological 
materials (Lowy et al., 2001).  In this review, only two studies were found in which 
biological materials were exposed to neutrons (Lowy et al., 2001, Singh, S. et al., 1990).  
Lowy et al. (2001) found that neutrons were less effective at inactivating bacteria than 
gamma radiation, with relative biological effectiveness (RBE) value of approximately 
0.5.  They showed this using two different methods and different bacterial strains (Lowy 
et al., 2001).  In contrast Singh, S. et al. (1990) had previously reported that neutrons 
were more effective than gamma photons at inactivating bacteria.  During this review no 
publications were found in which biological materials of any type were exposed to 
proton radiation. 
 
It has been found in a number of studies that viral replication is inactivated at a lower 
radiation dose than protein-dependent activities, such as antigenicity (Deflora and 
Badolati, 1973, Gamble et al., 1980, White et al., 1990, Elliott et al., 1992, Pang et al., 
1992, Lowy et al., 2001).  Lowy et al. (2001) were not able to associate inactivation of a 
virus with structural damage to any particular type of cellular component nor did they 
find that gross structural changes occurred in the majority of viruses (Lowy et al., 2001).  
The specific type of radiation damage to viruses could not be identified for either 
neutrons or gamma radiation (Lowy et al., 2001).  They also observed that if viral 
inactivation plateaus exist at a certain dose this would be very difficult to demonstrate, 
as it would require very accurate measurement and an extremely high radiation dose 
(Lowy et al., 2001).  These results suggest that proteins and other viral components 
may retain their functionality at higher radiation dose than is required for inactivation of 
the pathogen itself (Lowy et al., 2001). 
 
2.1.3.2 Cellular component exposure to radiation 
 
The effects of gamma radiation on proteins has been extensively studied under a 
number of different conditions, although the effects of other radiation types have not 
been investigated.  There are a number of common effects to all proteins exposed to 
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gamma radiation.  These include conformational changes, oxidation of amino acids, 
rupture of covalent bonds leading to fragmentation, and the formation of protein free 
radicals which can lead to cross-linking and aggregation of proteins (Lee et al., 2004, 
Lee et al., 2003, Lee and Song, 2002, Cho and Song, 2000, Cho et al., 1999, Filali-
Mouhim et al., 1997, Kume and Matsuda, 1995, Puchala & Schuessler, 1993, Davies 
and Delsignore, 1987, Garrisson, 1987, Cheftel et al., 1985, Schuessler and Schilling, 
1984, Yamamoto, 1977).  The dominant effect(s), and hence the resulting 
characteristics of the protein, appears to be dependent on a number of factors.  These 
include the radiation dose, the presence of water, oxygen and free-radical scavengers, 
protein concentration, and protein-specific factors such as the primary amino acid 
sequence, local conformation of amino acids, and accessibility to water radiolysis 
products or other free radicals (Lee et al., 2004, Lee et al., 2003, Lee and Song, 2002, 
Cho and Song, 2000, Filali-Mouhim et al., 1997, Kume & Matsuda, 1995, Woods and 
Pickaev, 1994, Davies and Delsignore, 1987, Garrisson, 1987, Cheftel et al., 1985, 
Schuessler and Schilling, 1984).  
 
In proteins, a large number of studies on different proteins in solution have 
demonstrated that a low radiation dose e.g. 100krad, results in fragmentation, 
observable by a decrease in the intensity of the major band in electrophoretic gels, and 
the corresponding appearance of new bands below the major band.  At higher radiation 
doses e.g. 500, - 1600krad, aggregation becomes the dominant effect and cross-linked 
products are formed, which are not able to penetrate electrophoretic gels.  At a given 
radiation dose, whichever effect is dominant (either fragmentation or aggregation), 
occurs more rapidly at lower protein concentrations i.e. lowering the protein 
concentration increases the rate of these radiation effects (Stevens et al., 1967, 
Schuessler and Schilling, 1984, Krumhar and Berry, 1990, Le Maire et al., 1990, 
Puchala and Schuessler, 1993, Kume and Matsuda, 1995, Cho and Song, 2000, Moon 
and Song, 2001, Lee and Song, 2002, Lee et al., 2003, Lee et al., 2004).  
 
Davies and co-workers produced a series of papers on protein damage and degradation 
by oxygen radicals (Davies, 1987, Davies and Delsignore, 1987, Davies et al., 1987ab) 
(Cho and Song, 2000).  Hydroxyl radical and super-oxide anion radical generated by the 
radiation could modify the primary structure of proteins, which would result in distortions 
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of the secondary and tertiary structures (Cho and Song, 2000, Davies and Delsignore, 
1987ab) 
2.1.3.3 Causes of aggregation 
 
The formation of protein aggregates during radiation exposure can be explained by the 
creation of protein radicals, which can cause cross-linking reactions to occur including 
the formation of disulphide bonds, and the stimulation of additional hydrophobic and 
electrostatic interactions e.g. by the exposure of new protein surfaces exposed by 
fragmentation or protein structure alteration (Lee et al., 2004, Lee et al., 2003, Lee and 
Song, 2002, Cho and Song, 2000, Cho et al., 1999, Davies and Delsignore, 1987, Le 
Maire et al., 1990, Garrison, 1987, Kato et al., 1981).  The exposure of new protein 
surfaces was shown in studies on myoglobin, in which UV spectra revealed that 
radiation disrupted the haem group and caused tryptophanyl residues usually present in 
a hydrophobic pocket of the haem group to be exposed to the protein surface (Lee and 
Song, 2002).  In a previous study the hydrophobicity of ovalbumin (OVA) was found to 
increase rapidly with radiation dose, reaching a maximum after a dose of 800krad.  This 
may contribute to protein aggregation at higher radiation doses (Kume and Matsuda, 
1995).  In contrast BSA, which is a hydrophobic protein, showed a significant decrease 
in hydrophobicity over the same range of radiation dose (Kume and Matsuda, 1995).   
 
Kume and Matsuda (1995) found that protein radiation products, i.e. fragments and 
aggregates, retain a significant proportion of their antigenicity, although the reactivity is 
reduced.  They concluded that this is because while radiation can alter the secondary 
structure of a protein and reduce the specificity of antibody binding, antigenicity relying 
primarily on the sequence of amino acids may remain even if the conformation is altered 
(Kume and Matsuda, 1995).  This is in general agreement with the work of Yang et al. 
(1996), who found that irradiated enzymes (which also rely on a specific binding site in 
their structure to bind to their target molecule) retain a proportion of their activity. 
 
Kume and Matsuda (1995) found that radiation dose required to reduce the antigenicity 
of 0.1% OVA in solution was 800kRad in a nitrogen atmosphere and 400kRad in 
oxygen.  In contrast the radiation-induced reduction of antigenticity of BSA in solution 
was independent of the atmosphere.  They also observed that aggregation of OVA and 
BSA was greater at high dose in a nitrogen atmosphere than in oxygen, indicating that 
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while oxygen appears to enhance fragmentation it also reduces aggregation effects.  
This effect was much greater on BSA than OVA, emphasising the effect of local protein 
structure on the effect of radiation.  The effect of radiation on hydrophobicity was less 
pronounced in the presence of oxygen, possibly because fragmentation of proteins by 
oxygen radicals prevented the detection of changes in hydophobicity.  This shows that 
oxygen has a role in the damage of some proteins by radiation, and the atmosphere 
must therefore be considered when determining the effect of radiation on proteins. 
 
These effects of oxygen are well known, and a number of studies have demonstrated 
that the fragmentation damage and aggregation caused by radiation can be significantly 
reduced by the addition of free radical scavengers such as ascorbic acid (Singh, A. et 
al., 1990, Cho et al., 1999, Moon and Song, 2001, Lee and Song, 2002).   
 
2.1.3.4 Fragmentation mechanisms 
 
The fragmentation of proteins has been found to produce both random and non-random 
products, depending on the experimental conditions (Lee et al., 2003, Lee and Song, 
2002, Cho and Song, 2000, Cho et al., 1999, Kempler, 1993).  Some specific 
mechanisms of radiation-induced protein fragmentation have been proposed. These 
include the formation of peroxyl radicals at the α-carbon by the reaction of α-carbon 
radicals with oxygen, followed by decomposition of these radicals which causes 
fragmentation of the polypeptide chain at the α-carbon (Cho and Song, 2000).  It has 
also been suggested that fragmentation occurs by the specific breakage of „fragile 
bonds‟ within a polypeptide chain (possibly linked to transfer of radiation energy within a 
protein to these specific points (Cho and Song, 2000, Le Maire et al., 1990), and by the 
oxidative destruction of proline residues (Lee et al., 2003, Cho and Song, 2000, Wolff et 
al. 1986, Schuessler and Schilling, 1984). 
 
2.1.3.5 Structural changes caused by radiation damage 
 
Radiation-induced changes in structure have been shown by studies of the far-UV CD 
spectra of irradiated proteins in solution (Lee et al., 2003, Lee and Song, 2002).  This 
technique has revealed increasing changes in the proportion of α-helices, β-sheets and 
random structures at higher radiation dose, which indicates that radiation disrupts the 
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secondary structure of proteins (Lee et al., 2003, Lee and Song, 2002).  A study on 
myoglobin (an α-helical protein) in solution found that a 1000kRad gamma radiation 
exposure caused the α-helix content to be reduced from 67% to 12%, with a 
corresponding increase in random coil structure from 23% to 44% (Lee and Song, 
2002).  The same trend of secondary structure breakdown was also found in other 
studies on BSA, another α-helical protein, and β-lactoglobulin, a typical β-sheet 
structure protein (Cho and Song, 2000).  In the case of β-lactoglobulin the absorption 
minimum was moved to a lower wavelength with increasing radiation dose (Cho & 
Song, 2000). In these studies the alteration in secondary structure was associated with 
damage by water radiolytic products (Davies and Delsingnore, 1987, Cho et al., 1999, 
Cho and Song, 2000, Lee and Song, 2002, Lee et al., 2003), but it is not clear if such 
changes would occur in the absence of water. 
 
Changes in the tertiary structure of proteins can be studied by the measurement of 
fluorescence emission intensity (Lee and Song, 2002).  Excitation at 280nm can reveal 
the tertiary structure through the excitation of trytophan and tyrosine residues, for 
example changes in the emission intensity or peak wavelength can indicate a change in 
the local environment of these residues (Cho and Song, 2000, Lee and Song, 2002).  
This technique has been applied to the detection of tertiary structure changes in 
irradiation of myoglobin, BSA, and β-lactoglobulin in which different changes were 
observed.  Irradiated myoglobin was found to have an increased emission intensity, 
whereas BSA and β-lactoglobulin had reduced emission intensities.  The peak intensity 
of irradiated BSA was at a slightly higher wavelength (blue shift) than unirradiated BSA, 
whereas the peak intensity of irradiated β-lactoglobulin reduced (red shift) (Lee and 
Song, 2002, Cho and Song, 2000).  These changes and difference in results with 
different proteins may reflect differences in the effect of radiation on proteins with 
different structures (Lee and Song, 2002, Cho and Song, 2000). 
 
The changes in the secondary structure caused by radiation can be clearly seen by 
comparing ellipticity values (measured by circular dichroism) of irradiated and control 
proteins (Lee and Song, 2002).  The spectrum of native myoglobin has a typical α-
helical structure, which has a negative minimum ellipticity values at 207 and 221nm, 
and a positive maximum at 193 nm (Cho and Song, 2000, Lee and Song, 2002).  
Myoglobin consists of eight helices that surround the haem group (Lee and Song, 
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2002).  However, gamma-irradiation clearly affected the CD-spectrum and disrupted the 
globin fold (Lee and Song, 2002).  The ellipticity values at 207 and 221nm increased 
with increasing radiation dose (Cho and Song, 2000, Lee and Song, 2002).  This 
indicates that gamma-irradiation at the level of 1000krad can alter the native function of 
a protein (Cho and Song, 2000, Lee and Song, 2002). 
2.1.3.6 Effect of radiation on dried biological materials 
 
There have been far fewer experiments carried out on dried biological materials than 
with materials in solution, and for this reason the effects are less well understood.  In all 
of the studies found during the preparation of this review it has been found that dried 
materials are much more resistant to damage by radiation than material in solution.  For 
example, studies on bovine and porcine powders, soy isolate and whey protein 
concentrate have found no significant change in the molecular weight profile or CD-
spectra of these materials after they were irradiated at doses above 1000krad (Lee et 
al., 2003, Cho and Song, 1999).  This indicates that while water is present the 
generation of oxygen and peroxide radicals is responsible for almost all radiation 
damage to proteins, and that when water is removed there is no other mechanism 
which causes large amounts of damage (Lee et al., 2003). 
 
Two studies have been carried out on the effect of gamma radiation on freeze-dried 
antibodies.  Caballero et al. (2004) and Grieb et al. (2002) both exposed freeze-dried 
antibodies to gamma radiation sources both alone and in the presence of a free radical 
scavenger.  Caballero et al. (2004) found that while no changes in the antibody could be 
observed by chromatography or UV-Spectroscopy, only 5% fragmentation of antibodies 
could be detected by high performance liquid chromatography at a dose of 500kRad.  In 
addition, free radicals could be detected in the antibody samples by electron 
paramagnetic resonance, and these were found to be stable for periods exceeding nine 
months.  However they did not carry out standard biological techniques such as an 
immunoassay or gel electrophoresis on the samples.   
 
Grieb et al. (2002) irradiated freeze-dried antibodies at 1.5Mrad and 4.5Mrad, and then 
carried out immunoassays on the samples.  They found that without a free radical 
scavenger a 1.5Mrad dose reduced the binding affinity of the antibody by three orders 
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of magnitude, and no binding activity remained after a 4.5MRad exposure (Grieb et al. 
2002).  In contrast, when ascorbate was present at an initial concentration of 200mM, 
no significant difference in the binding affinity of the antibody could be detected at either 
1.5Mrad or 4.5Mrad.  Furthermore, a detailed analysis of the structure of the antibody 
before and after radiation indicated that there was no alteration in the proportion or 
structure of the heavy and light chains, and that no changes in secondary structure 
could be detected after irradiation (Grieb et al., 2002).  This is a key observation for the 
potential inclusion of an LMC on the ExoMars mission, since it demonstrated not only 
that the antibodies can survive the mission radiation environment, but also that Gamma 
radiation could be used to sterilise the antibodies to meet the planetary protection 
requirements provided an antioxidant e.g. ascorbate is present. 
 
2.1.3.7 Tests involving biological materials in space environments 
 
In addition to the testing of biological materials for sterilisation purposes, some 
experiments have been carried to determine whether active Life or bacterial spores can 
survive the radiation environment in space, to provide evidence for or against the 
possibility of lithopanspermia, see for example Horneck et al. (2001) and references 
within.  This is because bacterial spores are one of the hardiest known forms of life, with 
samples of genus Bacillus spores having been shown to survive extreme desiccation, 
extremes of temperature and high vacuum environments including up to 6 years in 
space on the LDEF mission (Horneck et al. 2001).  However, when bacterial spores are 
exposed to the full spectrum of solar UV radiation in the laboratory (>170nm) 99% of the 
spores are killed within seconds (Horneck et al., 1984 as cited in Horneck et al., 2001).  
This was confirmed in an experiment on one of the ESA BIOPAN missions (BIOPAN-5) 
by spore samples which were exposed to the space environment with no shielding; in 
samples which initially contained 7 x 107 viable spores, less than 120 spores remained 
viable after exposure to approximately 7500rad.   
 
The lithopanspermia hypothesis is based on the transfer of meteorites between 
planetary surfaces.  In order to determine whether the meteorite material could provide 
radiation shielding from the solar UV radiation and therefore enable the survival of 
bacterial spores in space, Horneck et al. (2001) exposed bacterial spores either 
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shielded by or mixed with Mars analogue soils, ground meteorites and ground terrestrial 
rocks.  It was found that bacterial spores mixed with these materials had far greater 
survival rate than spores exposed directly to the solar UV flux, with up to 105 times more 
spores remaining viable after exposure (~80% of the original spore count).  This was 
comparable with the results for ground control samples, and provides strong evidence 
that bacterial spores within meteorites could be sufficiently shielded from the solar UV 
flux to allow transfer of Life between Earth and Mars (or vice-versa) by lithopanspermia 
(Horneck et al., 2001).   
 
2.1.3.8 Results from tests on Life Marker Chip components 
 
Testing of the basic components of a LMC assay was carried out during the work 
reported in this thesis.  Fluorophores have been exposed to a proton beam (Thompson 
et al,. 2006) (see Chapter 3). These tests showed that these basic components 
(antibodies and fluorescent dyes) in freeze-dried form are capable of surviving radiation 
doses from protons in excess of those expected during a mission, verifying the design 
approach of using reagents in freeze dried form. Tests exposing antibodies and 
fluorophores to Gamma-rays exposure were carried out and are also reported in 
Chapter 3.  Testing these components under neutron sources is planned for the near 
future but is not reported in this document. 
 
2.1.3.9 Planetary protection and effects of sterilisation on Life Marker Chip instruments 
 
As described in section 2.1.1.4, the Life Marker Chip must be sterilised to a level such 
that total spore count is ≤300 m-2 and the total spore burden does not exceed 3.0x105. 
Therefore any molecular or biological components of an instrument must therefore 
survive at least one of the approved procedures used to reach this level of sterilisation.  
The standard methods used to achieve this sterilisation (Mahaffy et al., 2004, 
DeVincenzi et al., 1996, DeVincenzi et al., 1984) include: 
 Dry Heat (125°C for 5 hours or 110°C for 50 hours) 
 UV 
 Gamma-ray  
 Chemical cleaning with hydrogen peroxide plasma 
 Precision cleaning with sterile wipes. 
Paul Kerr Wilson                                                          Literature Review: The Effect of Extreme Environments on Biological Materials 
Development of Life Marker Chip Technology for in-situ Life Detection on Mars  Page 28 of 206 
All the above methods are likely to be incompatible with the use of biologically based 
receptors as all techniques will damage or destroy biological material. It is not just the 
molecular receptors or fluorophores (if used) that may be affected but the bonding of 
any compounds to surfaces, or even the surfaces themselves where their surface 
properties may be changed (as described in section 2.1.1.6).  The incompatibility of 
antibodies with dry heat sterilisation has been tested and verified within this thesis in the 
context of freeze dried reagents, as it was hoped that these may have proved more 
robust to heating than reagents in liquid form.  These experiments are reported in 
section 3.1.    
 
One is left with the problem of how such a device may be sterilised.  The only viable 
route is sterilisation of optics, micro-fluidics, and LMC detectors by one of the above 
methods, with sterilisation of reagents and solvents via ultra-filtration (or possibly 
gamma irradiation), followed by assembly in an aseptic environment.  These limitations 
and approach requires any such instrument being integrated into the spacecraft rover 
only after any spacecraft terminal sterilisation procedure such as dry heat.  This 
approach has been taken as the baseline approach for the future LMC development 
programme. 
 
2.1.3.10 The likely effects of temperature 
 
Temperatures experienced during a mission fall into five areas: 
 
 Temperatures during pre-launch integration into the ExoMars Rover and final 
testing and storage 
 Temperatures during the time that the payload is under the rocket fairing 
immediately prior to and during launch 
 Temperatures during cruise to the target 
 Temperatures during entry, descent and landing 
 Temperatures on the surface. 
 
All the above temperature regions need to be taken into account. 
 
Temperatures during pre-launch integration and testing are unlikely to exceed normal 
laboratory conditions except in the case of qualification tests, which will be dealt with 
under surface temperatures. Care must be taken to allow for temperatures under a 
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rocket fairing, as most launch sites are in regions of high (~40°C) or low temperature.  
The potentially high temperature must be considered in the LMC design unless the 
fairing temperature is controlled by air conditioning. 
 
Temperatures during cruise are likely to relatively benign dependant on the thermal 
design of the spacecraft and may be slowly varying. It should however be noted that if 
an RTG/RPS is used that locally high temperatures may exist close to the unit unless 
care is taken with design of any cooling loops which are required to dissipate excess 
heat during the cruise. Typically temperature limits during cruise are not expected to 
exceed the surface constraints e.g. Mars Science Laboratory (MSL) (see MSL PIP 
2004).    
 
Any instrument designer and mission planner should allow for possible heat soak-back 
into a probe during its entry, descent and landing stage of the mission. High 
temperatures incompatible with the instrument could be generated for a limited time. 
 
The largest temperature challenge to the instrument will be the temperature regime on 
the target planet / moon, so for example on Mars a large number of repeated freeze 
thaw cycles (perhaps hundreds in terms of a long lived (RPS powered) mission) will be 
encountered with temperatures cycling from sub-zero ~-40°C to small or even large 
positive temperatures.  MSL expects temperature cycling of between limits of -40°C to 
+50°C with a diurnal cycle of ±20°C at the payload interface over a Martian year (MSL 
PIP, 2004). 
 
Allowance must be made for these cycles both in terms of design i.e. containers for 
reagents that have sufficient volume to allow for freezing of reagents including water to 
the effects on the biologically based components themselves. Tests of the effects of the 
this freeze–thaw are currently planned in the near future, however given the positive 
effects of freeze drying highlighted in terms of radiation sensitivity it is expected and 
hoped that this will not be a problem where freeze–dried reagents are utilised. 
 
Operation of any LMC instrument will require temperatures to be raised to such a level 
that liquid solvents can flow which requires careful thermal design of the instrument, 
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such temperatures will however be within typical laboratory levels and are not expected 
to be a design driver. 
 
2.1.3.11 Other Effects 
 
Any instrument will need to be delivered several months prior to launch and then must 
survive the cruise to the target which may be several years, even in the case of a Mars 
mission e.g. two years for ExoMars (Vago et al, 2003). The effects of long–term storage 
of reagents will also need to be addressed prior to flight of any instrument. On-going 
tests (Steele, 2005, private communication) indicate that long-term storage may not be 
an issue.  
2.1.3.12 Conclusions and Implications 
 
In this section the studies carried out on the potential to utilise biological materials for 
astrobiology missions involving extreme radiation environments has been reviewed.  
The radiation environment for a mission to Mars as proposed for the LMC instrument on 
board ExoMars has been characterised, both by in-situ measurements of the flight 
radiation dose by the NASA MARIE group, and by predictions using models as 
HZETRN and SPENVIS.  Both ExoMars and Mars Science Laboratory indicated at the 
time of these experiments that the minimum requirement for instruments to survive was 
a total ionising radiation dose of approximately 3krad, and a non-ionizing energy loss of 
between 5 x 107MeV/g and 3.2 x 1010 1MeV neutrons (equivalent to between 0.80 to 
512.6rad in air) (ESA, 2005, MSL PIP, 2004).  For comparison, the typical gamma 
radiation dose to achieve sterilisation is 1.5 – 4.5MRad (Grieb et al., 2002), illustrating 
that a gamma radiation sterilisation protocol would involve a significantly greater 
exposure to ionising radiation than the mission itself.  Later figures indicate a slightly 
greater ionising and non-ionising radiation exposure during the mission (Alex Hands 
and David Rodgers, QinetiQ, Personal Communication), but this does not invalidate the 
experiments carried out in this document due to the large over-tests and sterilisation 
dose exposures. 
 
The majority of studies on biological materials in radiation environments to date have 
been carried out on proteins in solution using gamma radiation; little research has been 
carried out using UV and particle radiation, extreme temperatures or freeze-dried 
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materials.  It is found that proteins in solution are significantly affected by gamma 
radiation, depending on a number of factors: exposure can result in specific or non-
specific fragmentation, aggregation and structural changes down to the secondary 
structure level.  Even though these effects can be reduced by the presence of free 
radial scavengers, active material in a sample is still lost and antigenicity may not be 
retained, rendering the materials unsuitable for biological assays in conditions 
resembling those required for astrobiology applications. 
 
 
The few studies that have been carried out on freeze-dried antibodies and proteins in 
the presence of free radical scavengers have shown that these effects are considerably 
reduced, an effect ascribed to the removal of damage caused by the ionisation products 
of water.  The possibility that antibodies survive gamma radiation exposure is a strong 
indication that the use of biological materials in astrobiology missions such as ExoMars 
may be possible.  Although some material may be rendered inactive and some radicals 
can remain stable under freeze-dried conditions for considerable periods of time, further 
investigation is required to determine more precisely the conditions the can be tolerated 
while maintaining a functional biological assay.  Some of this work has been carried out 
in the work reported in this document, and is described in chapter 3.  
2.1.4 Summary 
 
This section has focussed on describing the radiation and sterilisation environments the 
reagents proposed for use in the SMILE Life Marker Chip must tolerate, and literature 
relating to the effects of these environments on proteins, antibodies and fluorescent 
dyes.  Further research into previous work on the effect of these environments on other 
reagents such as any solvents or buffers that may be required or surface immobilisation 
chemistry has not been reviewed as yet, though there are expected to be few studies 
and few if any effects observed.  The materials selected for the optical waveguide and 
supporting microfluidic structures must also be tolerant to these environments.  In 
section 2.2 and 2.3 the requirements of the detection system and technologies capable 
of meeting those requirements will be reviewed.   
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2.2 The analytical problem and likely biomarker targets for the LMC  
2.2.1 Introduction and background to this review 
 
To outline the requirements of the detection system, this section is a brief discussion of 
the target molecules of interest to indicate the range and types of molecules that are 
relevant for detection by the LMC.  The next key area for the LMC to discuss the 
potential target molecules that such an instrument could detect.  Since the focus of the 
work reported in this document is the development of the instrumentation platform and 
not the individual assays for each target, the purpose of this section is to illustrate that 
there are a range of potential astrobiology targets relevant for detection by the LMC and 
describe the process by which the final range of targets will be selected, rather than to 
produce a final list of targets for the flight instrument and a detailed discussion of each 
target and its relevance to astrobiology. 
 
Although many members of the astrobiology scientific community have published 
opinions on what type of Life may exist on Mars, and how one might go about detecting 
it, prior to the work of the SMILE LMC consortium there was no single reference source 
discussing all approaches to the detection of Life on Mars or listing suitable targets, 
especially for antibody-based assays (Parnell et al. 2006).  Parnell et al. (2006) state 
that, “Numerous publications list, in general terms, the compound classes that should 
be sought. These place emphasis on amino acids, carboxylic acids, fatty acids, sugars, 
pigments, and cell membrane constituents/derivatives as a whole.  However they do not 
conclude a list of specific molecules or prioritize them.” Examples include publications 
by Mahaffey et al. (2004), Buch et al. (2003), Schweitzer et al. (2000), Westall et al. 
(2000), and Simoneit et al. (1998).  This was the reason that the Biomarker Workshop 
(Leicester, May 24-26th, 2006) was held, i.e. to take these potential target molecules 
and classes and prioritise them in terms of relevance not only to the LMC but to other 
Life detection instrumentation on the Pasteur payload. 
 
One of the core early objectives of the TRL Upgrade Study was to identify a range of 
astrobiology target molecules and class of molecules of scientific relevance and suitable 
for an instrument based on an antibody-based assay.  This was achieved through the 
two-day Biomarker Workshop, during which leading members of the astrobiology 
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scientific community, representatives from the European Space Agency and members 
of the SMILE consortium (including the author of this thesis) discussed the range of 
organisms that could potentially exist or have existed on Mars, classes of molecular 
marker both ubiquitous to Life and representative of specific classes of organisms, the 
effect of the environment and oxidative / radiation environment on these targets and the 
likely classes of breakdown products, and availability or likelihood of being able to 
produce antibodies to detect these molecular markers.  In addition, molecular markers 
suitable for control assays, molecular indicators of spacecraft contamination and 
meteoritic organic material were discussed, and linking some targets to those that could 
be detected by other instruments in the Pasteur Payload were also discussed.  The 
principal aim of the workshop was to generate a priority list of potential targets for the 
Life Marker Chip based on scientific relevance and feasibility to include in the flight 
instrument. 
 
The results of this Biomarker Workshop are pending publication (Parnell et al., 2006).  
While the author of this thesis was present at the workshop, he is not named on this 
publication due to not achieving full academic status at the time of publication.  Since 
this publication is by far the most useful and relevant reference source for this section of 
the literature review and this author was involved in the Biomarker Workshop on which it 
is based, the pending publication will be the main reference source in this section.  Non-
referenced statements not present in the draft publication are either the consensus of 
opinion of the astrobiology community or the authors own views.  
 
2.2.2 Types of Life and Strategy for Life Detection 
 
Although Life may potentially exist based on a wide range of different chemistries, the 
current strategy for Life detection is based primarily on water and carbon-based 
chemistry.  This is appropriate particularly to the Life Marker Chip, since in order to raise 
antibodies against a specific target, the target must be of known structure, have suitable 
chemistry to bind to proteins and be soluble in aqueous solutions at suitable 
concentraitons. In addition, recent evidence from the NASA Mars Exploration Rovers 
suggests that at one time in the history of Mars large areas of the surface were covered 
by liquid water, for a sufficient timescale that all rocks studied in areas where this 
Paul Kerr Wilson                                                 Literature Review: The Analytical Problem and Likely Biomarker Targets for the LMC 
Development of Life Marker Chip Technology for in-situ Life Detection on Mars  Page 34 of 206 
occurred have been altered by water in some way and that the depth of water-altered 
rocks extends for several tens of metres below the surface (Parnell et al., 2006, 
Harland, 2005).  Indeed, very recent observations indicate that there may be periodic 
flows of water in craters on the Martian surface even to the present day (Malin et al., 
2006). 
 
There are four possible scenarios that can be considered in the search for Life on Mars 
(Parnell et al., 2006): 
 Life never evolved on Mars, so any organic molecules present are simply 
accumulated from meteoritic in-fall and altered by the radiation and geological 
environment on the surface. 
 Life originated at a common point in the solar system, and was transferred 
between Earth and Mars by a meteoritic impact of sufficient magnitude that 
ejecta (containing early life forms) from one planetary surface was transported to 
the other planet – a process known as lithopanspermia (Mileikowsky et al. 2000).  
In this case the basic biochemistry of Martian and terrestrial life would be 
expected to be similar, since Life on both planets would have evolved from a 
common ancestor. 
 Life evolved independently on Earth and Mars.  In this case since it is known that 
the two planets had similar characteristics in their early history, organisms with 
similar biochemistry may have evolved independently – a theory known as 
convergionism (Parnell et al., 2006, Malin & Edgett 2000, Westall et al., 2002, 
Morris, 2003).  Alternatively, Life on other planets including Mars could have 
evolved with a completely different biochemistry, perhaps not even carbon-
based.  This alternative theory is known as divergionism (Darling, 2002). 
 Terrestrial contamination e.g. from spacecraft surfaces could prevent or cast 
doubt upon results indicating the detection of any Martian Life by providing false 
positive signals. 
In all of these cases, particularly to test for contamination of the spacecraft and the 
possibility that lithopanspermia has occurred, it appears that the initial approach of Life 
detection with the LMC should be to attempt to detect molecular targets similar to those 
that would indicate the presence of Life on Earth (Parnell et al., 2006, Schweitzer et al., 
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2005).  This is a key finding for this work, since it validates the approach of using 
antibodies to specific molecular targets based on terrestrial Life for the ExoMars LMC.   
 
The range of environments in which terrestrial life is known to exist is continually 
expanding.  Organisms have been found to survive and grow in high radiation 
environments, temperatures ranging from –7° to 115°C and at extremes of pH.  The 
discovery of these „extremophile‟ organisms raises the possibility that if Life did evolve 
on Mars, it could potentially survive to the present day by similar adaptations to those of 
existing organisms on Earth (Parnell et al., 2006, Malin & Edgett 2000).  This is also a 
key finding, since if this is the case there may be active Life on Mars today, and 
therefore indicators of extant Life are required for the LMC. 
2.2.3 The advantages of antibody-based assay systems 
 
Antibodies are capable of binding to a specific target, which may be either an entire 
molecule or a particular area of a molecule (epitope).  This property of antibodies can 
be utilised in the selection of biomarker targets for the LMC, by in some cases selecting 
an antibody that only binds to a specific molecules within one class, and in other cases 
selecting the antibody to bind to an epitope common to an entire class of targets of 
interest (Schweitzer et al., 2005).  The Viking mission indicated that oxidation reactions 
take place in the Martian regolith.  Such oxidation reactions may have degraded any 
molecular biomarkers, from past Life in particular.  There are a number of features 
which are common degradation products of biomarkers of particular types, for example 
a single common end-product or a structure common to a class of biomarker that is 
preserved throughout the degredation reactions (Parnell et al., 2006).  The selection of 
appropriate antibody epitopes could enable such common structures to be used to 
identify classes of molecule present, or to identify a specific molecule within a class.  
The particular antibody epitopes chosen for certain biomarkers is therefore important for 
the LMC.  Therefore, some of the targets selected in the pending publication by Parnell 
et al. (2006), are classes of molecular biomarker with similar or common elements in 
their structure, rather than individual specific molecules (Parnell et al., 2006). 
2.2.4 Effects of the Martian environment on Biomarker preservation and stability 
 
The cold dry environment of present-day Mars is conducive to the preservation of 
molecular fossil remains of extinct Life, since degradation by oxidation reactions cannot 
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occur at a high rate.  However, once the regolith sample is dissolved in an aqueous 
solution and raised to a higher temperature, oxidation may occur due to the presence of 
oxidising agents.  This may be overcome by the addition of an antioxidant, e.g. 
ascorbate, to the buffer, which would prevent oxidation reactions and is compatible with 
antibody-based assays (Parnell et al., 2006, Grieb et al., 2002, Simoneit et al.,1998). 
 
Another major factor affecting the preservation and possible presence of Life on or near 
the Martian surface is the radiation environment.  The radiation arises from a number of 
sources and has different penetration depths below the surface.  UV radiation and Solar 
Energetic Particles (SEP) only penetrate to a depth of ~30cm.  Galactic Cosmic Rays 
penetrate to a depth of approximately 300cm.  There may also be radioactive minerals 
within the Martian regolith, which would create a background level of radiation.  In terms 
of the effect of this radiation environment on the possibility of extant Life being present 
on Mars, the key conclusion drawn by Parnell et al. (2006) was that the UV radiation 
flux is the only environmental factor that would render active Life at the surface 
unviable.  This UV flux and resulting damage to organic materials would also be 
expected to degrade many potential biomarkers within the uppermost 10cm of aeolian 
dust / regolith, although stable degradation products such as organic acids and salts 
may be present and large meteorites may provide sheltered sites at some locations 
(Parnell et al., 2006).   
 
2.2.5 Sample site selection and the advantages of sub-surface drilling 
 
An important feature of the Mars surface environment is that at depths greater than 
10cm UV radiation is no longer present.  In addition, some localised sites may have 
surface coating of evaporite minerals that can absorb UV radiation, and would provide 
an environment with increased preservation of organic biomarkers and possibly 
supportive of extant life (Amaral, Martinez-Frias & Vázquez, 2005). Therefore, the 
radiation environment at depths greater than 10cm are more suitable than the surface 
environment for the preservation of some organic species of interest for the Life Marker 
Chip.  Since the ExoMars rover is to be equipped with a drill capable of extracting 
samples at depths up to 200cm below the surface, by direct drilling and selection of 
samples sites in appropriate locations it appears possible to extract samples that have 
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not been damaged by UV radiation (Parnell et al., 2006, Vago et al., 2003).  It is true 
that a 200cm drill would not reach material below the penetration depth of GCR unless 
an eroded area was discovered.  The level of GCR radiation may be sufficient to have 
inactivated any micro-organisms at a depth of 200cm if they have been dormant and 
exposed to the GCR flux for over 450,000 years, although more recently exposed areas 
may allow viable organisms to be found (Dartnell et al., 2007).  Martian surface erosion 
rates are currently unknown but are estimated to be within the range 1 – 20nm.yr-1 
(Parnell et al., 2006).  Importantly, active cratering due to meteoritic impact has been 
observed on Mars in the present day (Malin et al., 2006), exposing new surfaces and 
potentially allowing access to regolith material not exposed to GCR radiation for long 
periods of time (and therefore possibly containing viable organisms), should ExoMars 
be fortunate enough to land near enough to a location where this has occurred. 
 
While there are a range of local environments that are believed to be of interest for life 
detection, the molecular targets for the Life Marker Chip remain very similar for all 
sample sites due to the degradation of molecular targets by the environment particularly 
the radiation environment at the surface of Mars (Parnell et al., 2006, Simoneit et 
al.,1998). 
 
2.2.6 Potential Biomarker targets 
 
The complete list of Biomarker Targets produced by the Biomarker Workshop is 
included in section 2.2.7.   The principles behind the selection of these targets and 
typical examples will be given below. 
 
2.2.6.1 Indicators of extant Life 
 
Since there are environmental factors that would contribute to the rapid breakdown of 
amino acids, proteins and many other cellular components, if any of these were 
detected particularly in the upper layers of the surface this would indicate the presence 
of extant Life as they would have to be replaced by active Life.  To maximise the range 
of organisms that could be detected very general targets have been identified, such as 
adenosine tri-phosphate (ATP) and the molecular chaperone protein GroEL 
(chaperonin-60) (Parnell et al., 2006). 
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2.2.6.2 Indicators of extinct Life 
 
Indicators of extinct Life will only be found in the subsurface, where they may have been 
present for more than 3 billion years.  Over this length of time, the GCR radiation may 
have degraded the organic materials through the formation of free radicals and 
contributing to oxidation reactions. The detection of extinct Life would therefore be 
indicated by the detection of radiolytic / oxidation degradation products of proteins, fatty 
acids or other cellular components.  If these were detected in the absence of any 
indications of current Life, that would suggest that Life had once evolved on Mars but 
was no longer active.  As for indicators of extant Life, indicators of extinct Life have 
been selected for biological ubiquity but additionally with stable degradation products 
that are common to the degradation products of many biomarkers.  Typical molecules in 
this class of targets include hopanes and isoprenoids (Parnell et al., 2006),  
 
2.2.6.3 Indicators of the presence of organic material of meteoritic origin 
 
Since meteoritic in-fall is the original source of most organics unaltered by the Martian 
environment, it would be prudent to include some target molecules specific to unaltered 
meteorites to verify the detection of material from this source.  Since organics present of 
meteorites are not of biological origin, many more structural variations have been 
detected – for example on the Murchison meteorite over seventy-five types of amino 
acids have been detected of which only eight are used by Life on Earth.  This range of 
structural variation occurs because where Life is present the synthesis of specific amino 
acids is catalysed by the biochemistry of the organism(s), whereas in meteoritic organic 
chemistry no biological catalysis has taken place so all possible structural variations of 
amino acids are produced according to their energy requirements alone.  Typical 
examples in the biomarker list include isovaline and aminoisobutyric acid.  There are 
also variations of polyaromatic hydrocarbons (PAHs) that are specific to meteorites and 
could be used by the Life Marker Chip for the purpose of confirming the presence of 
meteoritic organic material (Parnell et al., 2006). 
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2.2.6.4 Indicators of spacecraft contamination 
 
Spacecraft contamination has to be considered for planetary protection as described in 
section 2.1.1.4, but also for the LMC some of the target biomarkers, particularly for 
current Life, may originate from contamination and cast doubt upon other results.  A key 
implication of this is that it would be difficult to differentiate between the detection of 
spacecraft contamination and Life with a common ancestor i.e. originating from 
lithopanspermia, because the basic biochemistry of these organisms would be expected 
to be similar.  To ensure that false positives can be identified, it is proposed to include 
antibodies corresponding to the most common species of bacteria in terrestrial 
environments, and those specifically associated with spacecraft / clean room.  This will 
be achieved using either antibodies against specific species or some highly specific 
targets indicative of these species.  The specific example species cited by Parnell et al. 
(2006) are Staphylococcus (57, A), Streptococcus (58, A), Bacillus (59, A), Micrococcus 
(60, A) and Pseudomonas (61, A).  In addition a fuel marker such as hydrazine will be 
included, dependent on the type of fuel used by the spacecraft (Parnell et al., 2006). 
 
2.2.7 Biomarker Workshop target list 
 
The biomarker target list (Table 2.2) produced by the Biomarker Workshop is included 
below in a tabular form (Parnell et al., 2006). The table includes data on the name, type 
and biological significance of the target molecule, whether it is polar or a-polar (i.e. 
which mode of extraction is appropriate for this target – see section 2.2.7 for a 
description of the possible sample extraction methods), molecular mass, oldest 
occurrence on Earth (to give an indication of whether this target indicates past or 
present Life, or both), whether this molecule is known to form abiotically i.e. in the 
absence of Life, and the radiation sensitivity of the target where known, to indicate 
whether breakdown products may be found and the lifetime of the molecule in the 
Martian environment. 
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Table 2.2.2: List of Biomarkers (and their properties) Identified during the Biomarker Workshop, grouped into categories of  indicators of Extant Life, Extinct Life, Spacecraft Contamination and Meteoritic 
organics. 
Target   Biomarker Molecular type Polar Molecular Biological Oldest Abiotic Radiation 
Category       Molecule Mass Significance Occurrence Origin Sensitivity 
              (where known) Known?   
No. Priority       No. of daltons         
Extant                   
1 A ATP Phosphate Yes 505 energy extant only   moderate 
2 A Phosphoenolpyruvate Phosphate Yes 185 energy extant only   moderate 
3 B Acetyl phosphate Phosphate Yes 162 energy extant only   moderate 
4 C cyclic AMP Phosphate Yes 323 signalling extant only   moderate 
                    
5 A 
Generic pyrimidine 
base Nucleobase Yes thy 124 Information   yes? moderate 
6 A Generic purine base Nucleobase Yes ad  135 Information   yes? moderate 
7 A DNA Nucleobase Yes macromolecule Information >100000 years   moderate 
                    
8 A Nicotinamide Vitamin Yes 122 electron transfer   Yes moderate 
    (generic  NAD, NADP)     NAD 685 electron transfer       
9 C Flavin Vitamin Yes 239 electron transfer     moderate 
    (isoalloxazine ring)               
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10 C Fe-S centres redox centre Yes 176-352 electron transfer   Yes moderate 
11 C Quinones electron transport No generic ~200 electron transfer   Yes lower 
12 B Generic carotenoid Pigment No ~ 150(chain),  
200 (chain plus 
cyclic),   
B carotene 536  
light harvest >million years   higher 
13 C Phycocyanin Pigment No 
~150 (ring),  
whole 525 light harvest million years?   moderate 
14 C Thiol Esters Ester Yes CoA 786 energy     moderate 
15 A Generic porphyrin Porphyrin No 310 electron transfer     lower 
16 B Chaperons Protein Yes 
E.coli GroEL 
65000 stress protein extant only?   moderate 
17 A ATP Synthase Protein Yes 52000 Enzyme extant only?   moderate 
                    
18 B Phytane Ihydrocarbon No 282 archaeal lipid 2.7Ga   higher 
19 A Fatty acids (1  or 2) Carboxylic acid Weakly stearic 284 bacterial lipid  
(18 bio, 19 not) 
>million years Yes higher 
20 A Teichoic Acid Amino acid +  
phosphate 
polymer 
Yes ribitol P ~ 612 Gram +ve wall     lower 
21 A LPS Macromolecule Yes macromolecule Gram -ve wall     lower 
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22 B Ectoine 
Compatible 
solute Yes 142 
osmotic 
protectant     moderate 
23 C Trehalose 
Compatible 
solute Yes 342 
osmotic 
protectant     moderate 
                    
24 B Squalene Hydrocarbon No 410 lipid biosynthesis  
(isoprenoid 
precursor) 
    higher 
25 C Diploptene Hopanoid No ~ 370? 
bacterial 
membrane     moderate 
26 B Melanoidins Macromolecule No macromolecule       moderate 
                    
    
Sediment/cell 
extracts:               
27 C 1. Acid mine drainage Multiple Some N/A whole cells     lower 
28 C 2. Methanogens Multiple Some N/A whole cells     lower 
29 C 3. Cyanobacteria Multiple Some N/A whole cells     lower 
30 C 4. Mars Energy Users Multiple Some N/A whole cells     lower 
31 C 5. Extract/abiotic mix Multiple Some N/A whole cells     lower 
                    
Extinct                   
32 A Generic isoprenoid Hydrocarbon No 142-563 Chlorophyll, 2.7Ga   moderate 
Paul Kerr Wilson                                                 Literature Review:  The Analytical Problem and Likely Biomarker Targets for the LMC 
Development of Life Marker Chip Technology for in-situ Life Detection on Mars                     Page 43 of 206 
33 A Pristane Hydrocarbon No 270 
quinones,  
archeal 
membranes 
2.7Ga   higher 
18 B Phytane Hydrocarbon No 284 2.7Ga   higher 
34 A B-carotane Hydrocarbon No 559 
Fossil 
carotenoids 1.7Ga   higher 
35 C Tetramethyl benzenes Hydrocarbon No >204 
Fossil 
carotenoids 1.7Ga If <C15 lower 
36 C 
Tetramethyl 
cyclohexanes Hydrocarbon No >210 
Fossil 
carotenoids 1.7Ga If <C15 moderate 
37 C Squalane Hydrocarbon No 422 Membranes  
(prokaryotes) 
1.7Ga   higher 
38 A Generic ABC terpane Hydrocarbon No   2.7Ga   lower 
39 A Generic hopane Hydrocarbon No >370 2.7Ga   lower 
40 C Gammacerane Hydrocarbon No 412 1.7Ga   moderate 
41 B Generic diasterane Hydrocarbon No >372 Membranes  
(euks & 
prokaryotes) 
2.7, not 1.7Ga   lower 
42 C Generic sterane Hydrocarbon No >372 2.7, not 1.7Ga   lower 
43 A Generic porphyrin Porphyrin No 460-500+   ?   lower 
    (ancient)               
44 A Generic Straight-chain Carboxylic acid Weakly 256-300+ Membrane 100s Ma Yes higher 
    Fatty Acid               
19a,b A 
2 individual Fatty 
Acids Carboxylic acid Weakly 256-300+ 18 bio, 19 not 100s Ma Yes higher 
45 A Generic amino acid Amino acid Yes       Yes higher 
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46 B 
Quaternary carbon 
alkane Hydrocarbon No   Origin unclear 2.2Ga   higher 
                    
Meteoritic                   
47 A Napthalene Hydrocarbon No 128 N/A   Yes higher 
48 A Coronene Hydrocarbon No 300 N/A   Yes lower 
49 B Pyrene Hydrocarbon No 202 N/A   Yes moderate 
50 A 1,3 Dimethylbenzene Hydrocarbon No 106 N/A   Yes higher 
51 A 1,4 Dimethylbenzene Hydrocarbon No 106 N/A   Yes higher 
45 A Generic amino acid Amino acid Yes   N/A   Yes higher 
52 A OR isovaline AND Amino acid Yes 117 N/A   Yes higher 
53 A a-aminoisobutyric acid Amino acid Yes 103 N/A   Yes higher 
54 B Generic aromatic  Carboxylic acid Yes   N/A   Yes lower 
    carboxylic acid               
55 A Experimental abiotic Complex     N/A   Yes lower 
                    
Contaminants                   
56 A Generic fungal     N/A Fungal     higher 
20 A Teichoic Acid Amino acid + 
phosphate 
polymer 
Yes ribitol P ~612- Cell wall Gram 
+ve 
    higher 
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21 A LPS Macromolecule Yes macromolecule 
Cell wall Gram -
ve     higher 
57 A Staphylococcus Bacterium genus   N/A whole bacterium     higher 
58 A Streptococcus Bacterium genus   N/A whole bacterium     higher 
59 A Bacillus Bacterium genus   N/A whole bacterium     higher 
60 A Micrococcus Bacterium genus   N/A whole bacterium     higher 
61 A Pseudomonas Bacterium genus   N/A whole bacterium     higher 
62 A Dipicolinic acid Carboxylic acid Weakly 168 spores     lower 
63 A Hydrazine Base Yes <110 (Fuel)     moderate 
    (or equivalent)               
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2.2.8 Implications of the biomarkers target list for the LMC sample processing system 
 
Since the range of target molecules of interest extends from the very polar to to very a-
polar, including hydrocarbons with extremely low solubilities in water e.g. PAHs, 
hopanes, the optimum sample processing and extraction system could be to split the 
sample in two and perform both aqueous and a-polar extractions.  In this case the 
sample processing system may become very complex, and considerations of the effects 
of solvents from the sample processing system being carried through into the biological 
assay chamber would need to be considered (Parnell et al., 2006).   
 
2.2.9 Summary of the analytical problem 
 
All of the evidence suggests that large areas of the Martian surface were once covered 
by liquid water.  The similarities in environment of the early Earth and early Mars, 
coupled with the possibility that Life could have been transported to or from Mars via 
panspermia indicate that aqueous based organic biomarker targets are the most 
appropriate molecular indicators for the Life Marker Chip to target as the initial approach 
to Life detection.  It has been established that the Life Marker Chip would be an 
appropriate instrument to detect a range of targets in many sampling environments, and 
a priority list of which target classes could be included in the flight instrument has been 
generated.  The important points arising from this is that due to differences in the 
chemical properties of the classes of target molecules, it is apparent that each Martian 
sample will require two assay channels; one dedicated to the detection of water-soluble 
targets (largely indicators of extant life) and one for a-polar molecules (largely indicative 
of past life or meteoritic organic material).  There are a number of target molecules of 
very high priority interest in each class, and the final sample volume will be low, so the 
proposed micro-array assay format in a microfluidic channel appears to be the most 
efficient way to detect all the targets of interest simultaneously.  In the following section, 
the current state of instrumentation technology on which the Life Marker Chip design is 
based will be reviewed. 
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2.3 Multianalyte sensor technologies for microlitre-scale sample volumes 
2.3.1 The SMILE solution and evolution of the instrument design concept 
 
In order to meet the requirements for detecting at least some of the wide range of 
molecular indicators of Life described in sections 2.2.6 and listed in Table 2.2.2, the 
proposed SMILE detection system will be capable of simultaneous detection of 
approximately 25 specific target biomarker molecules that could indicate the presence 
of extinct or extant life on planetary surfaces.  This will be carried out by the extraction 
and subsequent analysis of any organics within rocks on the Martian surface and at 
varying depths down to 2m below the surface.  At the current time, the Life Marker Chip 
Sample Processing System design is based on receiving ~1g of material the form of a 
dried powder with a maximum particle size of 40μm.  This sample will be split equally 
into two sample processing chambers, one for water-soluble biomarker targets and one 
for a-polar targets.  Each of these processing lines will incorporate a concentration step 
such that all of the target molecules available for extraction from the 0.5g of material will 
be concentrated into a volume of a few microlitres.  The two sample types will then pass 
into single use assay channels dedicated to the targets relevant to the extraction 
method, and the protein microarray assay format used to detect a number of relevant 
targets in each sample simultaneously.   
 
During the course of the work reported in this document the proposed design for the 
LMC instrument has been continuously evolving.  The initial concept proposed for the 
Pasteur Payload was outlined in a publication by Sims et al. (2005), but the design has 
subsequently become more refined.  The initial broad concept was a fluorescence / 
surface plasmon resonance dual readout system that utilised the specific molecular 
recognition properties of both antibodies and molecular imprinted polymers.  This was to 
be achieved by creating a microarray of approximately 100 spots of molecular 
receptors, each approximately 100µm in diameter, within a microfluidic channel system 
on a gold-coated optical waveguide (Sims et al., 2005).  Later developments have 
included removing molecular imprinted polymers from the design concept for two 
reasons, namely their relatively poor lower limits of detection compared to antibodies, 
and the wider range of well established immunoassay formats and labelling techniques 
available for antibody assays.  In addition, later work has focussed primarily on 
fluorescent readout alone rather than a dual readout system, due to the increased 
complexity and mass requirements of the dual readout design.  The current design is 
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therefore an antibody microarray within a microfluidic channel system mounted onto an 
optical waveguide with a fluorescent readout.  The readout is proposed to be based on 
a low light level CCD chip due to the potentially low levels of fluorescence and high 
signal/noise ratio of these devices.  In the final device it is proposed to use thin film 
optical waveguides rather than bulk waveguides since thin film waveguides have a more 
intense evanescent field than a bulk waveguide if the same amount of light passes 
through them, and therefore they would yield a higher signal.   
 
This section is a review of the different technologies used in multi-analyte detection 
systems that demonstrate the current state of technology in carrying out antibody or 
protein binding assays within microfluidic channels, in order to highlight the areas of 
established technology and those which required further development during the on-
going SMILE Technology Readiness Level Upgrade study, and the preceding and 
overlapping PhD study. 
 
2.3.2 Introduction to relevant analytical methods and technologies 
 
The growing pressure to increase throughput, reduce sample volumes and lower the 
price per test while maintaining high sensitivity and throughput has led to considerable 
effort towards, and some success in, the miniaturisation of classical immunological 
binding assays and chromatographic and electrophoretic separation methods 
(Weinberger et al., 2000, Duveneck et al., 1997).  However, these methods are limited 
in flexibility by their analytical speed, the requirement for serial throughput, moderate 
sensitivity and difficulties in coupling the separation methods with the detection 
systems.  These newer methods which enable multiple analytes to be tested 
simultaneously are becoming increasingly more important (Weinberger et al., 2000). 
 
While a number of targets have been detected simultaneously in ELISA format, the 
principal technologies being developed in multianalyte sensing are solid-phase based, 
fabricated by the immobilisation of a range of capture molecules at a distinct location on 
the sensing surface, and simultaneous analysis of all of these regions (Joos et al., 2001, 
Weinberger et al., 2000).  Highly sensitive multispot and multianalyte immunoassays 
were demonstrated over ten years ago, and the huge potential to address these needs 
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in diagnostic applications was recognised (Joos et al., 2001, Etkins et al., 1990, Etkins, 
1989). 
 
One of the most promising developments in multianalyte sensing is microarray 
technology, which has been applied mainly in DNA chips, and more recently protein 
chips (Song et al., 2004, Joos et al., 2001, Weinberger et al., 2000, Duveneck et al., 
1997).  The equipment use for both the preparation and reading of microarrays is now 
commonplace, with products available from over 100 companies, and can be used to 
fabricate both DNA and protein microarrays (Joos et al., 2001). 
 
Multianalyte sensing is the simultaneous detection of a number of different target 
molecules from the same sample and thus inherently involves the analysis of complex 
sample media. This in turn requires both recognition elements with very high specificity 
and binding affinity for their targets and a detection system with a very high signal to 
noise ratio (Duveneck et al., 1997).  The most commonly used recognition elements 
used in ligand binding assays are monoclonal antibodies immobilised on the sensor 
surface.  Monoclonal antibodies are preferred over polyclonal antibodies in these 
applications due to their higher specificity.  This is true for a number of different types of 
analytes including proteins, peptides and low-molecular weight molecules.  Alternative 
methods such as phage-display techniques are being developed to rapidly produce 
synthetic binder molecules with high affinities for their targets, but these have not yet 
reached the stage of replacing antibodies in most applications (Joos et al., 2001, Lecerf 
et al., 2001, Ryu & Nam, 2000).  This is principally because while a number of readout 
techniques such as fluorophores, radioisotope and enzyme labelling are well 
established with antibodies, this is not the case with other binding molecules (Joos et 
al., 2001).   
 
Since there is a wide range of potential target molecules for the LMC (see section 
2.2.7), different assay methods may be more effective for certain targets.  In addition to 
the advantage that more advanced labelling methods available with antibody assays, 
the range of assay formats that can be used is more advanced.  A number of 
competitive and non-competitive immunoassay methods have been developed and are 
commonly used to increase the specificity and sensitivity of immunoassays for specific 
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applications (Joos et al., 2001).  Therefore, in order to have greater flexibility in the 
assay system to optimise the assay for all targets, antibodies are currently preferred to 
molecular imprinted polymers for the SMILE LMC. 
 
The readout systems of choice for multianalyte sensing are optical sensors of various 
types, because these have the potential for easier fabrication, higher chemical stability 
and lower risk of exterior interferences than sensors based on electrical or piezoelectric 
transducers (Benini et al., 2006, Duveneck et al., 1997).  Techniques based on 
evanescent field analysis are highly suited to microarray spot analysis because they 
inherently analyse only processes occurring at the sensor surface.  This is because the 
strength of the evanescent field exponentially decreases with distance from the surface, 
limiting the penetration depth into the target solution to 100-150nm (Joos et al., 2001, 
Weinberger et al., 2000, Duveneck et al., 1997).  This surface-specific analysis is a 
major advantage of evanescent field sensing, as it means that species interaction in the 
bulk solution is not included in the analysis (Benini et al., 2006, Joos et al., 2001).  Once 
again, the advantages of evanescent field sensing over other transducer systems were 
considered in incorporating this method into the proposed LMC design. 
 
There are many optical readout systems that have been applied to waveguide or near-
field sensing, and therefore could be applied to the analysis of fluorescent microarray 
spots on a waveguide (Duveneck et al., 1997).  The most successful methods thus far 
are surface plasmon resonance (SPR), direct measurement of fluorescence by CCD 
imaging, fibre-optic evanescent field sensors, and optical waveguides utilising 
evanescent field excitation of fluorophores coupled to a CCD imaging system (Joos et 
al., 2001, Weinberger et al., 2000).  The final method is said to have greater sensitivity 
than other evanescent field sensing systems (Joos et al., 2001, Rowe et al., 2000, 
Rowe et al., 1999), consequently the most recent work on the SMILE LMC has 
focussed on evanescent field sensing of fluorescently labelled targets bound to the 
surface by antibody-antigen interaction. 
 
While the selection of methodology was made in the proposed LMC design before the 
work in this thesis began, it is of interest to discuss the reasons behind this selection.  
The evanescent field sensing methods can be divided broadly into two groups, those 
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based on fluorescence (using labels) and those which do not use fluorescence (label-
free) (Duveneck et al., 1997).  The principals and advantages of each of these 
approaches will be discussed below.   
 
2.3.3 Surface refractive index based sensors 
 
The principal advantage of using surface bulk property detectors such as surface 
plasmon resonance or grating couplers over fluorescence-based sensors is that they 
detect the target molecule directly, and do not require labels.  The signal obtained is 
related to the mass of material adsorbed to the sensor surface, and therefore can be 
affected by non-specific binding.  This can be a significant problem in multi-analyte 
sensors, as some biomolecules have multivalent binding characteristics i.e. they can 
bind non-specifically to unrelated array positions, and in doing to reduce the sensitivity 
of the device below the desired operating concentration level.  Consequently the 
development of array sensors based on label-free surface affinity methods has proved 
to be problematic (Weinberger et al., 2000, Duveneck et al., 1997).   
 
2.3.4  Detection systems utilising fluorescently labelled components 
 
The driving force behind the development of miniaturised fluorescence-based sensors 
had been the increasing demand for multiplexed bioanalytical technologies, including 
but not limited to genomic and proteomic microarrays.  The principle advantage of 
fluorescence-based detection schemes over refractive index based sensors is specific 
analysis of any given target and extremely high sensitivity, regardless of the size of the 
target molecule (since the readout is based on detection of a fluorescent label) 
(Weinberger et al., 2000, Rowe-Taitt et al., 2000, Duveneck et al., 1997).  The principle 
disadvantage of an immunoassay with a label-based readout is that only target 
molecules which can bind to the specific antibodies used, i.e. only known target 
molecules, can be detected, whereas other methods can identify organic species that 
would not expected to be present in a given sample (Weinberger et al., 2000).  The high 
specificity and sensitivity still make fluorescence-based detection systems the method 
of choice for the Life Marker Chip, due to the likelihood of any target molecules present 
to be at very low concentrations, in the parts per billion range (Vago et al., 2003).   
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As fluorescent-based detection based on optical evanescent field sensing has been 
selected for the design of the proposed SMILE Life Marker Chip, the development and 
principles of the different methods and applications will be described below.  The most 
fundamental component is an optical waveguide, so the discussion will be split into two 
sections according to the two basic waveguide types. 
 
2.3.5 Multi-mode (bulk) Waveguides 
 
The term „waveguide‟ encompasses a number of types of waveguide, but in this review 
it will be used in reference to either multi-mode (bulk) waveguides, a typical example of 
which is a commercial quality microscope slide, or mono-mode (thin film) waveguides.  
Both of these types of waveguide are described in this section.  Optical waveguides 
allow light to travel along them provided that the light is contained within the waveguide 
by total internal reflection (TIR) at the surface of the waveguide.  TIR occurring at the 
waveguide surface generates an evanescent field, which can be utilised to excite 
fluorophores bound to the sensor surface by specific receptors, and the light emitted 
can be recorded by a detection system in order to analyse binding events at the surface  
(Weinberger et al., 2000, Feldstein et al., 1999).  Use of the evanescent field method 
ensures that the signal obtained is specific to the surface of the sensor and not the bulk 
properties of the sample, and when optimised can give excitation intensities up to a 
hundred times greater than that of other techniques such as confocal excitation (Joos et 
al., 2001, Weinberger et al., 2000).  However, with a bulk waveguide this high excitation 
intensity is difficult to achieve since most of the light is contained within the waveguide 
and only a small proportion of light is present in the evanescent field (Feldstein et al., 
1999).   
 
Creating a set of conditions which enable a high evanescent field strength (and 
therefore high sensitivity) to be produced while keeping the optical parameters within 
the range required for total internal reflection is not straightforward (Feldstein et al., 
1999, Benini et al., 2006).  The difficulty is created because the conditions required for 
TIR are limited and dependent on many parameters, including the wavelength and 
incidence angle of the excitation light and the refractive index of both the waveguide 
material and the surrounding medium.  In addition, the refractive index of the waveguide 
must be higher than that of the surrounding media (Feldstein et al., 1999, Benini et al., 
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2006).  For a given waveguide and medium, the critical angle below which TIR will not 
occur is given by a special case of Snell‟s Law, which states that Sinθ1n1 = Sinθ2n2 
where θ is the angle measured from the surface normal and n1 and n2 are the refractive 
indices of the surrounding medium (low refractive index) and the waveguide material 
(high refractive index) respectively (i.e. n1<n2) (Feldstein et al., 1999).
 
 
For the case shown on the right, Sinθcn1 = Sin90n2 
Therefore Sinθcn1 = Sn2 
and Sinθcritical = n1/n2 
 
However there is also an inverse relationship between evanescent field penetration 
depth (dp) and the optical incidence angle (θ): 
dp = 1 / ((n2/n1)
2sin2θ – 1)2 
This means than while the evanescent field penetration depth increases with reducing 
angle of incident light the angle cannot be reduced below a critical value otherwise TIR 
will no longer occur.  For an air-glass interface this angle is ~40° and for a water-glass 
interface it is ~67°.  Both the penetration depth and the critical angle are dependent on 
the refractive indices of both the waveguide and the surrounding medium (Feldstein et 
al., 1999, Benini et al., 2006).   
 
There are a number of possible solutions to this.  One is to optimise sensitivity with a 
bulk waveguide and suitable detection system, as while this is not ideal it still has 
advantages over other methods.  Rowe et al. have demonstrated this in the form of an 
array immunosensor for both clinical analytes and biohazardous reagents in a sandwich 
immunoassay format.  In this case discreet regions of biotinylated antibodies were 
deposited onto avidin-coated waveguides to form specifically orientated immobilised 
capture molecules, which were then exposed to fluorescent-labelled targets and 
visualised using a 635nm diode laser with a CCD based imaging system (Joos et al., 
2001, Rowe et al., 2000, Rowe et al., 1999). 
 
Methods used to further enhance the sensitivity of waveguide based optical readout 
methods, and overcome the difficulties described above, include the application of 
θc 
n1 
n2 
Waveguide 
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tapered waveguides and mono-mode waveguides (which are described in the next 
section), both of which are designed to increase the penetration depth of the 
evanescent field while maintaining the incident light within the waveguide (Feldstein et 
al., 1999). 
2.3.6 Mono-Mode (thin film) Waveguides 
 
The development of mono-mode waveguide technology enabled a further increase in 
the sensitivity and lower limits of detection of this method (Duveneck et al., 1997).  This 
is because for the same amount of light transmitted, a mono-mode waveguide has a 
greater amount of light in the evanescent field, and therefore a greater amount of 
fluorescence is generated from fluorescent labels at the surface.  The disadvantage of 
mono-mode waveguides is that they are very thin and it is more difficult to achieve 
efficient coupling of light in to the waveguide (Duveneck et al., 1997).  Additionally, in a 
multi-mode waveguide the distribution of optical power between optical modes, and 
therefore amount of fluorescence at the surface, can vary.  This cannot happen in a 
mono-mode waveguide, so fluorescence intensity is more reproducible (Benini et al., 
2006) 
 
A mono-mode waveguide is fabricated by the deposition of a thin film (typically 150-
300nm) of high-refractive index material such as Ta2O or TiO2 onto a transparent base 
material with a lower refractive index, typically glass or plastic.  The precision required 
for this deposition process makes mono-mode waveguides relatively expensive.  In 
addition optical coupling of the light from the surface into the waveguide is more difficult 
in a thin-film waveguide than a conventional (multi-mode) waveguide.  Light will enter a 
multi-mode (bulk) waveguide if it is directed towards the edge face of the waveguide at 
an angle within the waveguides numerical aparture, making bulk waveguides fairly 
tolerant to slight misalignment.  However a thin film waveguide normally requires a 
diffraction grating or prism to efficiently couple light into the waveguide, necessitating 
much more precise construction (since the light source must be accurately aligned with 
the diffraction grating).  A diffraction grating allows areas of over a square centimetre to 
be homogeneously illuminated. This area is ideally suited to analysis by imaging, which 
is typically achieved by the use of CCD camera arrays which provide high sensitivity 
and readout times of less than a second (Joos et al., 2001, Weinberger et al., 2000, 
Feldstein et al., 1999).  In this way, highly sensitive miniaturised immunoassays can be 
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performed on a large number of analytes simultaneously using a very small sample 
volume, which is precisely the type of assay that is required and proposed for the 
SMILE Life Marker Chip. 
 
However, in order to make the best use of space for the LMC, it will be necessary to 
perform several assays on each waveguide, which will involve the attachment of a 
microfluidic system to the waveguide surface.  The addition of separate flow cells to 
waveguide surfaces complicates the development of these sensors, as any object in 
contact with the waveguide surface reduces the magnitude of the signals and therefore 
reduces the sensitivity.  There are two main causes of this reduction in performance, 
firstly the flow cell would be in optical contact with the waveguide so light would be 
coupled out of the waveguide and into the flow cell material, so the intensity of incident 
light is reduced.  Secondly light that entered the flow cell would be scattered in all 
directions including towards the detector array, so the level of system noise would be 
greater (Feldstein et al., 1999).  There are two possible solutions to such a problem.  
The most common is to use the low refractive index material covering as one surface of 
the microfluidic system.  An alternative is to use a reflective cladding layer to contain 
light within the waveguide until it reaches the area with the immobilised reagents (as 
described by Feldstein et al., 1999).  The former is the approach adopted in the design 
of the Life Marker Chip; specifically the waveguide is to be fabricated into a silicon chip, 
and a protective silicon layer covers the waveguide and forms the surface of the 
microfluidic channel until the area that will contain the microarray of immobilised assay 
reagents.  A window will be cut into the protective layer over this assay area, allowing 
the evanescent field to excite any labelled assay reagents that bind to the microarray 
spots.   
 
Normally microfluidic channel structures for use with optical waveguides are fabricated 
using polymer structures, as shown by Rowe et al. (1999, 2000).  However, for 
biological applications there are many advantages to the use of silicon microfluidics 
based on photolithography fabrication methods (Whitesides, 2006, Mitchell et al., 2004), 
including ease of attachment of the microfluidic structure to the waveguide and more 
reliable adhesion in aqueous environments within the temperature range compatible 
with surfaces coated with a functional protein (Rowe-Taitt et al., 2000).  Such 
microfluidic devices in silicon can be fabricated such that the microfluidic structure and 
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optical waveguide are a single unit in direct contact with one another, so have very 
similar refractive indices (Mitchell, 2004).  The Life Marker Chip design is based on 
mono-mode waveguides with integrated microfluidics in order to utilise all of these 
advantages over polymer based systems, namely increased compatibility with biological 
assays, improved adhesion and better optical properties due to the similar refractive 
indices of the materials.  In addition, very few polymeric materials are acceptable for 
space flight missions due to the potential for out-gassing of trapped gaseous 
polymerisation products. 
 
With the SMILE Life Marker Chip design therefore being primarily based on silicon 
mono-mode waveguide microfluidic devices, the next consideration is methods of 
producing the multianalyte sensing region and reviewing the current state of 
development of multianalyte sensors in microfluidic channels. 
 
2.3.7 Methods of Creating Multi-Analyte Sensors 
 
In addition to the well-established and accepted method of photolithography, there are 
two methods used to create multi-analyte sensors; physically isolated patterning (PIP) 
and the use of microarray spotting robots (Feldstein et al., 1999). 
 
PIP is based on the deposition of antibodies or antigens onto the waveguide surface 
using a poly(dimethylsiloxane) (PDMS) multiple flow cell template, which contains 
channels of 0.75-1.5mm width.  This template can be used to immobilise lines of 
substrate across the waveguide, and as PDMS forms a watertight seal with the 
waveguide surface the lines can be clearly separated without applying large pressure to 
the template or the waveguide.  However the pressure applied must be tightly controlled 
as PDMS deforms under pressure, and this must be a uniform deformation if a uniform 
batch of sensors is to be produced (Feldstein et al., 1999).  This method is not 
applicable to the production of high density arrays, since it requires a mask that 
physically separates the reagents for each spot and this is not established technology 
for spot sizes of the order of 100μm, as proposed for the LMC (see section 2.3.1).  The 
method will therefore not be expanded upon in this document. 
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2.3.8 Surface functionalisation 
 
In order to take full advantage of a highly sensitive detection system, the target analyte 
must be stably immobilised to the sensor surface in a functional state and accessible to 
the binding molecule.  There are a number of methods that have been used to achieve 
this, including surface modification with silanes, photo-immobilised polymers and self-
assembled monolayers (Weinberger et al., 2000 Brovelli et al., 1999, Pawlack et al., 
1999),  and immobilisation to native surfaces by physical adsorption.  Having selected a 
silicon-based waveguide and microfluidics system i.e. silicon oxide surfaces, the first 
surface functionalisation protocols considered for the LMC were based on silanes (see 
chapter 5), since these are routinely carried out on glass surfaces with similar chemical 
properties to silicon oxide.  This has the advantage of creating a covalent attachment as 
well as being well established in the literature and a relatively straightforward laboratory 
procedure. 
 
2.3.9 Imaging Systems 
 
There are a number of variations in the imaging systems used to capture and analyse 
signals obtained from fluorescent planar waveguides, and these will be discussed 
briefly.  The most important component of these imaging systems is an imaging 
detector, typically in the form of an array of charge-couple devices (CCDs) which may or 
may not be thermoelectrically (Peltier) cooled.    Peltier cooling reduces the background 
noise and interference in the image at the cost of making the device more complex 
(Feldstein et al., 1999, Rowe et al., 1999, Ligler et al., 1998).  Filters are placed over the 
CCD array to block out any scattered excitation light.    In some systems a lens array is 
included to focus the image onto the CCD array, enhance fluorescence capture 
efficiency and minimise the size of the sensor (Feldstein et al., 1999, Golden, 1998).  
The images produced are then analysed by averaging the fluorescent intensity over 
each spot and using this average to determine the level of binding that has occurred.    
Very low concentrations of analyte are typically distinguished from noise by the use of 
an intensity cutoff value (Feldstein et al., 1999).   
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2.3.10 Gas-chromatography-mass spectrometry  
 
Gas-chromatography-mass-spectrometry (GCMS) is the gold standard for multianalyte 
sensing and trace organic detection with large sample volumes, and is becoming 
increasingly developed for low volume applications.  It is therefore extremely well suited 
to applications in Life detection such as the analytical problem for biomarkers described 
in section 2.2.  Indeed, there will be a mass spectrometer on board the ExoMars Rover 
alongside the LMC and Urey instruments.  However, mass spectrometry cannot detect 
entire proteins or larger organic biomarkers, so although there will be some shared 
targets with the LMC for the purposes of multiple confirmations of particular biomarkers, 
the antibody assay format allows the detection of additional higher mass targets. 
 
2.3.11 Summary of Literature Review on technologies for the simultaneous detection of 
a number of different analytes using microlitre-scale sample volumes 
 
A number of methods and technologies have been developed for multianalyte sensing 
using small sample volumes, which are the requirements of the technology platform on 
which the SMILE Life Marker Chip must be based.  The three main technologies that 
are most commonly used for this purpose are gas chromatography mass spectrometry, 
surface plasmon resonance and optical waveguides.  The most developed of these 
technologies are fluorescence-based detection of analytes on thin film (mono-mode) 
optical waveguides.  GCMS is also well developed and will be included on board the 
ExoMars mission. 
 
Channel systems have been used on mono-mode waveguides, and this does not 
significantly affect the sensitivity provided an appropriate cladding layer is used to 
prevent loss of light from within the waveguide.  The detection system is usually based 
on charge-couple device (CCD) imaging system, as these have a number of 
advantages over alternative imagines system, including greater sensitivity, lower limits 
of detection and ease of miniaturisation. 
 
The SMILE LMC is currently proposed to be based on a biological receptor assay for 
detection of analytes on thin film mono-mode silicon wafer optical waveguide, utilising 
evanescent field excitation and imaging of the emitted fluorescence with a cooled CCD 
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chip.  This design combines the advantages of the most relevant, sensitive and specific 
approaches to multianalyte sensing found in the literature, but the combination of the 
proposed technologies and methods has not been demonstrated in existing work.  A 
number of elements of the proposed LMC instrument design have also been shown to 
have been used in microfluidic devices to assay very small sample volumes.  
Fluorescent optical biosensor devices are known to be capable of achieving high 
sensitivity, so the requirements of performing a multiplexed assay on microlitre-scale 
sample volume may be met with the proposed Life Marker Chip technology.   
 
Since the proposed Life Marker Chip design appears to be a logical development from 
current analytical technology in this area, it appears feasible to produce an instrument 
capable of space-flight with the required analytical capability for Life detection.  In the 
final section of this literature review, the environments in which the Life Marker Chip 
must function, and salts and solvents that may consequently be carried into the 
biological assay chamber, will be discussed.   
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2.4 Mars Geological Environments and Sample Related Media  
2.4.1 Review of the geological characteristics of the Martian surface relevant to Life 
detection, and reagents commonly used in sample processing and extraction. 
2.4.1.1 Introduction 
 
This section focuses on the chemistry of the Martian surface and reagents that may be 
considered in the sample processing and extraction system.  Since the design of the 
sample processing system is currently at a very early stage of development, this 
chapter does not describe in detail the system to be used, but briefly describes 
appropriate sample extraction methods and the types of reagent that may pass through 
into the Life Marker Chip assay area with these potential methods.  This literature 
review was used as the basis for developing experimental procedures to determine the 
effect(s) of Martian regolith salts on antibody assays, as while the potential 
environments are known no work has been done to determine whether antibody assays 
will function in the presence of these salts.  The results of these experiments are 
presented in chapter 5. 
 
2.4.1.2 Martian surface geology 
 
The first point to consider in this section is the geology of the areas that the ExoMars 
rover is likely to explore.  Observations from the Mars Express orbiter indicated the 
presence of hydrated magnesium and calcium sulphates on the Martian surface (Bibring 
et al., 2005), confirming the previous detection of sulphates during the Mariner 9 
mission (Clarke & Van Hart, 1981).   
 
Of greater relevance to the ExoMars Mission, the NASA MER Rover Opportunity has 
revealed that significant areas of the Martian surface and near-subsurface rocks 
accessible to ExoMars have been affected by water (Clarke et al., 2005).  This has 
been established due to the strong indications that the Meridiani Planum region 
contains substantial deposits of evaporite minerals formed only in the presence of 
water, particularly sulphates such as the epsomite form of magnesium sulphate 
(MgSO4·7H2O), Iron (III) sulphate in the form of jarosite (KFe3(SO4)2(OH)6), and calcium 
sulphate in the form of gypsum (CaSO4.2H2O) (Harland, 2005, Amaral, Martinez-Frias & 
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Vázquez, 2005, Clarke et al., 2005, Peterson & Wang, 2006).  The presence of these 
water-altered minerals is direct evidence that there was once a warmer, wetter period in 
the history of Mars during which life could have evolved (Clarke et al., 2005, Squyres et 
al., 2004). 
 
In addition to the formation of these minerals by water, there is also evidence that 
Martian salts have undergone paragenesis (mineral change over time) (Marion et al., 
2006, Clark et al., 2005).  Paragenetic processes of iron minerals, which are 
widespread on the surface of Mars, follow the following sequence on Earth:    
rock  ferrous sulfates  ferrous/ferric sulfates  ferric sulfates  ferric hydroxides  
ferric oxides. (Marion et al., 2006).  
This oxidation cannot be explained by the presence of sulphuric acid, which has 
previously been suggested as an oxidation source, since jarosite is stable in the 
presence of sulphuric acid (Marion et al., 2006).  It has been proposed that this 
oxidiation of iron occurred in liquid water that was present for long periods of time, 
providing support for the case for Life having evolved on Mars (Squyres et al., 2004).  
An alternative explanation for the oxidation of iron (III) jarosite minerals has also been 
proposed, based on the deposition of a volcanic ash and subsequent oxidation by 
gaseous sulphuric acid.  This gaseous sulphuric acid is formed by the reaction of water 
and sulphur dioxide emitted from fumaroles.  This could have occurred without the 
presence of standing water and at higher temperatures (McCollom & Hynek, 2005).  In 
either case, iron (II) minerals must be considered as a possible mineral constituent of 
ExoMars samples reaching the LMC. 
 
Jarosite is of particular significance for the Life Marker Chip since it has been proposed 
that it could function as an iron source for chemilithotrophic microorganisms on Mars, 
following the discovery of such organisms in the Rio Tinto river system, a site proposed 
to be an analogue for early Mars (Amaral, Martinez-Frias & Vázquez, 2005, Schweitzer 
et al., 2005).  In addition, it has been shown that even a 500μm layer of jarosite on the 
surface could shield microorganisms from UV radiation (Amaral, Martinez-Frias & 
Vázquez, 2005), which is critical for the preservation of Life since direct exposure to 
solar UV radiation is extremely harmful to even the most resilient of terrestrial 
organisms (Horneck et al., 2001). 
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Given the abundance of these minerals on the Martian surface and interest in Life 
detection associated with them, it is important for the development of the sample 
processing system to understand if the presence of these materials in the assay 
reaction chamber would have an adverse effect on the assay.  An adverse effect would 
not necessarily invalidate the Life Marker Chip approach, but may necessitate a 
demineralisation step in the sample processing system to remove mineral ions before 
they reach the assay chamber.  At the start of this work, the effects of these mineral 
salts on antibody assays were unknown. 
 
2.4.1.3 Sample processing system methods, reagents and solvents 
 
The second consideration regarding the effect of sampling on the antibody assay 
system is the possible transfer of organic solvents from the sample processing system 
into the assay chamber.  It is known that traditional monoclonal and polyclonal 
antibodies are not suited to function in non-polar solvents.  While modified recombinant 
antibodies may have an increased survival and performance, these are also not thought 
to survive and function in many non-polar solvents (Sims et al., 2005).  In addition there 
is the consideration that protein conjugates and fluorescently labelled control proteins 
that may be used for control spots or as a part of a competitive assay system must also 
be functional in the final solvent in which the assay takes place. 
 
As discussed in section 2.2.8, due to the desire to detect both polar and a-polar 
biomarkers, there are likely to be two independent sample extraction lines.  The first will 
be based on aqueous solvents and used to extract proteins and water-soluble polar 
biomarkers, while the second will use non-polar organic solvents to extract a-polar 
biomarkers.  Many of the most efficient methods to extract proteins from soil samples 
are based on guanidine-hydrochloride (see for example Simoneit et al., 1998).  Since 
this reagent at the high concentrations it is normally used at will denature any proteins it 
encounters, including antibodies, it may denature both some target molecules of interest 
and any antibodies it encounters (Schweitzer et al., 2005).  This is clearly not 
compatible with the Life Marker Chip, so the antibody assay must be tested with 
guanidine-HCl to determine the significance of any adverse effects.  Other extractions 
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based on phosphate buffers can be used instead of a guanidine-HCl extraction, but 
these are less efficient (Schweitzer et al., 2005). 
 
A typical organic solvent extraction of lipids and polyaromatic hydrocarbons from a soil 
sample is carried out in two stages; firstly the organic molecules of interest are removed 
by dissolving the sample in a mixture of solvents of different polarity, e.g. 
dicloromethane, methanol and phosphate buffer, and passing this solvent through a 
solid phase extraction cartridge to trap the target molecules in the solid phase.  In the 
second stage specific targets are eluted with a series of different solvents of increasing 
polarity, such as hexane, chloroform, acetone, ethyl acetate and methanol (Aga & 
Thurman, 1993, Fang and Findlay, 1996).  However, modifying this traditional approach 
to fit the mass and volume constraints of an instrument for space flight is not 
straightforward, partly due to the availability and selection of SPE columns of 
appropriate sizes and materials, and partly because the mass limits the number of 
different solvents that can be used. 
 
The proposal therefore is to use a single extraction medium in the a-polar extraction 
line, to capture as many targets of interest as possible simultaneously.  This may be 
achieved by combining a number of solvents as described in the first stage of lipid 
extraction by Fang and Findlay (1996) or by using a single organic solvent that provides 
the best compromise between extracting target molecules of interest and compatibility 
with the antibody assay system e.g. propanol (Buch et al., 2003).  Water-methanol 
mixtures are also being considered as previous work has shown that ELISA assays are 
tolerant to limited presence of methanol, dependant on the specific antibody-antigen 
pair (Aga & Thurman, 1993). 
 
2.4.1.4 Additional considerations 
 
In addition to the effect of dissolved mineral salts there is also the possibility that 
oxidants are present in the Maritan regolith, inferred by the failure of the Viking 
experiments to detect any organics (Klein, 1979, Parnell et al., 2006).  This is most 
commonly thought to be hydrogen peroxide (H2O2), but other oxidising species e.g. 
superoxide, hydroxide and perhyroxyl radicals have also been proposed.  Regardless of 
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the specific oxidising agent present, if oxidising species come in to contact with 
antibodies or other assay reagents they may damage them and disable the assay 
(Parnell et al., 2006).  To counter this possibility, an antioxidant such as ascorbic acid 
may be added to the assay buffer to prevent oxidising reactions (see section 5.3.3.2). 
 
2.4.1.5 Summary of possible environmental and sample processing reagents that may 
have an effect on antibody assays  
 
The likely target areas of interest for Life detection include areas of the Martian surface 
that contain rocks altered by the presence of water, including large deposits of evaporite 
minerals such as iron, calcium and magnesium sulphates.  At present the sample 
processing system for the Life Marker Chip is in the early design stage, but is likely to 
be based on standard solid phase extraction in which the sample is passed over a 
column that selectively binds to organic species of interest, then these species are 
removed from the column in a single stage with a single solvent (or combination of 
solvents).  Due to the extreme range of polarities of the target molecules of interest, two 
lines of extraction may be required, one for polar and one for a-polar targets (see 
section 2.2.8).  Examples of possible reagents and organics solvents that could be used 
in the sample processing system include guanidine-HCl, methanol and n-hexane, and 
these are the solvents used to test the effect of organic solvents on immunoassays in 
section 3.3.4. 
 
It is prudent prior to further development of the sample processing system to determine 
any limitations imposed on the sample extraction methods required by any effects of 
Martian regolith components or carry-over of solvents used in the sample extractions 
system on the assay.  Antioxidants may be required to counter and chemical reactions 
caused by the presents of oxidising agents in the sample.  Very little previous work has 
been done in this area, so the generation of experimental data to support the 
development of the LMC sample processing system is timely and will be explored in this 
thesis. 
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2.5 Literature Review Summary 
 
Four key areas of scientific interest and knowledge have been discussed in this 
literature review.  Firstly, we have considered whether it appears feasible to use an 
antibody-based assay in space due to the effects of radiation on the biological 
components of the assay, particularly proteins including antibodies.  The balance of 
evidence on studies using gamma radiation suggests that while antibodies in a liquid 
state are likely to be inactivated by radiation particularly at the levels required for pre-
flight sterilisation, antibodies in a dried state are much more stable since they cannot be 
attacked by the secondary radiolytic products of water.  Very little work has been done 
to study the effects of particle radiation on antibodies.  This is an area that is critical to 
the development of the Life Marker Chip and it was important at the time this study 
began that some initial experiments were carried out to validate the use of antibodies in 
space environments. 
 
The second area of importance, which includes sections 2.2 and 2.3 of this literature 
review, is the analytical problem to be addressed by the Life Marker Chip.  The 
Biomarker workshop held by members of the SMILE LMC consortium identified a large 
number of target biomarker molecules that would be of interest to the Life Marker Chip, 
many of which are beyond the detection capabilities of other instruments in the Pasteur 
Payload.  In order to detect as many of these targets as possible simultaneously with 
the likely amount of material available, it was proposed to utilise immunoassays in a 
microarray format within a microfluidic channel, that would enable the detection of up to 
25 different „targets‟ (as discussed in section 1.1.1), with each target being one epitope 
(some of which may be parts of a molecule allowing detection of an entire class of 
biomarkers) in any particular channel.  It was also recommended that each sample was 
divided into two, and different sample extractions performed on the two parts in order to 
achieve detection of both polar targets, mainly indicative of extant life, and a-polar 
targets, which are more closely linked to extinct life.  The most suitable technology 
available to base this instrument on appeared to be a fluorescent assay on a mono-
mode planar waveguide, since this type of instrumentation has extremely high 
sensitivity.  Previous work has also been carried out with fluorescent assays on planar 
waveguides within microfluidic channels, although not with the number of assay spots 
required for the Life Marker Chip assay.  Although the technology in this area is already 
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at an advanced stage, further development and optimisation of an instrument platform is 
required for the Life Marker Chip and was carried out during this thesis as part of the 
European Space Agency Technology Readiness Level Upgrade Study. 
 
The final area of importance is consideration of the effects of the Marian environment on 
the assay system, particularly with regard to the development of the sample processing 
system.  It is likely that target areas of interest for the ExoMars rover will include 
deposits of sulphates and evaporite minerals, including specifically magnesium 
sulphate, calcium sulphate and iron (II) and iron (III) sulphates, that are not normally 
present in biological assays.  The sample processing system may use guanidine-HCl 
and / or organic solvents in order to remove organic target molecules of interest from 
rock samples.  It is possible that these reagents may pass through the sample 
processing system into the assay chamber and therefore affect the assay in some way.  
Work is therefore required to determine what effects these salts and organic solvents 
may have on the assay so that the design of the sample processing system can be 
modified to prevent any harmful reagents reaching the assay chamber e.g. by addition 
of a demineralisation step or evaporation of organic solvents. 
  
In this chapter the current state of knowledge in the areas of literature relevant to this 
thesis has been reviewed.   In the following three chapters, the work carried out in the 
three key areas of work; radiation and pre-flight sterilisation, development of the 
instrumentation platform, and studies on the effect of Mars related media and sample 
processing of the assay system, will be reported. 
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Chapter 3: Exposure of Fluorescent Dyes and Antibodies to simulated Radiation 
and Sterilisation protocols1 
3.1 Introduction 
 
As discussed in section 2.1, a key unknown in terms of the use of antibody-based Life 
detection technologies in space is the effect of radiation and other environments 
associated with space missions.  The range of radiation environments encountered 
during a flight to Mars, includes gamma rays, protons, neutrons and heavy ions at 
energies ranging from a few MeV to thousands of GeV and beyond, peaking at around 
1 GeV (Benton, 2001).  Low energy radiation has a higher level of interaction with 
substances, while higher energy radiation can do significantly greater damage on the 
occasions when it does interact. 
 
In order to consider designing instrument for use on Mars, such as the Life Marker Chip 
to be included on the ExoMars rover, i.e. for use in these radiation conditions, it is 
necessary to understand the effects of this radiation exposure on both the individual 
components and the assembled device.  In the case of an optical biosensing system, 
many of the hardware components such as microfluidic systems and electronics can be 
designed based upon materials and systems that have been established as suitable for 
space flight in previous missions.  However, the critical biological components of the 
Life Marker Chip (LMC) have never been used in space before.  The effect of each 
radiation type and combinations of radiation effects therefore needed to be investigated 
and understood before significant instrument development was carried out, particularly 
ensuring that any effects of radiation on the peak emission wavelengths of fluorescent 
dyes, since this would affect the decision on appropriate dyes, light sources and optical 
systems.  The effect of radiation on antibodies is also critical since damage to 
antibodies could prevent or inhibit antibody-antigen interaction, and / or reduce the 
specificity of the antibody to its target. 
 
As described in section 2.1.1.4, planetary protection procedures are in place to prevent 
contamination of planetary surfaces with terrestrial Life and reduce the likelihood of 
false positive detection of extraterrestrial life due to spacecraft contamination.  This is 
implemented in the form of an acceptable “bioburden” which is measured by bacterial 
spore count per m2 of surface.  The acceptable bioburden varies depending on the 
potential of the spacecraft to come into contact with the planetary surface i.e. surface
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 rovers have a more stringent sterilisation requirement than orbiters.  For surface rovers 
on Mars, such as the ExoMars rover that will carry the Life Marker Chip, the bioburden 
of the material surfaces must be by six orders of magnitude during the pre-flight 
assembly of the rover.  (Mahaffey et al., 2004, Divincenzi et al., 1996,1984).  This is 
typically achieved by a dry heat sterilisation protocol, normally a minimum of 50 hours at 
120°C, as was carried out for the Viking missions (Mahaffey et al., 2004).   
 
The effect of this treatment on fluorescent dyes and antibodies at the time of this study 
was unknown, although it was considered highly unlikely that an antibody would survive 
such treatment.  The reason for this expectation is that antibodies are proteins with a 
highly complex structure, and much of this structure is held together by relatively low 
strength molecular interactions e.g. hydrogen bonding.  These weak molecular 
interactions are low energy bonds, and heating to high temperatures would be expected 
to destabilise these and so change the protein structure, thus inactivating any structure-
dependent binding.  Given the likely detrimental effects of heat sterilisation on biological 
materials, gamma irradiation is being considered as a potential sterilisation technology 
that may be more suitable for biological components than the dry heat method. 
 
 
In this section, the results of a series of experiments in which antibodies and fluorescent 
dyes commonly used as labels in biological assays were exposed to different types of 
radiation and a heat sterilisation procedure will be described and discussed.  As 
discussed in the literature review, prior to these studies very few studies had been 
carried out using gamma irradiation on antibodies, and we are not aware of any 
previous work in which fluorescent dyes have been exposed to gamma radiation.  
Similarly, we are not aware of any reported particle irradiation exposures of either 
antibodies or fluorescent dyes.  Therefore, in this section both the methods and the 
results are novel.  The results of a heat sterilisation tests are also included.  As far as 
the author is aware, no previous work has been carried out to determine whether 
antibodies and fluorescent dyes survive dry heat sterilisation procedures, although in 
the case of antibodies this is largely because it is considered unlikely that any specific 
binding activity would be retained. 
 
Since it is impractical to expose samples to all of the types of radiation encountered in a 
mission scenario simultaneously (there are no facilities capable of simulating the 
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complete spectrum of radiation types and energies simultaneously), the effect of each 
type of radiation was investigated, and will be reported, separately.   
 
3.2 Proton and helium ion exposures – introduction 
 
Proton and helium ion exposures were both carried out at Birmingham University using 
a cyclotron to generate a beam of either a protons or helium ions. This facility was 
selected because it is capable of generating an essentially mono-energetic particle 
beam (protons or helium ions) at any single energy between 9 and 35 MeV, and is 
capable of providing equivalent mission fluences of protons in a convenient timescale 
(however, the calculated mission fluences used are near the lower limit of the cyclotron 
facility‟s range).  The term fluence is used to describe the amount of protons that the 
sample is exposed to rather than dose, since dose implies that a known amount of 
radiation has been absorbed by the sample (while in the case of antibodies and 
fluorescent dyes the absorption characteristics are unknown).  The available range of 
energies using the cyclotron facility (9 to 35MeV) covers a significant proportion of the 
lower energies of particle radiation likely to be present during flight.  The most desirable 
energy range to study would be at 3 MeV or higher, since protons at lower energies are 
likely to be absorbed by the spacecraft shielding, and the lower energy radiation is 
expected to be more damaging.  However at the time of this study the cyclotron 
provided the best compromise between most appropriate energy range, availability and 
convenience of generating appropriate fluences of particles. 
 
It is worth noting that whilst Galactic Cosmic Rays (GCR) are generally much higher 
energy than the radiation used in these experiments, the actual Life Marker Chip device 
will be positioned inside the spacecraft where lower energy secondary radiation and 
fragments generated by GCR will play a large role.  The spacecraft shielding is likely to 
prevent much damage from the lowest energy radiation particles incident upon it from 
space, but an understanding of the effect of radiation on unshielded fluorescent dyes 
and antibodies is useful to know from a basic science viewpoint, and a “worst case” 
scenario in terms of the mission.  The effects of radiation shielding were therefore not 
considered when calculating estimated mission fluences of particle radiation for the 
tests reported in this thesis. 
 
Since the cyclotron facility generates mono-energetic proton beams, we1 were unable to 
produce an energy spectrum such as that one would expect the samples to see in 
Paul Kerr Wilson                               Exposure of Fluorescent Dyes and Antibodies to simulated Radiation and Sterilisation protocols  
Development of Life Marker Chip Technology for in-situ Life Detection on Mars                                  Page 69 of 206 
space. Instead we divided the energy spectrum into two parts; 9-35 MeV, and 35 MeV 
upwards. The SPace ENVironment Information System (SPENVIS) model (see section 
2.1.2.4) was used to calculate the total fluence of protons with energies lying within 
these two energy ranges for an Earth-Mars transit, basing the transit parameters on 
those suggested in the Mars Transportation Environment Definition Document 
(Alexander et al., 2001), which gives a 179-day Earth–Mars transfer period during the 
„on‟ season for solar particle events within the JPL model (Thompson et al., 2006). 
 
An “over test” philosophy was adopted where the exposure times were based on an 
integrated fluence over a large energy range, but the range of energies was replaced 
with exposure at a single energy (the lowest in the range). Noting that the cross-section 
for proton damage for example in water peaks at low energies ~0.1MeV we assumed 
using the lowest energy in the range would be potentially more damaging to the sample 
than if it were exposed to the same fluence using the range of (higher) energies. Given 
the cross-section of water to protons the beam was expected to penetrate significantly 
into the samples and distribute energy throughout the samples (Thompson et al., 2006). 
 
Cyclotron beam currents of 50pA and 500nA were used to achieve the required 
fluences.  Using these beam currents, which were the lowest currents at which a stable 
particle beam could be generated, it was not possible to expose the sample to 1X the 
mission fluence of protons.  This is because the exposure would take only 0.7 seconds, 
and the proton beam exposures could not be accurately controlled to achieve an 
accurate exposure of that timescale. The test samples were therefore exposed to 
various multiples of this basic fluence, namely 10X, 100X and 10,000X, including some 
very high exposures to enhance the “over test” principle adopted within this work.  In 
order to validate the exposures and assess the uniformity of the proton beam across the 
exposed area, radiochromic film was exposed to the same fluence of protons 
immediately after each sample exposure. 
 
3.2.1 Preliminary particle radiation testing  
 
The goal of this section is to expose representative biological materials for the Life 
Marker Chip, in the form of an antibody, and representative fluorescent dyes that may 
be used as labels in the Life Marker Chip immunoassays, to a series of proton and 
helium ion fluences.  The fluorescent dyes selected for the initial tests were fluorescein, 
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a commonly used dye in biological assays, and Alexa Fluor® 633, a modified rhodamine 
dye that is being considered for use in the Life Marker Chip due to it‟s resistance to 
photobleaching and compatibility with low mass light sources.  The antibody selected for 
proton radiation exposure was an anti-atrazine single chain recombinant antibody 
(scAb).  This antibody was selected as it is raised against a broadly similar target to 
many biomarkers i.e. a small organic compound, atrazine is extremely unlikely to be 
present on the surface of Mars so the assay could be used as a control assay in the 
flight instrument, and the anti-atrazine scAb was conveniently available as it was kindly 
provided to Cranfield University by Haptogen (Aberdeen, UK). 
 
Since these experiments were carried out and developed at the same time and using 
the same basic sample preparation techniques as the gamma irradiation studies 
reported in section 3.3, the changes in experimental protocol for these sections were 
made concurrently and the result sections refer to one another. 
 
3.2.1.1 Preliminary particle radiation testing – materials and methods 
 
 
As described in the introduction to this chapter, all proton and helium ion exposures 
were carried out at the cyclotron facility at the University of Birmingham.  At this facility, 
the selected energy level and current of protons generated leave the cyclotron though a 
1cm2 beam port (see Figure 3.1).  The particle beam could be „turned on and off‟ by 
moving a Faraday cup, which prevents protons entering the beam port when in the 
„closed‟ position.  The fluence could therefore be controlled by calculating the required 
number of particles for a particular exposure using the HZETRN model described in 
section 2.1.2.2, and using the beam current to calculate the time taken for the required 
number of particles to pass through the sample.  The Faraday cup was then removed 
from the beam path for that calculated time period and replaced when the exposure was 
complete. 
  
In order to expose multiple samples to the same radiation treatment, an 864 well 
microtitre plate (Helix BioMedical Accessories, Ramona, USA) was customised to fit 
onto the end mounting of the Cyclotron beam port such that a 3 x 3 well area could be 
held directly in the 1cm x 1cm particle beam.  This was done by drilling holes 
corresponding to the size and position of the spigots above and below the beam port 
(shown in Figure 3.1) in 4 locations across the microtitre plate (one location is shown in 
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Figure 3.2).  An additional 9 wells elsewhere on the plate, which were not in the beam 
line, were used as control wells (shown in Figure 3.2).  These wells were used to 
expose triplicate samples of antibodies or fluorescent dyes to proton radiation in this 
initial experiment. 
 
 
Figure 3.1: Cycloton beam port attachment used to mount samples in front of the 1cm x 1cm particle 
radiation beam 
 
Figure 3.2: Customised 864 well microtitre plate with 9-well sample and control areas marked 
 
In this initial experiment only fluorescein was used as an example of a fluorescent dye, 
since the Alexa Fluor® 633 dye is more expensive and it was desirable to have a greater 
understanding of the experimental procedure before using the more expensive dye in 
an experiment.  10μl of 0.5mg.ml-1 fluorescein (Sigma-Aldrich Poole, UK, Product Code 
32615) or 10μl of ~0.075mg.ml-1 anti-atrazine scAb (Haptogen, Aberdeen, UK) antibody 
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were pipetted into the two sample areas in a random known pattern.  The microtitre 
plate was then placed into a –80°C freezer for 4hours, then transferred as rapidly as 
possible (to prevent melting of the frozen samples) into a freeze-drier (Edwards 
Modulyo) and dried overnight.  After freeze-drying the microtitre plate was wrapped in 
aluminium foil, in an attempt to prevent material entering the wells while minimising the 
chance of electrostatic interactions removing material from an insulating cover, and 
transported to the University of Birmingham.  In order to minimise physical disturbance 
of the samples, the aluminium foil was left in place over the sample areas during the 
exposure, only pierced sufficiently to allow the microtitre plate to be mounted on the 
mounting rods (see Figure 3.3).  The assumption was made that this very thin layer of 
shielding would have little effect on the radiation exposure. 
 
 
Figure 3.3: Modified 864 well microtitre plate mounted on the cyclotron beam port.  The aluminium foil 
was left in place since it was considered difficult to remove it without disturbing the dried material in the 
samples and it would have a negligible shielding effect. 
 
The proton exposures were carried out using a cyclotron beam current of 5pA.  This 
equates to 2.12x107 protons per second.  The samples were exposed to two proton 
fluences, 1.38x1010 and 1.48x108 protons, taking 653 and 6-7 seconds exposure 
respectively.  These proton fluences are low compared to the expected mission fluence 
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discussed in section 2.1.2.4.  This is due primarily to a miscalculation of the proton 
fluences in this initial experiment.  However the experiment was continued as this error 
was realised at a very late stage, and it was useful to continue the experiment to 
validate and develop the protocol. 
 
After exposure, the microtitre plate was transported back to Cranfield University for 
analysis.  Each fluorescein sample was reconstituted in 15μl deionised water and 
transferred to an Eppendorf vial containing 850μl of RO water.  Each sample well was 
then washed 9 times with 15μl of deionised water, adding this water to its corresponding 
Eppendorf vial, to produce a final concentration of 0.05mg.ml-1 fluorescein.   
 
3.2.2 Fluorimeter analysis of Fluorescein and Alexa Fluor® 633 samples 
 
The fluorimeter used throughout this work was a Cary Eclipse Varian 
spectrophotometer.  The fluorimeter was controlled with Cary Eclipse Scan Software 
(version 1.0(78)).  In this first experiment only fluorescein was used, but the settings for 
Alexa Fluor® 633 are also included here as this protocol will be referred to in later 
sections. 
 
In all of these experiments, the software was used with the default settings with the 
following specific details and exceptions.  The excitation and emission slit widths were 
set to 5nm.  The photomultiplier tube gain for fluorescein was set to 600, and for Alexa 
Fluor® 633 it was set to 800.  For some samples, different photomultiplier tube gains 
were required to obtain a signal within the working range.  Where this was the case, the 
output signal was normalised.  This normalisation was based the experimental 
observation that the measured signal for a given sample doubled with a photomultiplier 
gain increase of 8%.   
 
The emission and excitation spectra of the dyes were both measured, and the peak 
wavelengths and intensities determined automatically by the software.  For fluorescein 
the excitation wavelength was scanned between 400nm and 510nm, (with emission 
measured at 520nm), and the emission wavelength was scanned between 500nm and 
600nm (with the excitation wavelength set to 488nm).  In the case of Alexa Fluor® 633, 
the excitation spectra was scanned between 550 and 650nm, (with the emission 
wavelength set to 650nm), and the emission wavelength was scanned between 635 and 
720nm (with the excitation wavelength set at 633nm). 
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The peak emission and excitation wavelengths and intensities were recorded and 
analysed in Microsoft Excel 2000. 
 
3.2.3 ELISA method  
 
All antibody assays were based on an ELISA, testing the antibody over a range of 
antibody concentrations, in order to observe changes in the shape and signal in the 
antibody binding curve.  This method was used throughout sections 3.1 and 3.3 
   
The ELISA method used was as follows:  
 
 Microtitre plates (Immulon 4 ELISA, Fisher Scientific, UK) were coated with BSA-
atrazine conjugate by adding 100 μl of 10 μg.ml-1 BSA-atrazine conjugate (kindly 
provided by Haptogen Ltd., Aberdeen, UK) in 10mm HEPES buffer (pH 7.4) to 
each well.  The plate was covered with aluminium foil and incubated overnight at 
20°C. (approximately 14 hrs). 
 
 The antigen solution was removed by flicking to empty and slapping the plate 
onto a bench surface covered with absorbent paper (Kimwipe) to remove 
residual liquid. 200 µl of blocking buffer (0.25g.ml-1 skimmed milk powder (Marvel 
brand) in HEPES buffer) was added to each well to block non-specific protein 
binding.  The plate was then incubated at 20°C for 4 hrs. 
 
 The blocking buffer was removed by flicking and slapping the plate.  The plate 
wells were washed twice with 200μl HEPES buffer, flicking and slapping the plate 
to remove the washing buffer. 
 
 100µl of the appropriate dilution of primary antibody sample (humanised anti-
atrazine scAb) was added to each wells. The plate was then incubated at 20°C 
for 2 hrs.  See below for details of preparation of test antibodies. 
 
 The plate wells were washed three times with 200µl of wash buffer (10mm 
HEPES buffer pH7.4 containing 0.05% Tween 20) followed by one wash with 
200µl of HEPES buffer.  
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 100μl of secondary antibody (anti-human C-kappa light chain (bound & free) 
labelled with horseradish peroxidase enzyme) (Sigma-Aldrich, Poole, UK) diluted 
1/1000 (from supplied stock) in HEPES buffer was added to each well, and the 
plate incubate for 1 hr at 20°C 
 
 The plate wells were washed three times with 200µl of wash buffer followed by 
one wash with 200 µl of HEPES. 
 
 One 3,3‟,5,5‟-tetramethylbenzidine (TMB) tablet was dissolved in 10ml of 0.05M 
citric phosphate perbonate buffer.  100μl of this solution was added to each well 
and allowed to develop a desired colour intensity (measured after 10 minutes at 
20°C). The reaction was stopped by adding 50μl of 1M H2SO4
 to each well. The 
plate was read at a wavelength of 450 nm using a Lab Systems iEMS Reader 
MF microtitre plate reader. 
 
3.2.3.1 Test antibody preparation methods 
 
During this thesis, antibody samples for ELISA were prepared in a number of different 
ways and then included in the protocol described in section 3.2.3.  This section 
describes how antibodies were prepared for the liquid control assays, antibodies 
exposed to radiation or heat treatments, and (as described in Chapter 5) ELISAs in 
buffers containing Martian regolith salts or organic solvents. 
 
Liquid control assays: 
 
Antibody serial dilutions were prepared in the desired concentration ranges, of which 
the first/highest anti-atrazin(e) antibody concentration was a 0.3mg.ml-1 solution of the 
anti-atrazine scAb in HEPES buffer. The subsequent antibody solutions were prepared 
by double-diluting the antibody across the plate (10 times) (with HEPES buffer). 
 
Dried antibody samples (for radiation, and heat sterilisation): 
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Dried antibodies were produced by adding a volume (typically 30 µl) of 0.3mg.ml-1 anti-
atrazine scAb to a plastic vial, and placing the vial(s) into a sealed vessel containing 
excess silica hydride desiccant in an oven at 30°C for 24 hours. 
 
Dried antibodies were reconstituted in the same volume of deionised water from which 
they were dried (since equivalent buffer salts would be present in the dried sample).  
They were then diluted to 0.03mg.ml-1 in HEPES buffer.   The subsequent antibody 
solutions were prepared by double-diluting the antibody across the plate (10 times) (with 
HEPES buffer or other test solution as specified below).  The remaining 2 wells were 
used for control assays. 
 
Assays with buffers containing sulphate minerals: 
 
Anti-atrazine scAb was dried (as above) and reconstituted to a concentration of 
0.3mg.ml-1 in 10mm HEPES buffer (pH 7.4) containing commercially available calcium, 
magnesium or iron(II) sulphate (Sigma-Aldrich, Poole, UK), dissolved at specified 
concentrations. The subsequent antibody solutions were prepared by double-diluting 
the antibody across the plate (10 times) (with the HEPES buffer containing the 
appropriate concentration of sulphate).  The remaining 2 wells were used for control 
assays. 
 
Assays with buffers containing organic solvents: 
 
Anti-atrazine scAb was dried (as above) and reconstituted to concentration of 0.3 
mg.ml-1 in a specified (combination of) organic solvent(s).  The subsequent antibody 
solutions were prepared by double-diluting the antibody across the plate (10 times) (with 
appropriate organic solvent).  The remaining 2 wells were used for control assays.  
During the antibody incubation step the microtitre plates were sealed with AlumaSeal 
(Sigma-Aldrich, Poole, UK), a foil coated with adhesive, to prevent evaporation of the 
solvent. 
 
Assays with buffers containing guanidine-HCl: 
 
Anti-atrazine scAb was dried (as above) and reconstituted to concentration of 0.3mg.ml-
1 in a specified concentration of Guanidine-HCl or Guanidine-HCl – HEPES buffer mix.  
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Only 0.3mg.ml-1 antibody concentrations have been tested.  A control assay was carried 
out by reconstituting dried anti-atrazine scAb in HEPES buffer.   
 
3.2.3.2 Preliminary particle radiation testing – fluorescent dyes results and discussion 
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Figure 3.4: Effect of proton irradiation on fluorescent properties of fluorescein.  The error bars indicate 
standard errors of the mean from three scans of the each sample. 
 
Figure 3.4 shows the results of the 1.38 x 1010 and 1.48 x 108 proton fluence exposures 
on the fluorescent properties of fluorescein.  Since these proton fluences were later 
found to be very low, the results of this experiment were considered to be largely a test 
of the reproducibility of the sample preparation i.e. freeze-drying and reconstituting the 
samples.  It appears from Figure 3.4 that the fluorescent properties of untreated 
fluorescein, the freeze-dried control and the freeze-dried samples exposed to proton 
radiation all have similar fluorescent properties, although the large error bars indicate 
that the process is not very reproducible.   
 
With hindsight, it was considered that the reproducibility issues in this data, particularly 
in the fluorescent intensity, could be attributed to a small loss of material from the 
sample wells during the freeze-drying process.  Given that this poor reproducibility could 
be explained by a loss of material from the sample wells, and that there was no change 
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in the peak emission or absorption wavelengths, the implication of the results in Figure 
3.4  is that these levels of proton irradiation does not have a significant effect on the 
fluorescent properties of fluorescein.  In addition, the fluorescein free acid preparation 
used in this experiment was near its solubility limit in water at the concentrations used to 
prepare the samples.  While this is unlikely to have had a significant effect on the results 
of this experiment because all of the samples were prepared from the same stock 
solution of fluorescein, in all subsequent proton radiation tests a more water-soluble 
fluorescein sodium salt was used. 
 
3.2.3.3 Preliminary particle radiation testing – anti-atrazine scAb results and discussion 
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Figure 3.5: Effect of initial proton exposures on anti-atrazine scAb antibody, compared to samples outside 
the beam line and a stock antibody sample that was not included in the cyclotron tests. 
 
Figure 3.5 shows the results of an ELISA carried out with the anti-atrazine scAb after 
the proton radiation exposures.  What is immediately clear from this graph is that the 
test samples only have data points at relatively low concentrations.  This is because the 
relatively low concentration of the stock solution of antibody meant that it was not 
possible to achieve a high concentration of reconstituted antibody.  The maximum 
concentration achievable was limited because of the volume of the 864 microtitre plate 
wells, and difficultly of inserting and removing liquids from these wells, limited the 
sample volume to a maximum of 10μl.  This sample then had to be diluted to a minimum 
Paul Kerr Wilson                               Exposure of Fluorescent Dyes and Antibodies to simulated Radiation and Sterilisation protocols  
Development of Life Marker Chip Technology for in-situ Life Detection on Mars                                  Page 79 of 206 
of 200μl in order to carry out the ELISA, resulting in a 20-fold dilution of the stock 
antibody concentration.  It was therefore decided to adapt the protocol in future 
experiments to start with a higher stock concentration of antibody such that a higher 
concentration of reconstituted antibody could be used in the ELISA after particle 
radiation exposures. 
 
In Figure 3.5, the binding curves of the antibodies exposed to proton radiation appear to 
show a higher binding affinity than the corresponding control samples.   However, this 
result is highly questionable, and may be explained by two key factors.  Firstly, it is 
possible that a greater amount of dried antibody was lost from the control wells during 
the sample handling process, therefore reducing the amount of antibody available in the 
assay.  Secondly, as is discussed in the following paragraph, the control antibody 
samples would also have been exposed to a significant amount of proton radiation, so 
may not be appropriate as control samples.  Therefore it is not possible to draw any 
conclusions about the effect of the proton radiation exposures on the antibody from this 
experiment.  As mentioned in the discussion of the results of the fluorescein exposed to 
protons in this experiment (see section 3.2.3.2), this variability was thought, with the 
benefit of hindsight, to be due primarily to the loss of material during the freeze-drying 
process (this will be discussed further in section 3.2.4.2). 
 
Also, in the light of practical experience of carrying out experiments within the cyclotron 
facility, it was realised that the experimental controls in this experiment were not the 
most reliable.  This is because while the control sample wells were not in the beam 
path, when the particle radiation beam is active, a high background level of radiation 
(arising from scattered and secondary radiation from the beam and shielding of the 
cyclotron chamber) is generated around the cyclotron equipment.  The cyclotron is 
house in a 2m thick concrete shielding known as a cyclotron vault to contain this 
radiation.  Therefore anything in the cycloton vault during the exposure is subjected to a 
relatively high level of particle radiation, including the control samples in this 
experiment.   
 
As a final point of consideration it was realised after this initial experiment had been 
carried out that there had been a calculation error in the proton fluence, such that the 
highest amount of protons used in this experiment was significantly lower than the 
calculated mission fluence of protons.  However, since the principal goal of this initial 
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experiment was to develop the experimental method, this was not critical and the 
calculations were corrected for the subsequent experiments. 
 
3.2.4 Evaluation and refinement of sample preparation procedure for ion beam 
exposures 
 
To overcome the issue of the control samples being exposed to a significant radiation 
dose, the format of the sample exposures was changed.   1cm2 squares containing 3 x 
3 wells were cut out of a 864 well microtitre plate, and a custom aluminium holder was 
fabricated at the University of Leicester to hold the sample blocks in front of the beam 
for the exposures.  This sample holding block (shown in Figure 3.26 ) was made from 
aluminium, simply because it was a conveniently available material, and contained a cut 
out section in which the blocks of 864 well microtitre plate could be inserted, and holes 
for the mounting spigots on the cyclotron beam port such that the sample block could be 
mounted in front of the beam port.  With these sample blocks each radiation exposure 
could be carried out by taking an individual sample block into the cyclotron chamber for 
the exposure on that block, storing the remaining sample blocks including the control 
samples outside the cyclotron vault for all other exposures.  
 
At this stage in the project, the initial experimental results for both particle and gamma 
irradiation tests (reported in section 3.3.1) showed poor reproducibility.  The common 
factor in both of these sample preparation procedures was the freeze-drying stage, and 
a likely explanation for the results was thought to be that freeze-dried dye or antibody 
material, which is very light and susceptible to both physical disturbance and 
electrostatic interactions with nearby materials, could be escaping the vials or sample 
wells during the freeze-drying process.  This would explain some of the variation 
between samples within each batch of results behaving differently, since a lower mass 
of dye or antibody present in the sample well or vial would mean a lower concentration 
in the reconstituted sample, and therefore a lower fluorescent intensity or antibody 
binding signal. 
 
Since at this stage in the work the loss of material from gamma radiation samples 
during freeze-drying had become apparent, a series of experiments were carried out 
with the new sample blocks to optimise the drying process prior to further particle 
radiation tests. 
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3.2.4.1 Initial freeze-drying experiment with sample blocks – materials and methods 
 
The sample blocks for each experiment were prepared in the same way.  10μl of either 
1mg.ml-1 fluorescein in RO water or 1mg.ml-1 chicken egg albumin in 10mM PBS pH7.4 
were added to a number of sample wells in each block.  Chicken egg albumin was used 
as the anti-atrazine scAb was available in only limited quantity, whereas chicken egg 
albumin is a similar size protein readily available and was expected to have very similar 
physical properties to the antibody fragment.  The sample blocks were then placed into 
a freezer at –80°C for at least 3 hours.  Immediately prior to freeze-drying, the sample 
blocks were placed into a petri dish, in an attempt to prevent the initial rapid de-
pressurisation and re-pressurisation of the freeze-drier sample chamber by application 
and removal of the vacuum which could produce air flows.  Air flows could disturb the 
frozen or dried material and remove bulk amounts of samples from the wells.  The petri 
dish was then placed in the freeze-drier and the vacuum applied as quickly as 
reasonably achievable to minimise the chance of the fluorescein and antibody samples 
melting.  After the freeze-drying process was complete the samples were examined for 
any signs of material disturbance.  They were not used in radiation exposures or 
analysed except by visual inspection, since the purpose of this series of experiments 
was simply to determine whether material loss from the sample wells was a cause of 
poor reproducibility in the previous work. 
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3.2.4.2 Initial freeze-drying experiment with sample blocks – results and discussion 
 
 
Figure 3.6: A petri dish used as a baffle to protect sample clocks during the freeze-drying process.  
Figure 3.6 shows a photograph of a petri dish used to protect the sample blocks from 
the pressure change on application or deactivation of the vacuum pump, after 
completion of the freeze-drying cycle and removal of the sample blocks.  There are blue 
deposits visible on the inner surface of the petri dish lid (areas circled in red in Figure 
3.6).  These match up precisely with the locations of the sample blocks within this petri 
dish during the freeze-drying protocol.  This indicated that sample was being 
transported from the sample block well to the inner surface of the petri dish by some 
mechanism.  Importantly this observation confirmed that the freeze-drying protocol was 
a source of experimental error that could be the cause of the discrepancy between 
control samples and those exposed to protons in the initial experiments (see sections 
3.2.3.2 and 3.2.3.3). 
 
There are a number of potential causes of this transportation of sample material, of 
which the most likely were considered to be electrostatic charge build-up between the 
polypropylene sample blocks and the polystyrene petri-dish, or the presence of an air 
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bubble in the liquid samples after pipetting into the sample block which would be a 
source of outward pressure under vacuum and could cause frozen material to be 
ejected from the sample block.  Melting of the frozen sample material particularly at the 
interfaces could also contribute to enabling either of these processes to remove sample 
material from the wells.   
 
3.2.4.3 Experiment to eliminate causes of material loss from sample wells – materials 
and methods 
 
A number of alternative sample preparation protocols were tested to try to find a way to 
prevent this sample loss, using chicken egg albumin as a model protein solution and 
fluorescein as a fluorescent dye solution, since it is cheaper than Alexa Fluor® 633 and 
has similar physical properties. 
 
The first of these was to try to minimise or eliminate electrostatic charge build-up as a 
potential cause of material loss, by wrapping both the petri dish and individual sample 
blocks in aluminium foil (see Figure 3.7).  The sample blocks were pierced above each 
the wells in order to allow sublimed water to easily escape from the wells during freeze-
drying. 
 
 
Figure 3.7: Petri-dish and sample blocks wrapped in aluminium foil 
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These sample blocks and petri dishes wrapped in aluminium foil were used in two 
experiments, firstly as in the previous experiment using them directly after the 3 hour 
incubation at –80°C, and secondly with the addition of an immersion of the sample 
blocks in liquid nitrogen (see Figure 3.8) immediately prior to the freeze-drying, as this 
would ensure that the samples were at a lower temperature at the start of the freeze-
drying process and would therefore be less likely to melt during transfer into the freeze-
drier.  Samples were held partly immersed in liquid nitrogen until they had been cooled 
sufficiently to ensure that they had cooled to the temperature of the liquid nitrogen (as 
judged by the cessation of boiling liquid nitrogen around the sample block), then fully 
immersed for approximately 2 minutes.  The sample blocks were then immediately 
transferring into the freeze-drier and the freeze-drying cycle started. 
 
 
Figure 3.8: Immersion of Sample Blocks in Liquid Nitrogen  
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3.2.4.4 Experiment to eliminate causes of material loss from sample wells – results and 
discussion 
 
The foil-covered petri dish top used in this experiment is shown in Figure 3.8.  Spots of 
a white material, the chicken egg albumin, have been deposited on the foil covering and 
are clearly visible above each location where a sample block had been placed during 
the freeze-drying.  Orange-red spots are also present near the white spots, indicating 
that some fluorescein has also been deposited on the petri-dish lid, therefore both 
proteins and dyes escape the sample wells during the freeze-drying process.   
 
There are two possible explanations for this.  The first is that air bubbles are present in 
the liquid samples when they are placed in the wells prior to freeze-drying.  Throughout 
this series of sample preparation development experiments, various pipetting 
techniques were used in order to try to minimise or prevent the inclusion of air bubbles 
within the solutions when placing them into the sample blocks.  While bubble formation 
could be prevented in most cases by a skilled operator, it was not possible to prevent 
completely.   
 
An alternative explanation is that material is removed from the well either as it is freeze-
dried (and therefore changes to a free powder rather than being frozen in ice) due to 
electrostatic interactions, or when the sample chamber is re-pressurised at the end of 
the freeze-drying sample, as the in-rush of air disturbs the dried materials in the sample 
wells.  This was tested by visually observing a petri-dish containing sample blocks 
prepared as described in section 3.2.4.3 (without foil wrapping) during a freeze-drying 
cycle.  Observation during this test revealed that some material was removed from the 
sample block wells almost immediately after the vacuum was applied, and built up on 
the petri-dish lid throughout the freeze-dry cycle.  This eliminated the presence of 
bubbles in the samples when they were frozen as a cause of material loss (since such 
an effect would result in the rapid removal of a large amount of sample from the wells 
almost immediately after applying the vacuum).  However, the cause of material loss 
was still unknown, since coating the surfaces with aluminium foil should have prevented 
electrostatic effects. 
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.  
Figure 3.9: The foil coated lid of a petri-dish after a freeze-drying cycle, clearly showing material escaping 
the sample block wells and building up on the surface of the aluminium foil. 
3.2.4.5 Solution to sample preparation issues associated with freeze-drying 
 
Since neither of the protocols described in sections 3.2.4.1 and 3.2.4.3 were successful 
in preventing the loss of material from the wells in the sample block, and  the difficulties 
with freeze-drying the samples to prepare them for radiation treatments could not be 
overcome easily, a different approach was adopted.  In all subsequent experiments the 
antibody and fluorescent dye samples were dried down instead of freeze-dried.  This 
was carried out by placing filled sample blocks in a sealed container containing excess 
self-indicating silica gel desiccant, and placing the container in a 37°C oven overnight.  
This simple drying procedure overcame the difficulties with sample preparation by 
freeze-drying, although the samples were likely to contain trace amounts of water 
absorbed from the ambient environment during the radiation exposures.    It is also 
likely that the presence of water would enhance any damage caused by particle 
irradiation, so these conditions are consistent with the over-test philosophy adopted 
throughout this series of experiments. 
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3.2.5 Particle radiation testing with modified sample preparation and exposure 
procedures 
 
At this stage an experimental method had been developed that allowed samples 
exposed to the cyclotron beam in sample blocks (which contained nine wells and were 
used to carry out triplicate exposures of up to three sample types), rather than doing 
multiple exposures in different locations on the same microtitre plate.  This development 
of the method significantly reduced the level of background radiation during the particle 
radiation exposures because each sample block was only placed into the cyclotron vault 
during one exposure.   In addition the sample preparation procedure had been modified 
to prevent the loss of material from the sample block wells by drying down the samples 
rather than freeze-drying.  As mentioned in section 3.2.3.3, the calculation of the 
mission fluence of protons for the cruise phase of a nominal Mars mission during the 
„on‟ season for solar flares was modified to correct for the error in the previous 
experiment.  With these new methods, a second round of testing was carried out at the 
cyclotron facility at the University of Birmingham. 
 
The final value for the mission fluence of protons would have been difficult to use for 
sample exposures.  This is because, even with the lowest stable beam current from the 
cyclotron, the exposure time would be in the order of seconds, which would be difficult 
to carry out accurately and reproducibly given that the proton beam was turned on an 
off by manually controlling a Faraday cup (as described in section 3.2.1.1). Therefore 
the lowest level of exposure used in this experiment was ten times the mission fluence. 
 
3.2.5.1 Proton radiation testing with modified sample preparation and exposure 
procedures – materials and methods 
 
10μl of either 1 mg.ml-1 fluorescein in RO water, 1mg.ml-1 Alexa Fluor 633 in RO water 
or 0.3mg.ml-1 anti-atrazine scAb in 10mM PBS pH 7.4 was carefully pipetted into the 
sample block wells in a random known pattern.  The sample blocks were then placed 
into a sealed container with excess self-indicating silica hydride desiccant, and the 
container stored in a 37°C oven overnight to remove the water from the solutions. 
 
In an attempt to test the samples to destruction, exposures of 10 times, 100 times and 
10,000 times the mission fluence of protons were carried out.  The proton exposures in 
this experiment were carried out at 9MeV, the lowest energy proton beam the cyclotron 
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can generate.  The current used for the 10 and 100 times mission fluence was 50pA, 
and a 500pA current was used for the 10,000 times mission fluence.   
 
After the exposures the samples were transported to Cranfield University.  The 
fluorescein and Alexa Fluor® 633 samples were reconstituted as described in section 
3.2.1.1, such that the final concentration of both fluorescein and Alexa Fluor® 633 was 
0.05mg.ml-1, and their peak emission and excitation wavelengths and intensities 
measures in a Cary Eclipse Varian Spectrophotometer.  The anti-atrazine scAb samples 
were reconstituted and an ELISA assay carried out as described in section 3.2.1.1. 
 
3.2.5.2 Proton radiation testing with modified sample preparation and exposure 
procedures – fluorescent dye results and discussion 
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Figure 3.10: Effect of proton radiation (10, 100 and 10,000 times the mission fluence) on the fluorescent 
properties of fluorescein.  The error bars represent the standard errors of the mean values of triplicate 
samples. 
 
Figure 3.10 shows the effects of the proton radiation exposures on the fluorescent 
emission properties of fluorescein.  Only the emission data is shown, but the absorption 
properties were also tested and found to correlate with the emission results i.e. no 
changed in peak excitation wavelength were observed, and slight variations in emission 
intensity were matched the excitation intensity results.  It is apparent that none of the 
9MeV proton exposures, even up to 10,000 times the expected mission fluence, had a 
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significant effect on either the peak emission wavelength or emission intensity of 
fluorescein, and this was confirmed by Student‟s T test (P = 42.87%, 51.59% and 
65.54% for 10x, 100x and 10,000x the mission fluence of protons, respectively) 
compared to the control sample which was not exposed to any particle radiation. 
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Figure 3.11: Effect of proton radiation (10, 100 and 10,000 times the expected mission fluence) on the 
fluorescent emission properties of Alexa Fluor
®
 633.  The error bars represent the standard errors of the 
mean values of triplicate samples. 
Figure 3.11 shows the effects of the proton radiation exposures on the fluorescent 
emission properties of Alexa Fluor® 633.  As for the fluorescein, only the emission data 
is shown in this thesis, but the absorption properties were also tested and found to 
correlate with the emission results.  It was also found that none of these 9MeV proton 
exposures significantly affected either the peak emission wavelength or emission 
intensity of Alexa Fluor® 633, as Student‟s T tests on the fluorescent intensity gave 
probabilities of 70.53%, 48.95% and 44.98% of the samples exposed to 10x, 100x and 
10,000 times the mission fluence of protons (respectively) being different from the 
control sample which was not exposed to any particle radiation.   
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3.2.5.3 Proton radiation testing with modified sample preparation and exposure 
procedures – antibody results and discussion 
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Figure 3.12:Effect of proton radiation (10, 100 and 10,000 times the mission fluence) on the binding 
properties of a representative recombinant antibody (anti-atrazine scAb).  The error bars represent the 
standard errors of the mean values of triplicate samples. 
Figure 3.12 shows the effect of 10, 100 and 10,000 times the calculated mission fluence 
of protons on the antigen binding properties of the anti-atrazine antibody fragment.  The 
red solid line curve shows the binding curve of the untreated control.  This shows a 
sigmoid binding curve as expected, although the top of the curve is not visible at the 
range of antibody concentrations used in this experiment.  The binding curves for anti-
atrazine scAb exposed to 10 and 100 times the mission fluence appear to show that the 
binding affinity of the antibody decreases with exposures to greater proton fluences.  
Overall the antibody binding signal (indicated by optical density) has been reduced to 
50-75% of the untreated antibody.  There are two possible causes of this effect.  One is 
that all antibody molecules were equally affected by proton damage, although it is 
difficult to conceive of a mechanism by which many antibody molecules would lose a 
similar level of activity when damaged by ionising radiation at an energy level easily 
sufficient to break a covalent bond.  The second explanation is that antibody molecules 
damaged by ionising radiation would in most cases be rendered inactive and possibly 
be fragmented, but that a significant proportion of antibody molecules would not be 
affected by such interactions.  Further tests, such as analysis of irradiated antibody 
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samples by electrophoresis, MALDI-TOF-MS and thin layer chromatography need to be 
carried out to determine which of these hypotheses is correct. 
 
Although the precise mechanism of damage remains unconfirmed, it is apparent that 
the antibody is damaged in some way by proton irradiation.  However, a significant 
proportion of the antibody signal (<50%) is retained even at 100 times the expected 
mission fluence of protons for the ExoMars mission.  This is a key result, particularly 
considering the “worst case” scenarios used for this proton damage test i.e. that the 
radiation model used to calculate the proton fluences did not take into account any 
spacecraft radiation shielding, and no attempt was made to reduce the effect of ionising 
radiation on the antibody e.g. by the addition of ascorbate or other free-radical 
scavengers.  This result indicates that the expected mission fluence of protons for 
ExoMars does not cause a critical level of damage to antibodies, therefore supporting 
the use of antibodies in the Life Marker Chip.  
 
The exposure to 10,000 times the mission fluence of protons appears to have shown 
that the antibody has lost almost all of it‟s activity.  However, observation of the sample 
blocks after the exposures indicated that a different factor may have contributed to this.  
Figure 3.13 shows the sample blocks after the particle radiation exposures and removal 
of the fluorescent dye and antibody fragment samples.  Note that sample block 3 in the 
lower right of the image appears to have a more curved and reflective upper surface 
than the other sample blocks.  This change in appearance was thought to be due to the 
higher beam current of protons used in this exposure (500pA) compared to the other 
proton exposures (50pA).  A higher beam current would mean a faster rate of proton 
impacts i.e. energy generation and less time for heat loss from the sample block, and 
this build up of energy could have caused the surface of the sample block to begin 
melting. 
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Figure 3.13: Sample blocks after proton and helium ion exposures.  Note the surface appearance of block 
no. 3 (bottom right) is different from the other sample blocks 
This melting would in turn transfer heat into the samples, which in the case of antibodies 
would disrupt hydrogen bonding and therefore cause significant structural damage, 
resulting in the loss of the specific binding properties of the antibody to its antigen.  This 
would considerably reduce the binding signal for this sample block regardless of the 
effect of the proton radiation alone. 
 
3.2.5.4 Helium ion radiation testing with modified sample preparation and exposure 
procedures – materials and methods 
 
Helium ion exposures were also carried out in this experiment.  Since less data was 
available regarding the expected mission fluence of helium ions than for protons, the 
assumption was made that the same number of helium ion particles as protons would 
be encountered.  This is a greatly exaggerated value, since the number of helium ions 
would in fact be approximately one third of the number of protons (see Figure 3.13), but 
the same value was used to ensure and „over-test‟ was carried out in the absence of 
accurate data.  The helium ion fluences used in this experiment were ten and 100 times 
this overestimated mission fluence.  The helium ion exposures in this experiment were 
carried out at 30MeV using a beam current of 50pA. 
 
After exposure to the particle radiation beam the sample blocks were wrapped in 
aluminium foil and stored in a sealed petri dish containing silica hydride desiccant, to 
prevent moisture affecting the samples.  The fluorescent dyes were then reconstituted 
as described in 3.2.1.1, and analysed in the Cary Eclipse Varian Spectrophotometer.  
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The scAb antibody fragments were reconstituted to a concentration of 0.3μg.ml-1 and 
analysed by ELISA, following the same protocol described in section 3.2.1.1 
 
3.2.5.5 Helium ion radiation testing with modified sample preparation and exposure 
procedures – fluorescent dye results and discussion 
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Figure 3.14: Effect of helium ion radiation (10 and 100 times the mission fluence) on the fluorescent 
properties of fluorescein.  The error bars represent the standard errors of the mean values of triplicate 
samples. 
 
Figure 3.14 shows the effects of the helium ion radiation exposures on the fluorescent 
emission properties of fluorescein.  As in the previous experiments, only the emission 
data is shown but the absorption properties were also tested and found to correlate with 
the emission results.  It is immediately clear that neither of the 30MeV helium ion 
radiation exposures had a significant effect on either the peak emission wavelength or 
emission intensity of fluorescein, since all of the exposed samples have very similar 
emission properties to the control sample, which was not exposed to any particle 
radiation.  This was confirmed by Student‟s T test on the fluorescent intensity of the 
samples (P = 68.41% and 61.25% for 10x and 100x the expected mission fluence of 
helium ions, respectively). 
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Figure 3.15: Effect of helium ion (10 and 100 times the mission fluence) radiation on the fluorescent 
properties of Alexa Fluor
®
 633. The error bars represent the standard errors of the mean values of 
triplicate samples. 
Figure 3.15 shows the effects of these radiation exposures on the fluorescent emission 
properties of Alexa Fluor® 633.  As for the results of the analysis of the fluorescein 
samples, 30MeV helium ion radiation exposures have not had a significant effect on 
either the peak emission wavelength or peak emission intensity of Alexa Fluor® 633 (P 
values for the fluorescent intensities being different from the control samples were 
79.74% and 46.05% for 10x and 100x the mission fluence of helium ions respectively, 
calculated by Student‟s T test).  These results indicate that particle radiation does not 
induce changes in the peak absorption or emission wavelengths of fluorescent dyes.  
This is an important finding for the LMC instrument development, as it means that the 
choice of wavelength for the excitation light source in the flight instrument and the 
wavelength for which the fluorescent readout system will be optimised, will not be 
complicated by radiation-induced changes to the fluorescent dyes. 
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3.2.5.6 Helium ion radiation testing with modified sample preparation and exposure 
procedures – antibody results and discussion 
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Figure 3.16: Effect of helium ion radiation (10 and 100 times mission fluence) on the binding properties of 
a representative recombinant antibody (anti-atrazine scAb).  The error bars represent the standard errors 
of the mean values of triplicate samples. 
 
Figure 3.16 shows the effect of 30MeV helium ions at 10 and 100 times the calculated 
mission fluence on the binding affinity of anti-atrazine antibody fragment.  While the 
antibody exposed to ten times the mission fluence of helium ions at 30MeV shows a 
slightly misshapen binding curve, this could be due to experimental error rather than an 
affect on the antibody caused by radiation damage.  Neither the 10 nor 100 times the 
mission fluence of helium ions have resulted in complete inactivation of the antibody, in 
fact neither treatment appears to have had a significant effect.  As was the case for all 
previous radiation treatments, this result shows that radiation effects do not 
fundamentally rule out the use of antibodies in the ExoMars mission scenario. 
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3.2.5.7 Particle radiation testing with modified sample preparation and exposure 
procedures – reproducibility 
 
0
100
200
300
400
500
600
700
9MeV Proton
50pA 10x
9MeV Proton
50pA 100x
9MeV Proton
500nA
30MeV
Helium ion
30MeV
Helium ion
Control
F
lu
o
re
s
c
e
n
t 
in
te
n
s
it
y
 (
a
.u
.)
450
460
470
480
490
500
510
520
530
540
550
P
e
a
k
 e
m
is
s
io
n
 w
a
v
e
le
n
g
th
 (
n
m
)
Wavelength Average Intensity Well 2 Flourescein Intensity
Well 6 Flourescein Intensity Well 7 Flourescein Intensity
 
Figure 3.17: Effect of proton and helium ion radiation on the fluorescent properties of fluorescein samples 
in Figure 3.10 and Figure 3.14 showing the intensities of each sample.  The well numbers refer to the 
sample block wells containing fluorescein samples (wells 1, 5 and 9 contained Alexa Fluor
®
 633, and 
wells 3, 4 and 8 contained anti-atrazine scAb)  The error bars represent the standard errors of the mean 
values of triplicate samples.   
 
Figure 3.17 shows the reproducibility of the data in Figure 3.10 and Figure 3.14, by 
including all the individual data points for fluorescent intensity.  This is included as a 
demonstration that the drying-down protocol overcame the reproducibility issues that 
were encountered with the freeze-drying method. 
 
3.2.6 Summary and discussion of particle radiation testing results 
 
 
In this section, methods for exposing fluorescent dyes and antibodies to particle 
radiation at a cyclotron facility have been developed and the protocols refined to 
improve the reproducibility of the results.  The method was then used to carry out a 
series of proton and helium ion radiation exposures on representative immunoassay 
components of the Life Marker Chip, including two fluorescent dyes and a recombinant 
antibody.  The results overall support the use of antibodies and fluorescent dyes in 
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astrobiology missions to Mars, since the peak emission and excitation wavelengths of 
the dyes were not affected by any of the particle radiation treatments, and the 
fluorescent intensity of both dyes was not greatly reduced even at radiation levels far in 
excess of the expected mission dose for ExoMars.  A significant loss of antibody binding 
signal (~50%) was observed at 10 and 100 times the expected unshielded proton 
radiation dose for the ExoMars mission.  However, since a large amount of activity 
remained this could be taken into account in the configuration of the final instrument, for 
example by including excess antibody and adjusting the level of dye labelling and 
optical readout setting to allow for some loss of antibody activity.  In addition, these 
tests were carried out with a “worst case scenario” philosophy in particular assuming 
that there was no spacecraft shielding in the dose calculations. 
 
A number of other particle radiation tests are still to be carried out, including lower 
energy levels of protons and helium ions, neutrons and if possible heavy ions.  Work is 
in progress towards carrying out these tests and will be discussed further in section 6.2.  
In addition to particle radiation, gamma radiation is an important radiation source not 
only because it is a common secondary radiation type generate from spacecraft 
shielding, but also because it has been used to sterilise biological materials including 
antibodies (Grieb et al., 2002) and therefore may provide a method to sterilise the Life 
Marker Chip for ExoMars.  A number of gamma radiation tests were carried out during 
this work, and will be reported in the following section. 
 
3.3 Gamma irradiation exposure of fluorescent dyes and antibodies  
 
While the spacecraft shielding will significantly reduce the amount of gamma radiation 
from space reaching the instrument, gamma radiation is likely to be generated as a 
secondary radiation product when particle radiation interacts with the shielding.  As 
discussed in section 2.1.2.12, the expected gamma radiation levels encountered for the 
ExoMars mission scenario were calculated based on the NASA Mars Science 
Laboratory Proposal Information Package, which states that an instrument in the 
payload module can expect to encounter a total ionising dose of 3.0krads during a 300-
day transfer to Mars and one Martian year (687 earth days) of surface operations (MSL 
PIP, 2004).  This was broadly in agreement with the European Space Agency 
calculation for the ExoMars mission (ESA, 2005).  
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Based on this, samples were exposed to a range of gamma radiation doses.  The initial 
experiment was a very low dose 150mrad, because at that time only a low energy 
gamma radiation source was available.  This experiment was used to develop the 
experiental method.  A series of gamma radiation exposures from 3krad to 2.5Mrad was 
then performed using a GammaCell Cobalt-60 source with an output of ~50krad hr-1.  
This GammaCell unit was conveniently available at the University of Leicester and had 
an output that was compatible with completing exposure to these levels of gamma 
irradiation in a convenient time period (a few minutes for mission doses, and a few days 
for sterilisation doses).  In addition, GammaCell units are widely used in previous 
gamma irradiation work in the literature so their use for this type of work has some 
precedent (Caballero et al., 2004, Grieb et al., 2002). 
 
All of the samples were tested in a dried state, achieved either by freeze-drying or dried 
at 37ºC with desiccant.  This was done because the indications from the literature were 
that biological materials are less likely to be damaged by radiation in a dried state.  
Liquid controls were also used to determine any effect of the drying procedure on the 
fluorescent dyes and antibodies. 
 
 
3.3.1 Preliminary Gamma Irradiation Experiment  
 
Since the exposure of dried biological materials to gamma irradiation is not carried out 
routinely, the work reported here focuses initially on establishing and developing an 
experimental protocol, and moves on to using this protocol in a controlled experiment to 
represent various mission environments.  Since this work was carried out concurrently 
with the proton and helium ion work (reported in section 3.1), there are similarities 
between the sample preparation methods used and development of the experimental 
protocols.   
 
3.3.1.1 Preliminary Gamma Irradiation Experiment - Materials and Methods 
 
In the initial experiment, 100μl of 0.5 mg.ml-1 fluorescein (Sigma-Aldrich, Poole, UK, 
Product Code 32615) in RO water was placed into four polypropylene vials.   Two of 
these samples were then dried in a freeze-drier (Edwards Modulyo) overnight, while the 
samples that were not freeze-dried were stored at room temperature.    The samples 
were then transported to the University of Leicester, where one liquid and one dried 
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sample were exposed to 150mrad of Gamma radiation in a GammaCell unit.   This 
Gamma cell unit was used because it was conveniently available and similar units have 
been used in the literature (Caballero et al., 2004, Grieb et al., 2002).  The samples that 
were not exposed to the gamma radiation were subjected to the same transportation 
and environmental conditions as the dried sample to provide a liquid and a freeze-dried 
control, which would indicate any effect of the sample handling procedure on the 
samples.  The samples were then returned to Cranfield University, reconstituted in RO 
water to a concentration of 0.05 mg.ml-1, and the fluorescent properties tested in 
flourimeter as described in section 3.2.2. 
3.3.1.2 Preliminary gamma irradiation experiment – results and discussion 
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Figure 3.18: Effect of preliminary 150mrad gamma radiation exposure on peak emission wavelength and 
intensity of fluorescein.  The blue bars indicate fluorescent intensity, while the red bars indicate the peak 
emission wavelength.  Since these tests were carried out on single samples, the error bars indicate the 
reproducibility of the fluorimeter measurements. 
 
Figure 3.18 shows the results of this experiment. The peak emission and excitation 
wavelengths of each sample were measured, but since the results are directly related 
i.e. a reduction in fluorescent excitation corresponds to a reduction in fluorescence 
intensity, and no change in peak emission or absorption wavelengths was observed, 
only the emission data is shown here.  The liquid control sample gives a baseline on 
where the intensities would be expected if the sample processing and irradiation had no 
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effect on the fluorescent properties of the dyes.  The fluorescein samples that were 
freeze-dried both appear to have the same peak emission wavelength as the liquid 
control, but a lower emission intensity.  This indicates that while the freeze-drying 
process may have affected the dye in some way, gamma irradiation of dried fluorescein 
has little or no effect on the fluorescent properties.  The samples exposed to gamma 
radiation in the liquid state appear to have a higher emission intensity than the control.  
However in this experiment there was one 1 of each sample type, so it is possible that 
this variation is caused by the sample handling method.  Therefore none of these 
results can be considered significant other than to state that low dose gamma irradiation 
does not have a great effect on fluorescein in either the liquid or dried state. 
 
In this initial experiment the free acid form of fluorescein was used, but since this was 
found to have poor solubility in water (possibly contributing to the variability in 
experimental results above) it was decided to use a more water-soluble fluorescein 
sodium salt (Sigma-Aldrich, Poole, UK, Product code 46960) in all future experiments. 
 
3.3.2 Gamma irradiation method development and reproducibility study  
 
 
Taking the observations from the initial experiment in section 3.2.3.2, including that the 
use of the fluorescein free acid resulted in problems of making solutions of known 
concentration due to solubility issues, the methodology for exposing fluorescent dyes to 
gamma radiation was adapted and a more detailed experiment carried out.  In this 
second experiment, a more representative dye for the Life Marker Chip was also 
exposed to gamma radiation, namely Alexa Fluor® 633.  This dye was not used in the 
initial experiment since it is more expensive than fluorescein and it was desirable to 
have an established method before using it.  Since the Alexa Fluor® dye has a higher 
quantum yield than fluorescein, and is more expensive, the mass of Alexa Fluor® 633 
dye exposed to gamma radiation in this experiment was lower than the mass of 
fluorescein, and similarly the concentration of Alexa Fluor® 633 tested in the fluorimeter 
is lower than the concentration of fluorescein used. 
 
3.3.2.1 Gamma irradiation method development and reproducibility study – materials 
and methods 
 
Triplicate samples containing 100μl of 1.0mg.ml-1 fluorescein sodium salt in RO water, 
and 10μl 0.1 mg ml-1 Alexa Fluor® 633 were prepared in polypropylene vials and dried in 
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a freeze-drier (Edwards Modulyo) overnight.  Corresponding control samples were also 
prepared and stored in darkness at room temperature during the freeze-drying step.  A 
larger number of control vials (9) containing fluorescein were prepared in this 
experiment to determine the reproducibility of the sample preparation with fluorescein 
sodium salt with no gamma radiation exposure.  Three samples were exposed to 
gamma radiation doses of 30 and 300kRad using the GammaCell facility at the 
University of Leicester.  Higher doses were not carried out at this stage since they 
involved overnight exposures, and it was considered prudent to ensure the exposure 
method was reproducible before performing longer experiments.  The samples were 
then transported back to Cranfield University, where the fluorescein samples were 
reconstituted in RO water to a final concentration of 0.01mg.ml-1, and Alexa Flour® 633 
samples were reconstituted in RO water to a concentration of 0.0001mg.ml-1. 
 
3.3.2.2 Gamma irradiation method development and reproducibility study – fluorescein 
results 
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Figure 3.19: Effect of 30krad and 300krad of gamma irradiation on the fluorescent emission properties of 
fluorescein.  The error bars indicate standard errors of the mean intensity.  The control result is based on 
8 samples, and the 30krad and 300krad gamma exposure results were from triplicate samples. 
 
Figure 3.19 clearly shows that the intensity variation between samples of fluorescein in 
this experiment was relatively small for the 30krad and 300krad samples, having CV of 
4.0% and 10.9% respectively from triplicate samples.  The control samples had a CV of 
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59.2%, but this large value was largely influenced by one particular sample which gave 
a very low intensity signal, possibly due to an operator error in sample handling.  When 
this sample was removed from the analysis the CV was reduced to 10.4%.  The 
standard error used to calculate the error bar in Figure 3.19 does not include this much 
lower sample.  These results indicate that the drying protocol with fluorescein sodium 
salt is a reproducible method of preparing fluorescein samples for gamma radiation 
exposures.    Figure 3.19 shows that neither 30krad nor 300krad of gamma radiation 
had a large effect on the either the fluorescent peak emission wavelength or intensity of 
fluorescein.  
 
3.3.2.3 Gamma irradiation method development and reproducibility study – Alexa 
Fluor® 633 results 
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Figure 3.20: Effect of 30krad and 300krad of gamma irradiation on the fluorescent emission properties of 
Alexa Flour
®
 633. 
 
Figure 3.20 shows that neither 30krad nor 300krad of gamma radiation had a significant 
effect on the fluorescent peak emission wavelength or intensity of Alexa Flour® 633.  
Solubility was not considered to be a problem for the Alexa Flour® 633 dye since this 
dye is modified to have a high solubility in water.  This was supported by observations 
during the experiment.  
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3.3.2.4 Gamma irradiation method development and reproducibility study – discussion 
 
Since the nominal mission dose of gamma irradiation for the ExoMars mission is 
expected to be 3krad and both of these fluorescent dyes appear not to be affected by a 
ten-fold excess of this mission dose, Gamma radiation damage alone does not rule out 
use of these dyes for use in the mission.  However resistance to other radiation types 
not tested in this work e.g. neutrons and lower energy levels of protons and helium ions, 
and combinations of gamma irradiation with other types of radiation must also be 
considered in future experiments (see Section 6.2).  A further experiment was then 
designed to evaluate the possibility of using a gamma radiation as a sterilisation 
method, which would require a significantly higher radiation dose than the mission itself. 
 
 
3.3.3 Investigating the potential for sterilisation of the Life Marker Chip by gamma 
irradiation  
 
The experiment described in section (3.3.1) had demonstrated that two fluorescent dyes 
(fluorescein and Alexa Fluor® 633) could be exposed to gamma radiation doses 
significantly higher than the expected mission dose.  In this experiment, the same dyes 
were exposed to the actually mission dose of gamma radiation, and a higher dose 
corresponding to a gamma sterilisation procedure, in order to build up evidence as to 
whether gamma sterilisation could be used as a sterilisation technique for the Life 
Marker Chip. 
 
3.3.3.1 Use of gamma irradiation as a sterilisation technique for fluorescent dyes – 
Materials and Methods 
 
In a slight modification of the protocol used in the previous experiment (see section 
3.3.1), 100μl of 1.0ml.ml-1 fluorescein sodium salt or 10μl of 0.1 mg ml-1 Alexa Fluor® 
633, both in RO water, was added to polypropylene vials and dried down at 37°C 
overnight in a sealed vessel containing excess silica gel desiccant.  This change was 
made based on methods developed for the proton and helium ion exposures described 
in section 3.2.4, which had been found to be more reproducible than freeze-drying.  
Unlike freeze-drying, trace amounts of water may remain in the sample with this 
method, as the samples are stored and exposed to gamma radiation in the ambient 
atmosphere and could absorb water.  However, this is not a critical factor for this 
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experiment since the samples in the flight instrument will be prepared differently, by 
freeze-drying biological samples into glass-fibre pads (see section 6.2), and the 
atmosphere and pressure in the flight instrument will be controlled and will remain at low 
pressure and temperature for most of the mission radiation exposure (Sims et al., 
2004).  Any enhanced radiation damage due to the presence of water was considered a 
contribution to the over-test philosophy adopted throughout these radiation tests. 
 
The samples were then exposed to doses of 3kRad and 2.5MRad of gamma radiation in 
the Gammacell unit at the University of Leicester.  The 3kRad dose was representative 
of the expected mission dose of gamma radiation (MSL PIP, 2004, ESA, 2005), and 
2.5MRad was selected as it is in the mid-range of the values selected for sterilisation of 
antibodies by Grieb et al. (2002) and could be carried out in a convenient exposure time 
at the University of Leicester GammaCell facility.  
3.3.3.2 Use of gamma irradiation as a sterilisation technique for fluorescent dyes – 
results and discussion 
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Figure 3.21:  Effect of mission and sterilisation doses of gamma irradiation on the fluorescent emission 
properties of fluorescein 
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Figure 3.22: Effect of mission and sterilisation doses of gamma irradiation on the fluorescent emission 
properties of Alexa Flour
®
 633.  The error bars represent standard errors of the mean intensities from 
triplicate samples. 
Figure 3.21 and Figure 3.22 show the effect of these 3kRad and 2.5MRad gamma 
radiation exposures on the fluorescent emission properties of fluorescein and Alexa 
Flour® 633 respectively.  As expected from the result of the earlier experiments at 
higher radiation doses (reported in sections 3.3.2.2 and 3.3.2.3), the 3kRad exposure 
had no significant effect on the peak emission intensity or peak emission intensity of 
either fluorescein (P=48.54% by Student‟s t-test) or Alexa Flour® 633 (P=67.73% by 
Student‟s t-test).  The 2.5MRad exposure did appear to reduce the fluorescent intensity 
of both fluorescein and Alexa Flour® 633.  In the case of fluorescein this effect was not 
statistically significant (P=84.54% by Student‟s t-test).  For Alexa Fluor® 633, the 
intensity reduction was significantly different from the control (P=98.04% by Student‟s t-
test), but was not significantly lower than the 3krad exposure (P=97.39% by Student‟s t-
test).  A small reduction in the emission intensity of the dyes would not be expected to 
be a problem in the flight instrument, since intensity controls, e.g. assay spots 
containing only fluorescently labelled protein, could be included and used to calibrate 
the Life Marker Chip for any loss in signal caused by radiation damage to the 
fluorescent dyes.   
 
Having observed a loss of fluorescent intensity, it is important to understand the 
mechanism that causes it.  Since there has been little or no previous work to 
characterise the effects of radiation on fluorescent dyes, the potential causes of 
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intensity loss here are the opinions of the author.  There are two possible structural 
causes of a change in fluorescent intensity in a fluorescent dye.  The first is a 
rearrangement of chemical bonds within the dye to create a new molecular structure 
that is either not fluorescent or has significantly different fluorescent properties, and the 
second is fragmentation of the molecule leading to loss of active fluorescent dye.  Given 
that there was no observed change in peak emission or excitation wavelength, 
fragmentation of the dye seems the more likely explanation since a structural 
rearrangement would be likely to produce structures that show fluorescence.  In 
addition, gamma radiation is likely to break covalent bonds, also favouring dye 
fragmentation as the likely mechanism.  This could be verified by a chromatography 
method such as thin layer chromatography, or spectroscopic methods such as nuclear 
magnetic resonance (NMR) or infra-red spectroscopy.  This was not carried out during 
the work reported here because the primary goal of this work was to determine the 
functionality of the dyes under radiation conditions rather than to identify any 
mechanisms of damage.  This loss of fluorescent intensity shows that further work is 
required to characterise any radiation damage to fluorescent dyes at sterilisation doses, 
and determine possible solutions to any issues this may cause for the Life Marker Chip.  
These further tests to characterise radiation damage will be discussed further in section 
6.2.   
 
3.3.4 Determination of the maximum tolerated gamma radiation dose for fluorescein 
 
The final experiment carried out in this series of gamma radiation tests on fluorescent 
dyes aimed to establish the point at which gamma radiation would cause complete 
deactivation of the fluorescent properties of a fluorescent dye.  In addition, this was 
used as an opportunity to carry out a gamma radiation exposure at a number of different 
doses using samples that were all prepared and analysed at the same time, since the 
results of the two previous experiments (in sections 3.3.1 and 3.3.2) cannot be directly 
compared with each other as the sample preparation methods were different.  In this 
experiment, gamma radiation doses of 3krad and 30krad were used for consistency with 
the expected mission dose and previous experiments, 3Mrad was used as a sterilisation 
dose rather than the 2.5Mrad used in section 3.3.2.1 since this dose was a more 
convenient exposure time for this experiment, and 9Mrad was added as a very high 
dose in the expectation that is would cause a greater level of damage to the dyes than 
3Mrad. 
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3.3.4.1 Determination of the maximum tolerated gamma radiation dose for fluorescein - 
materials and methods 
 
In order to demonstrate the benefit of removing water from the dyes prior to radiation 
exposure, and the fluorescein was exposed to  a series of gamma radiation doses in 
both the liquid (aqueous solution) and dried (heated at 37°C overnight) state.  100μl of 
1.0ml.ml-1 fluorescein sodium salt in RO water was added to polypropylene vials, then 
the vials were placed either open (to dry down the dye) or closed (to prepare samples to 
be exposed to radiation in the liquid state) into a sealed vessel containing excess silica 
gel desiccant, and the vessel was heated to 37°C overnight.  Triplicate samples were 
then exposed to a series of different doses of gamma radiation (3krad, 30krad, 3Mrad, 
and 9Mrad) in the Gammacell unit at the University of Leicester.  Control samples were 
also prepared and transported to the University of Leicester under the same conditions 
as the exposed samples, but were stored at room temperature and not exposed to 
gamma radiation during the experiment.  After the exposures the samples were 
transported to Cranfield University and the fluorescent properties analysed in the Cary 
Eclipse Varian Spectrophotometer. 
 
3.3.4.2 Determination of the maximum tolerated gamma radiation dose for fluorescein – 
results and discussion 
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Figure 3.23: Effect of Gamma irradiation on fluorescent emission intensity of dried down and liquid 
fluorescein.  The error bars represent standard errors of the mean intensities from triplicate samples.  
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Figure 3.23 shows the effect of this series of gamma irradiation doses on the peak 
emission intensity of fluorescein.  It is clear that, in contrast to the initial experiment 
(section 3.3.1.2), the peak emission intensity of dried fluorescein samples appears to be 
very similar or slightly greater than the corresponding samples in the liquid state.  This 
shows that the modifications to sample preparation methods throughout this work have 
resulted in a significantly more reliable protocol.  As with the particle radiation sample 
preparation described in section 3.2.1, this is due to the freeze-drying procedure 
causing significant loss of material from the sample vials, in particular when the vacuum 
is applied.  The drying down method based on heating at 37°C in a sealed vessel 
containing desiccant removed the problem of poor reproducibility in sample preparation 
since a vacuum was not required.  Additionally, there appears to be a trend in the dried 
samples in which lower radiation doses, 3krad and 30krad, show a significantly higher 
peak emission intensity than the control sample (P=98.59% and 98.72% by Student‟s t-
test, respectively).  However at higher gamma exposures, 3Mrad and 9Mrad, the 
fluorescent intensity is not significantly different from the controls (P=91.18% and 
74.23% by Student‟s t-test, respectively).  If this effect were proven to be reproducible 
with larger sample numbers, gamma radiation treatment could have applications in 
increasing the emission intensity of fluorescein and possibly other fluorescent dyes.  
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Figure 3.24: Effect of Gamma irradiation on fluorescent peak emission wavelength of dried down and 
liquid fluorescein.  The error bars represent standard errors of the mean intensities from triplicate 
samples. 
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Figure 3.24 shows the effect of these gamma radiation exposures on the peak emission 
wavelength of fluorescein.  All of the results appear very similar, so it is clear that any 
changes in peak emission wavelength have been very small, except in the case of the 
9Mrad liquid sample.  In this sample the fluorescent emission intensity when the sample 
was excited at 488nm (the excitation wavelength of fluorescein used throughout these 
experiments) was below the detection limit of the spectrophotometer, sp no peak 
emission wavelength could be recorded.  This result is consistent with the previous 
experiment (see section 3.3.3.2), and continues to support the conclusion that changes 
in the peak fluorescent wavelengths are unlikely to occur during the ExoMars mission 
and therefore the selection of components such as light sources and filters will not be 
complicated by changes in the wavelengths of the dye due to radiation exposure. 
 
3.3.4.3 Determination of the maximum tolerated gamma radiation dose for fluorescein – 
conclusions 
 
As observed in previous experiments (see sections 3.3.1 and 3.3.2), gamma radiation 
up to 3Mrad does not appear to have a great effect on fluorescein exposed in the dried 
state.  However, after exposure to 9Mrad of gamma radiation the emission intensity of 
dried fluorescein has been reduced by ~10% compared to the control.  However, in the 
liquid state, while the dye appears to be unaffected by gamma radiation up to exposures 
of 30krad, after a 3Mrad exposure the emission intensity has been reduced to below 
25% of the untreated sample, and no fluorescence is observed at all after a 9Mrad 
exposure. 
 
This experiment supports the initial hypotheses that samples in the liquid state would be 
less resistant to radiation damage due to the possible interaction of the radiolytic 
products of water (free radicals and ions) with the dye structure.  It has also provided 
some evidence that gamma irradiation could be used as a sterilisation method for 
astrobiology instruments, such as the Life Marker Chip, that contain labelled biological 
molecules, since the fluorescent properties of the dyes were not significantly affected at 
representative sterilisation doses (3Mrad) (as given by Grieb et al., 2002).  It may be of 
scientific interest in the future to investigate the cause of the small loss of fluorescent 
intensity observed after the 9Mrad exposure (for example by carrying out thin layer 
chromatography and/or Nuclear magnetic resonance on exposed dye samples to 
identify degradation products).  This is discussed further in section 6.2. 
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3.3.5 Summary of Gamma Irradiation Experiments 
 
 
In this series of gamma irradiation experiments, the potential for the use of the 
fluorescent dyes fluorescein and Alexa Flour® 633 has been investigated.  Methods 
have been developed to expose these or similar dyes to gamma irradiation in the dried 
state in a reproducible way, such that dried and reconstituted control samples have 
similar fluorescent emission intensity and identical peak wavelength to liquid control 
samples (see Figure 3.23 and Figure 3.24).  This method development is, in itself, an 
important step towards the validation of biological assays utilising fluorescent dyes in 
astrobiology instruments such as the Life Marker Chip. 
 
The experiments have shown that in addition to retaining their fluorescent properties 
after exposure to equivalent mission doses of gamma irradiation in both the liquid and 
dried state, a sterilisation dose of gamma irradiation does not significantly degrade the 
dyes used in these experiments in a dried down form.  The finding that up to a hundred 
times the expected mission dose (in the case of Alexa Fluor® 633) and up to 3Mrad (in 
the case of fluorescein), does not significantly affect the fluorescent properties of these 
dyes in terms of their peak emission wavelength and fluorescent intensity, is a key 
result supporting the use of biological assays based on fluorescent dye labels in 
astrobiology missions to Mars.  In addition, these results support gamma irradiation as a 
potential method for sterilising the instrument prior to launch, another important 
consideration for astrobiology instruments since is it paramount that viable organisms 
from terrestrial sources are eliminated, for the purpose of meeting planetary protection 
requirements (see section 2.1.1.4).  However further work needs to be done to establish 
the reasons for some loss of fluorescence, particularly if this arises from fragmentation 
of dye molecules. 
 
The expectation would be that structurally similar dyes, for example Alexa Fluor® 750, 
would behave in a similar way to the specific dyes used in these experiments, so the 
instrument design could potentially be modified to use different dyes if required.  This is 
important for the flexibility of the design of the Life Marker Chip, since at the time of 
writing the breadboard model of the SMILE Life Marker Chip is designed to be based on 
Alexa Fluor® 633, but due to the availability of lower mass and more intense optical 
sources other dyes including Alexa Fluor® 750 are still being considered for the flight 
instrument.   Therefore if a different dye was selected further gamma radiation testing 
would be required to confirm this hypothesis that the effects would be similar. 
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No gamma irradiation studies on antibodies were performed during this work.  This was 
in part due to time constraints, and the finding that in previous publications antibodies 
have been exposed to sterilisation doses of gamma radiation and found to show little 
structural damage and retain their binding affinity for their specific antigen in 
immunoassays (Cabalero et al., 2004, Grieb et al., 2002).  These findings indicate that 
antibodies will be suitable for use in the Life Marker Chip, but tests are planned in the 
future to confirm the findings in the literature (see section 6.2). 
 
3.3.6 Particle and gamma radiation testing summary 
 
In sections 3.1 and 3.3 a number of radiation tests have been carried out on fluorescent 
dyes and antibodies to determine firstly whether these reagents could survive the likely 
levels of radiation encountered during a mission to Mars, and secondly whether gamma 
irradiation could be considered as a possible radiation treatment. 
 
None of the radiation conditions tested to data have resulted in complete inactivation of 
either the dye or antibody under exposures at levels comparable with the (un-shielded) 
mission scenario, or even a 10-100 times greater exposure than the levels expected for 
the ExoMars mission.  This was critical in establishing that a labelled antibody-antigen 
based detection system was a feasible technology for the detection of organic 
biomarkers on Mars in the Life Marker Chip.   
 
Further work still needs to be carried out particularly testing the effect of gamma 
irradiation on antibodies and lower energy protons and helium ions on both antibodies 
and fluorescent dyes, and whether irradiation of assembled devices has a different 
effect than irradiation of dried antibody in isolation (see section 6.2).  The effect of 
neutrons and combinations of radiation types also need to be investigated, and tests are 
planned to investigate this.  The SMILE Life Marker Chip consortium are preparing a set 
of samples of LMC components for exposure to the space environment including launch 
and re-entry on the BIOPAN-6 mission in September 2007.  This opportunity will allow 
antibody and fluorescent dye samples and microarrays mounted on silicon wafers to be 
exposed to the complete spectrum of space radiation (although at dose levels 
significantly lower than those expected for ExoMars) and will take into account different 
levels of shielding. 
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Since these radiation tests have proved that gamma radiation at the expected mission 
levels for ExoMars did not cause significant degradation of fluorescent dyes, sterilisation 
doses were also tested.  The results of gamma irradiation of fluorescein at sterilisation 
doses showed that while a sterilisation dose of gamma irradiation would significantly 
degrade fluorescein in aqueous solution, dried fluorescein was much less susceptible to 
damage.  Antibodies have been used in immunoassays after exposure to sterilisation 
doses of gamma radiation (Grieb et al., 2002), indicating that they would survive the 
ExoMars mission environment. 
 
In order to confirm the need for an alternative sterilisation method for the Life Marker 
Chip, a number of heat sterilisation tests were carried out, and the results of these are 
included in the following section.  
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3.4 Heat sterilisation tests on antibodies and fluorescent dyes 
 
As stated in section 2.1.1.4, heat sterilisation is a standard method to reduce the 
spacecraft bioburden, i.e. the spore count per m2. While this may inactivate viable 
organisms, it may not remove all potential contamination from the Life Marker Chip, 
since organic materials e.g. cellular components and their degradation products may 
remain and could be a source of false positive measurements.  A higher level of 
cleanliness may be required to remove all organic contamination from the LMC, but the 
purpose of the experiments carried out in this work was to establish whether antibody-
based assays could be incorporated into the ExoMars rover prior to the heat sterilisation 
procedure.  The critical components i.e. antibodies and fluorescent dyes were therefore 
subjected to a heat sterilisation procedure to determine how much, if any, activity they 
retained.  There are several standard protocols for heat sterilisation, but during these 
experiments we adopted a method from the NASA Procedures and Guidelines 
document NPG: 8020.12B, which consisted of holding the samples under vacuum at 
125°C for 50 hours.  The heat sterilisation is performed under vacuum, which removes 
water and oxygen.  This therefore prevents prevent degradation of the antibodies and 
fluorescent dyes by reaction with water and oxygen, and may increase their stability. 
 
The exposures were carried out in a vacuum oven chamber at the University of 
Leicester.  This equipment was capable of generating a high vacuum and maintaining 
the required temperature for 50 hours. 
 
3.4.1 Preliminary heat sterilisation test – materials and methods 
 
A custom aluminium sample holder was designed and fabricated for the exposure of 
fluorescent dyes and antibodies to heat sterilisation protocols.  This consisted of sample 
wells 1.5mm in diameter and 8mm deep, machined in an aluminium block (see Figure 
3.26).  The dimensions of the wells were based on the approximate dimensions of the 
864 well microtitre plate wells used in the second run of particle radiation experiments, 
since controlled sample handling in the microtitre plate wells was possible.  Aluminium 
was selected as the sample holder material because it was conveniently available, easy 
to machine and has a high thermal conductivity, thus would transfer the maximum 
amount of heat to the samples (continuing the “worst-case” scenario testing philosophy 
used throughout this work). 
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As was the case for the early work in both gamma and particle radiation studies, this 
work was carried out in parallel so the same reagents were as used in early 
experiments.  25μl of fluorescein (Sigma-Aldrich, Poole, UK, product code 32615) in RO 
water at a concentration of 0.5mg.ml-1 was added to each sample well.  The sample 
block was then placed into a freezer at –80°C for 3 hours to ensure complete freezing of 
the sample.  The sample block was then transported in a cool box and dried in a freeze-
drier (Edwards Modulyo) for 3 hours, starting the freeze-drying process as quickly as 
possible, to ensure minimum thawing of the samples.   
 
The sample block was then wrapped in aluminium foil and placed in a petri dish 
containing excess self-indicating silica gel desiccant while the samples were transported 
to the University of Leicester, to minimise the amount of water present in the sample 
prior to the heat sterilisation and prevent particulate contaminants entering the sample 
wells.   
 
A Mars environment simulation chamber (University of Leicester) consisting of a 
pressure-sealed chamber with access to a vacuum pump and oven was used for all 
heat sterilisation tests.  The sample block was placed inside and a high vacuum applied, 
then the chamber was heated to 125°C for 3 hours.  After this treatment the sample 
block was returned to Cranfield University under the same transportation conditions as 
described.  The fluorescein was reconstituted into 1ml of deionised water to a final 
concentration of 0.0025 mg.ml-1.  This was carried out by adding 10μl of RO water to 
each of the wells in the aluminium block and incubating for 1 minute to allow the 
fluorescein to dissolve, then transferring that 10μl from the wells to a vial containing 
900μl deionised water.  This was repeated 9 times to give a total of 10 washes with RO 
water.  The peak emission and absorption wavelengths and intensities of the dye 
samples were then tested in the Cary Eclipse Varian Spectrophotometer. 
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3.4.2 Preliminary heat sterilisation testing - results and discussion 
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Figure 3.25: Effect of a heat sterilisation run consisting of 125°C for 3 hours on the fluorescent properties 
of fluorescein.  The error bars represent standard errors of the mean intensities from triplicate samples. 
 
In this initial test only one sample was exposed to the heat sterilisation procedure.  
Given that the results of the proton and gamma radiation tests carried out using similar 
sample preparation procedures were not very reproducible (see sections 3.2.3.2 and 
3.3.1.2), few definite conclusions can be drawn from the result in Figure 3.25.  The 
results only confirm that the fluorescent properties of fluorescein were not completely 
inactivated by this heat treatment, and that the peak emission wavelength was not 
affected.   A similar set of changes in procedure to those implemented for the gamma 
and proton work after the initial test run were also considered and incorporated into the 
next heat sterilisation run.   
 
An additional factor that would contribute to poor reproducibility heat sterilisation test 
was that manually inserting and particularly removing samples from the 1.5mm diameter 
aluminium block wells was extremely difficult to do in a reproducible way.  In contrast to 
the polystyrene 864 well microtitre plates and sample blocks used for the particle 
radiation exposures, the aluminium block is not transparent and has a much more 
hydrophilic surface.  These two factors in combination meant that even using a thinner 
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than standard pipette tip it was extremely difficult to avoid creating air bubbles inside the 
wells when filling them with solution, and consequently over-filling the wells and 
contaminating adjacent wells.   
3.4.3  Modified protocol for heat sterilisation testing  
 
The simplest solution to the difficulty in manually placing and removing liquid samples 
from the aluminium block wells was to machine larger plate wells into the block, 
therefore wells of 3mm diameter and 8mm depth were drilled into the aluminium block 
and used for all subsequent heat sterilisation experiments (see Figure 3.26).  In 
addition, as for the gamma and particle radiation tests (see sections 3.2.3.2 and 
3.3.1.2), in the second run fluorescein sodium salt (Sigma-Aldrich, Poole, UK, Product 
Code 46960) was used in the second run to increase the reproducibility of the results.  
 
3.4.3.1 Modified protocol for heat sterilisation testing – materials and methods 
 
10μl of either 1mg.ml-1 fluorescein sodium salt or 1mg.ml-1 Alexa Fluor® 633 in RO water 
was placed in each well.  The freeze-drying protocol was modified to include immersing 
the sample block in liquid nitrogen for 1 minute immediately prior to freeze-drying.  This 
was done to prevent the sample melting at the interface and therefore allowing trapped 
air to cause samples to be ejected from the block under vacuum.   
 
 
Figure 3.26: Second design of the heat sterilisation sample block. 
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After immersion in liquid nitrogen the sample block was immediately placed into the 
freeze-drier and the freeze-drying process started.  As in the previous experiment, the 
samples were freeze-dried for 3 hours, and after removal from the freeze-drier the 
sample was stored with excess silica gel desiccant for transportation to the Mars 
environment simulation chamber. 
 
After placing the sample block in the heating chamber, a high vacuum was applied, and 
then the chamber was heated to 125°C and held at that temperature for 50 hours.  The 
sample block was then returned to Cranfield University under the same transportation 
conditions as described.  The fluorescein and Alexa Fluor® 633 samples were 
reconstituted into 1ml of deionised water to a final concentration of 0.0025 mg.ml-1, 
using the protocol described in section 3.4.1.  The peak emission and excitation 
wavelength and intensity of the dye samples were then tested in the Cary Eclipse 
Varian Spectrophotometer. 
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3.4.3.2 Modified protocol for heat sterilisation testing – results and discussion 
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Figure 3.27: Effect of modified heat sterilisation on the fluorescent emission properties of fluorescein.  
Error bars represent the standard error of the mean fluorescent intensity from 5 samples exposed to 
radiation and 4 control samples. 
Figure 3.27 shows the results of this heat sterilisation protocol on the fluorescent 
emission properties of fluorescein.  While there are still some problems with 
reproducibility of the intensity, which was thought to be due to further issues with the 
freeze-drying sample preparation method (as seen from the relatively large error bars), 
it is clear that the 50 hour heat sterilisation treatment has not had a significant adverse 
effect on the fluorescent properties of fluorescein.  The peak emission wavelength was 
not affected, and while the average emission intensity is lower after the heat sterilisation 
treatment this is within the experimental error, so no conclusions can be drawn from this 
in terms of significant differences. 
Paul Kerr Wilson                               Exposure of Fluorescent Dyes and Antibodies to simulated Radiation and Sterilisation protocols  
Development of Life Marker Chip Technology for in-situ Life Detection on Mars                                  Page 119 of 206 
0
200
400
600
800
1000
1200
1400
1600
1800
H
ea
t S
te
ril
is
ed
 A
le
xa
 F
lo
ur
 6
33
 
C
on
tro
l
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 /
 a
rb
. 
u
n
it
s
600
610
620
630
640
650
660
670
680
690
700
P
e
a
k
 e
m
is
s
io
n
 w
a
v
e
le
n
g
th
 /
 n
m
Intensity
Wavelength
 
Figure 3.28: Effect of modified heat sterilisation on the fluorescent emission properties of Alexa Fluor
®
 
633.  Error bars represent the standard error of the mean fluorescent intensity from 3 samples exposed to 
radiation and 3 control samples. 
Figure 3.28 shows the results of this heat sterilisation protocol on the fluorescent 
emission properties of Alexa Fluor® 633.  In this case, the emission intensity of the heat-
sterilised dye is significantly lower than the control.  However, since the control dye was 
not exposed to either freeze-drying or heat sterilisation, it is not possible to determine 
whether this was due to material loss caused by the freeze-drying process or any effect 
of the heat treatment.  Regardless of the cause of this loss of intensity, the effect of this 
reduced fluorescence on the detection limit of the instrument must be determined if heat 
sterilisation is used in the flight instrument.  Importantly, the peak excitation and 
emission wavelength was not affected so changes in fluorescent wavelengths do not 
have to be considered in the selection of the excitation light source or excitation and 
emission filters on the flight instrument,   
 
Since at this stage in the project drying down fluorescent dye and antibody samples into 
sample wells and vials had been proven to increase the reproducibility of the fluorescent 
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dye signal in particle and gamma radiation exposures, this approach was also adopted 
for the following heat sterilisation experiment.   
 
3.4.4 Improved reproducibility heat sterilisation test  
 
In order to improve the reproducibility of the results for heat sterilisation tests, a third 
round of testing was carried out in which the fluorescent dye and antibody samples 
were dried down into the aluminium block wells using the same procedure as for the 
particle and gamma radiation tests (see section 3.2.4.5), i.e. placing the sample block in 
a sealed vessel containing silica gel desiccant and heating it to 37°C overnight. 
 
3.4.4.1 Improved reproducibility heat sterilisation test – materials and methods 
 
In this heat sterilisation test run, 30μl of 1mg.ml-1 fluorescein sodium salt (five samples), 
30μl of 0.1 mg.ml-1 Alexa or 30μl (three samples), or 0.3mg.ml-1 anti-atrazine scAb 
(three samples) were placed into 3mm diameter wells in the aluminium block.  The 
sample block was then placed into a sealed vessel containing excess silica gel 
desiccant, and the vessel placed into an oven at 37°C overnight to remove the water 
from the samples.  The method used for the previous heat sterilisation test was then 
repeated for this test run (see section 3.4.3.1).  
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3.4.4.2 Improved reproducibility heat sterilisation test – fluorescein results and 
discussion 
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Figure 3.29: Effect of optimised heat sterilisation on the fluorescent emission properties of fluorescein.  
Error bars represent the standard error of the mean fluorescent intensity from 5 samples exposed to 
radiation and 3 control samples. 
Figure 3.29 shows the effect of this 125°C heat sterilisation for 50 hours on fluorescein.  
It is clear that the reproducibility has improved compared to the previous experiments, 
as more samples were tested only single samples were tested in the preliminary 
experiment)  and the error bars have become smaller.  However, this procedure could 
be developed to further improve the quality of the results.  Nonetheless, Figure 3.29 
shows that the heat sterilisation procedure does not have a significant effect on dried 
down fluorescein, either on the peak emission wavelength or intensity.  Similar results 
were found for the excitation properties (data not shown).   
 
In the previous heat sterilisation experiment, the poor reproducibility of the sample 
handling process was a big contributor to the result.  In contrast the improved 
reproducibility of these results allows more reliable interpretation of the effect of heat 
sterilisation on the biological material than the previous heat sterilisation experiment, so 
the conclusions for this section are based primarily on these results. 
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3.4.4.3 Improved reproducibility heat sterilisation test – Alexa Fluor® 633 results and 
discussion 
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Figure 3.30: Effect of optimised heat sterilisation on the fluorescent emission properties of Alexa Fluor
®
 
633.  Error bars represent the standard error of the mean fluorescent intensity from 5 samples exposed to 
radiation and 3 control samples. 
Figure 3.30 shows the effect of the 50 hour 125°C heat sterilisation on Alexa Fluor® 
633.  As for the fluorescein, it is clear that the reproducibility has improved compared to 
the previous experiments, but further improvements to the quality of the results could be 
made.  However, this result demonstrates that the peak emission wavelength is not 
affected by heat sterilisation at all, and any reduction in emission intensity is small.  
Similar results were found for the excitation properties (data not shown).  As for the 
fluorescein results for this experiment, these results were far more reproducible than the 
previous experiment which gave the opposite conclusions (see section 3.4.3.2), 
therefore these results are considered to be more reliable.   
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3.4.4.4 Improved reproducibility heat sterilisation test – anti-atrazine scAb results and 
discussion 
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
-7 -6 -5 -4 -3
Log10 Antibody Concentration / mg.ml
-1
O
p
ti
c
a
l 
d
e
n
s
it
y
 a
t 
4
5
0
n
m
 (
a
.u
.)
Heat Sterilised Sample 1
Heat Sterilised Sample 2
Liquid Control
 
Figure 3.31: Effect of heat sterilisation on the antigen binding properties of anti-atrazine scAb assessed 
by binding ELISA.  The error bars represent the standard error of the mean binding signal from triplicate 
samples. 
Figure 3.31 shows conclusively that antibody fragments do not withstand heat 
sterilisation at 125°C for 50 hours.  This is not an unexpected result, and could be due 
to a number of factors.  These include denaturation of the antibody, which would 
destroy the binding site for the target molecule and render the antibody inactive in the 
assay.  Also in this experiment since a secondary antibody (anti-human kappa light 
chain) was used in the assay, damage to the region targeted by this secondary antibody 
may also affect the antibody binding signal measured.  It is likely that all antibodies and 
proteins that may be used in the Life Marker Chip would behave in a similar way under 
these heat sterilisation conditions, so dry heat sterilisation appears to be an unsuitable 
approach for preventing terrestrial contamination of the Life Marker Chip. 
3.5 Summary and conclusions from radiation and sterilisation experiments 
 
In sections 3.1, 3.3 and 3.4 of this chapter, three sets of experiments were carried out in 
parallel to determine the effect of different aspects of the mission environment; gamma 
radiation, particle radiation and heat sterilisation, on both fluorescent dyes and 
antibodies.  Through a series of experiments, a protocol was developed to expose the 
antibody and fluorescent dyes to each of these environments in a controlled and 
reproducible way.  In the final experimental formats, none of the heat sterilisation tests 
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has shown a large enough detrimental effect on the fluorescent dyes to invalidate their 
use in the conditions that they would encounter in Life Marker Chip instrument.  Heat 
sterilisation has been shown to be inappropriate for antibodies.  However, this work has 
demonstrated that fluorescent dyes survive gamma radiation sterilisation doses, albeit 
with some degradation of their excitation and emission intensities, and gamma radiation 
for the sterilisation of antibodies have been reported in the literature (Grieb et al., 2002).  
Therefore, it may be possible to sterilise the Life Marker Chip by gamma radiation, and 
therefore dry heat sterilisation would not be required.  
 
Both fluorescein and Alexa Fluor® 633 in a dried down state appeared to retain their 
fluorescent properties with little or no change in fluorescent intensity or peak emission 
or excitation wavelengths under a number conditions.  These included gamma radiation 
up to and beyond the 3Mrad levels used for sterilisation, 9MeV protons up to and 
beyond 10,000 times the expected mission fluence, 30MeV helium ions at least 100 
times greater than the expected mission fluence, and heat sterilisation at 125°C for 50 
hours.  In addition, in the liquid state the fluorescent dyes were not significantly affected 
by the expected mission dose of gamma radiation.   
 
The anti-atrazine scAb, representative of one of the types of antibody proposed for the 
flight instrument, was also not rendered inactive by the environments used in these 
experiments.  The antibody was found to lose approximately half of its binding affinity 
after exposure to 10 or 100 times the expected mission fluence of 9MeV protons, and 
was not affected by up to 100 times the expected fluence of 30MeV helium ions.  The 
antibody did not however retain any function after the heat sterilisation treatment, 
confirming that an alternative sterilisation method must be identified for the flight 
instrument.  Unfortunately there was no opportunity to expose the anti-atrazine scAb to 
gamma irradiation in the timescale of this work, however this will be carried out in future 
work as part of the development of the Life marker Chip. 
 
Since this work none of the mission environments tested to date proved to be 
fundamentally incompatible with the use of antibodies and fluorescent dyes in 
astrobiology mission to Mars, the development of the Life Marker Chip was continued in 
the area of developing a suitable instrument platform in which the fluorescently labelled 
antibody assay could be incorporated into the mission design specifications including 
mass and size.  This involved miniaturising standard biological assays from the ELISA 
plate format to a protein microarray design.  This work is described in the following 
chapter. 
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Chapter 4: Development of the Life Marker Chip Microarray Readout Breadboard 
System 
4.1 Introduction 
 
 
As discussed in the literature review, all of the proposed instrument designs for the Life 
Marker Chip (LMC) are based on a protein microarray assay system operating within 
microfluidic channels.  While the technologies required to achieve the proposed specification 
of each component do exist, no complete system incorporating all aspects had been 
developed prior to this work.  In this chapter, the development of an example assay and 
breadboard instrument using representative assay systems (utilising anti-atrazine scAb and 
anti-GroEL antibody receptors) will be described. 
 
The main objectives of this instrument development work were to demonstrate the following: 
 
 Printing of homogeneous microarray spots within a microfluidic channel 
 Imaging of fluorescent microarray spots within a microfluidic channel 
 Demonstration of an immunoassay in a microarray spot format within a channel 
 Developing a suitable blocking protocol to minimise non-specific binding 
 Functionalisation of glass and silicon surfaces to enable covalent attachment of 
proteins and antibodies 
 Demonstration of covalent immobilisation of spotted reagents onto surfaces 
 
Since demonstration of pin-printing of microarray spots was a critical step for many of these 
objectives, and had not previously been carried out at Cranfield University, a series of 
experiments were conducted in order to confirm that the microarray equipment was 
functioning as expected.  Initially the printed spots were imaged with a fluorescent 
microscope or a Digital Blue QX3 microscope, and dyes and fluorophores compatible with 
these imaging systems were used.  The fluorescent microscope readout was used in an 
initial demonstration that fluorescence-based immunoassays of the type proposed for the 
SMILE Life Marker Chip instrument could be carried out and imaged fluorescently with 
available equipment.  The results of these experiments were not analysed in detail, since 
they were not directly relevant to the development of the Life Marker Chip, but are included in 
Appendix A.   
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After the initial work had been completed, additional funding became available and allowed 
the assembly of a breadboard imaging system that was more representative of the flight 
design of the Life Marker Chip.  The breadboard system was used to establish readout 
protocols for immunoassays for relevant biomarker molecules in the proposed microarray 
format, test additional fluorescent dyes, develop an additional assay, and to investigate 
means to reduce non-specific binding.  The flight design of the Life Marker Chip is based on 
silicon wafers, which, unlike the glass microscope slides used in this study, are not available 
pre-treated with a surface chemistry to allow the covalent attachment of proteins and 
antibodies.  Therefore a standard method to functionalise glass and silicon surfaces was 
adopted and demonstrated on silicon and glass components, in order to show that these 
materials could be functionalised for inclusion in the breadboard system and the flight 
instrument.  The first key development in this area was the assembly of the breadboard 
system, which is described in the following section. 
4.2 Development of a breadboard imaging system and adaptation of assay protocols 
to use representative Life Marker Chip biomarker targets and Alexa Flour® 633 
dye  
4.2.1 LMC readout design considerations and development of the breadboard imaging 
system – introduction 
 
The preliminary experiments and method developments made in Appendix A confirmed that 
it is possible to fabricate an antibody or protein microarray chip with the desired array and 
spot sizes (100 - 200µm) for the flight Life Marker Chip instrument (as described in section 
2.3.1).  However, the readout and immobilisation methods in these experiments were not 
representative of the proposed instrument, and the assay used was not directly 
representative of a true biomarker target.  In this section, the development of an imaging 
system more closely representative of the flight model designed for the Life Marker Chip is 
described, followed by the development of an additional assay using a biomarker target 
relevant to Life detection, and the optimisation of this assay protocol.  In addition, protocols 
for the surface modification of glass and silicon services to introduce functional groups for the 
covalent attachment of proteins to the surface were developed. 
 
Throughout the Life Marker Chip development, fluorescent dyes of higher wavelengths (red 
and near infra-red) were always thought to be more suitable for space flight and use in a 
radiation environment than lower wavelength dyes (green and blue).  There are a number of 
reasons for this, including that longer wavelength dyes are less prone to interference from 
auto-fluorescence that could reduce the sensitivity.  Use of longer wavelength dyes would 
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therefore mean that the instrument could achieve a higher sensitivity, which is important 
since the concentration of biomarker targets in the samples is likely to be very low, in the 
parts per billion range (Sims et al., 2005).  Another factor is that optical glasses (for example 
in lenses in the imaging system) can lose some of their transmission properties when 
exposed to radiation, particularly at blue end of spectrum (Firestone & Harada, 1979), 
therefore potentially reducing their transmission of light at lower wavelengths.  Other 
considerations for dye selection include some resistance to photobleaching in ambient light, 
since some experiments such as the radiation tests in Chapter 3 require handling the dye in 
ambient light for small amounts of time, and availability in a convenient format for protein 
labelling, as developing a protocol for in-situ labelling of proteins is a key objective of this 
section.  
 
Taking these factors into consideration, the dye selected for further investigation for use in 
the Life Marker Chip was Alexa Fluor® 633, which operates at a long wavelength (in the near 
infra red region), and has a high resistance to photobleaching.  It is available in a succimidyl 
ester form, which allows it to be covalently attached to both proteins and functionalised 
surfaces if required.  Another potential benefit of Alexa Fluor® 633 is that structurally similar 
dyes operating at other wavelengths are available, so that if the development of the Life 
Marker Chip indicated that a change of wavelength would aid in design of the flight 
instrument, the work done with the fluorescent dye would still have some relevance if a 
similar dye was used.  
4.2.2 Breadboard imaging system development - specifications and assembly 
  
In order to be able to detect these longer wavelength dyes with reasonable sensitivity and 
exposure times, and in a format similar to a possible LMC flight instrument design, a 
breadboard system was assembled for optical imaging of microarrays at 633nm.  The layout 
of this breadboard is shown in Figure 3.2.1.  A microscope slide holder was attached to an X-
Y-Z translation stage, which was in turn mounted on a manual rotation stage.  This entire 
assembly was placed onto an optical rail (all components were from Edmund Optics York, 
UK).  A 10mW Helium-Neon 633 laser (Polytec, Waldbrom, Germany) was mounted in front 
of the microscope slide holder, and positioned such that the central position of the stage 
movement axes was directly in front of the laser.  The rotation stage was adjusted such that 
the microscope slide holder was at an angle of ~30° from the laser beam.  A second optical 
rail was placed facing directly towards the microscope slide holder.  A low light level Peliter-
cooled CCD camera (SXV-H9, Starlight Express, Holyport, Berkshire, UK) was mounted on 
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an X-Y stage, and this assembly mounted on the second optical rail facing the microscope 
slide.  The X-Y stage allowed movement of the camera for focussing images.  The SXV-H9 
camera was selected because it is black and white camera, and was a reasonable 
compromise between cost and pixel density on the CCD chip (it has 1392 x 1040 pixels in a 
8.9 x 6.7mm area).  A number of optical spacers (Edmund Optics, York, UK) were mounted 
onto the CCD camera to reduce the focal distance to approximately 2.5cm, as to achieve 
maximum sensitivity, the objective should be as close to the surface as possible.  2.5cm was 
the smallest focal length that could be practically achieved with the available equipment, and 
offered the best compromise between having a wide field of view and imaging detail within 
the spots.  A x4 microscope objective was also added to provide some magnification of the 
image of the surface.  The images taken with the CCD camera in this configuration show an 
area of approximately 2mm x 2mm.  A notch filter with an optical density of 6 at 633nm was 
mounted within a specialised optical spacer in front of the CCD camera.  This filter is 
designed to block out much of the reflected and scattered 633nm light from the surface, to 
allow images to taken without fluorescent light being saturated out by reflected or scattered 
incident light (as would be the case without the notch filter present). 
 
 
4.3 Determining the detection limits of the new breadboard imaging system – 
introduction 
 
In order for this imaging system to be used for the readout of immunoassays it was 
necessary to be able to produce images of monolayers of fluorescently labelled proteins or 
Figure 4.1 Schematic layout of the breadboard imaging system. 
He-Ne 633nm Laser 
Sample 
Beam Expander (not used 
in initial experiments) 
CCD Camera 
633nm Notch Filter 
Optical spacer 
Microscope 
objective 
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antibodies in microarray spots.  Therefore, to show that this was possible before attempting 
an immunoassay, the detection limit of the newly assembled imaging system was determined 
by printing microarray spots from different concentrations Alexa Fluor® 633 in RO water onto 
a glass microscope slide, drying the slide to remove the liquid, and then imaging the slide.  A 
series of appropriate concentrations of Alexa Fluor® 633 dye to model a monolayer was 
calculated as follows. 
 
Given that the nominal spot diameter of the SMP3B spotting pin spots is 110µm 
(http://arrayit.com/Products/Printing/Stealth/stealth.html, accessed 03 April 2007) (see 
Appendix A), and that the molecular footprint area of a protein is typically ~100Å2, one can 
calculate that a monolayer of protein molecules covering the whole spot area would contain 
~95,000,000 protein molecules. 
 
Since the nominal volume of liquid deposited by the SMP3B spotting pin is 900 pl 
(http://arrayit.com/Products/Printing/Stealth/stealth.html, accessed 03 April 2007) (see 
Appendix A), and the molecular weight of the Alexa Fluor® 633 dye is 1200Da, one can 
calculate approximate values for the number of dye molecules per protein footprint area for 
Alexa Fluor® 633 dye solutions of different concentrations, assuming that the dye is dried 
down evenly across the whole of the spot area as the spot solution evaporates.  Since during 
a covalent immobilisation, not all of the immobilised protein may be available for antibody-
antigen interaction, in this simple model it is assumed that 50% of the protein footprint sites 
may contain immobilised antibody / antigen.  A series of calculations of relevant Alexa Fluor® 
633 concentrations are shown in Table  4.1 
Table  4.1  Calculation of the resulting number of dye molecules per protein for a series of Alexa Fluor
®
 633 dye 
concentrations after the spotting solution was evaporated away from the surface.  This calculation assumes a 
monolayer of protein covering the whole spot area, a molecular footprint size of 100Å
2
 for the protein or 
antibody on the surface and an even distribution of dye across the spot area when the spotting solution is 
evaporated off. 
Concentration of 
Alexa Fluor ® 
633 in spotting 
solution (mg.ml-1) 
Mass of 
dye per 
spot (g) 
Molecular 
Weight of 
Alexa 
Fluor® 633 
(Da) 
Moles of 
dye per 
spot 
(Moles) 
Number of dye 
molecules per 
spot 
50% of no. of 
dye 
molecules 
per protein 
footprint  
10-2 9E-12 1200 7.5E-15 4515000000 23.754862 
10-3 9E-13 1200 7.5E-16 451500000 2.3754862 
10-4 9E-14 1200 7.5E-17 45150000 0. 2375486 
10-5 9E-15 1200 7.5E-18 4515000 0.02337548 
 
In immunoassays targets are typically labelled with between 5 and 20 dye molecules per 
protein (Document No. MP10168 (Alexa Fluor® Succimidyl Esters), Molecular Probes).    
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Table  4.1 shows that, if the simple modelling scenario used was valid, printing and imaging 
spots from a range of Alexa Fluor® 633 concentrations between 10-2 and 10-5 mg.ml-1 would 
be appropriate to confirm that the imaging system could image protein microarray spots both 
at typical labelling levels, and with fluorescent labelling levels down to ~0.02 dye molecules 
per available protein binding site.  If such spots could be imaged, the levels of fluorescence 
would correspond to the level of fluorescence from a monolayer of labelled material bound to 
a protein or antibody on the surface that would be present in an immunoassay.   
  
4.3.1 Determining the detection limits of the new breadboard imaging system – materials 
and methods 
 
Alexa Flour® 633 dye in RO water was spotted on untreated glass microscope slides (Fisher 
Scientific, Loughborough, UK) at a number of different concentrations (1x 10-2mg.ml-1 and a 
series of 10-fold dilutions down to 1x 10-5 mg.ml-1) to cover the range of surface dye 
concentrations representing those calculated for a monolayer in Table  4.1.   
 
The microarray equipment and robotic control software used for microarray printing 
throughout this work are described in detail in Appendix A.  Briefly, the equipment comprises 
Stealth™ SMP3B spotting pins (Telechem International, Sunnydale, CA, USA) with a nominal 
spot size of 110µm diameter placed in a Stealth™ print head.  The print head is mounted on 
an optically controlled robot which can be programmed to move to a series of locations with 
sub-micron positional accuracy. 
 
The spotting program for this experiment printed the microarray with a 600µm centre-to-
centre spacing between adjacent spots, in both horizontal and vertical directions.  The 
spotting robot program printed each dye solution in increasing order of dye concentration i.e. 
the lowest concentration of dye was printed first to form the top row of the array, the next 
highest concentration was printed in the second row, etc..  This protocol required some 
washing of the spotting pin to remove one concentration of dye solution before printing the 
following solution.  A study on Stealth™ SMP3 spotting pins 
(http://www.fda.gov/nctr/science/journals/text/vol6iss1/rrp0306.htm Accessed: 23-Oct-06) 
showed that 5 cycles of washing in deinionised water with sonication removed all carry over 
between two oligonucleotide solutions.  Since the Alexa Flour® dyes are highly soluble in 
water and less likely to adhere to the pin surface, the pin was washed by moving it in and out 
of a reservoir of deionised water five times in between different dye concentrations.  The 
slides with printed arrays of dye were then left to dry in darkness under ambient conditions 
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for at least 2 hours, and then placed into the breadboard imaging system and imaged in 
darkness with a 60 second exposure. 
4.3.2 Determining the detection limits of the new breadboard imaging system – results and 
discussion 
 
Figure 4.2 is an image of the array described in section 4.3 taken with the imaging system 
described in section 4.2.2 with a 60 second exposure time.  Two rows of spots are clearly 
visible in the centre of image, and appear by visual inspection to be of different intensities, 
i.e. of different fluorescent intensities.  Since this image covers the entire area in which 
microarray spots of Alexa Fluor® 633 dye was printed, one can surmise that these two rows 
of spots were the dye rows printed at 1x 10-2 and 1 x 10-3 mg.ml-1 respectively. 
 
 
Figure 4.2: A 60 second exposure image of an array of difference concentrations of Alexa Flour
®
 633 dye taken 
with the Starlight Express CCD camera with a 60 second exposure time. 
Figure 4.2 was processed using the Starlight Express SXV-H9 camera software (version 
3.5), such that the palette was readjusted to highlight weaker features.  This analysis 
produce the following image (Figure 4.3), which also shows a lower concentration of Alexa 
Flour® 633 spots 
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Figure 4.3: A 60 second exposure image of an array of difference concentrations of Alexa Flour
®
 633 dye taken 
with the Starlight Express CCD camera and enhanced with the software filters 
The enhanced image in Figure 4.3 shows that a third row of dye spots at a lower 
concentration is visible, at the top of the image, in the location corresponding to the Alexa 
Fluor® dye printed from a solution of 1 x 10-5 mg.ml-1 concentration. The appearance of this 
row of spots after image processing indicated that they could be imaged directly with a longer 
exposure time.  This was not investigated at this time, but was noted for future experiments.   
The location where it would be expected to see a row of spots corresponding to Alexa Fluor® 
633 dye printed at 1 x 10-4 mg.ml-1 does not contain any spots, and it was later found that this 
was due to an error in the printing program.  The intensity of the top two visible rows of spots 
in this image (Figure 4.3) corresponding to Alexa Fluor® 633 dye printed at 1 x 10-5 and 1 x 
10-3 mg.ml-1 were analysed using the find objects function of ImageTool (version 3.0), and 
exporting the intensity values into Microsoft Excel.  The results of this analysis are shown in 
Figure 4.4 below.   
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Figure 4.4: Analysis of the 60-second exposure image of Alexa Flour 633 spots at difference concentrations 
(Figure 4.2). 
 
This analysis shows that there is a significant difference in the pixel intensity of these two 
rows of spots.  The dye spotted at a concentration of 1 x 10-5mg.ml-1 gave a mean signal of 
6150 arb. units with a 20% CV, and the spots printed from 1x10-3mg.ml-1 dye solution have a 
mean signal of ~20130 arb. units with a CV of 19.1%. Although the difference in measured 
intensity is not a factor of 100, this could be because the pixels for the 1 x 10-3 row of spots 
are saturated in the processed image. 
 
 
Figure 4.4 shows that a numerical analysis confirms what appears to be the case in the 
Figure 4.3 there is a clear difference in the average intensity of spots printed at the 1 x 10-5 
and 1 x 10-3 mg.ml-1, and the intensities of spots at the same concentration is broadly similar.  
There is some variation due to the presence of particulates and drying effects over some 
spots.   
 
Having now confirmed that the imaging system was able to detect Alexa Flour® 633 dye at 
relevant concentrations and clearly resolve the concentrations, an initial assay experiment 
was carried out.   
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4.4 Immunoassay protocols used during the assay development 
 
During the development of the immunoassays in a microarray format, a number of variations 
of immunoassay protocols were used in an attempt to overcome some non-specific binding 
issues.  In this section, all of these protocol variations will be summarised.  The specific 
protocol for each experiment and reasons for the selection of that method will be described in 
the appropriate materials and methods section for that experiment.  
4.4.1 Anti-atrazine scAb immunoassay 
 
When amine coated slides were used, the assay areas of the slides were activated by a 15 
minute incubation in a freshly prepared solution of 2.5 x 10-5M BS3 (Pierce, Rockford, IL, 
USA) in pH 9.0 sodium carbonate-bicarbonate.  The BS3 solution was then washed off in 
deionised water and the slide dried under a nitrogen gas stream.  Epoxy slides were used 
directly as supplied with no preparation step. 
 
The assay protocol was then carried out as follows, using one of the methods: 
 
 20μl of 0.03mg.ml-1 anti-atrazine antibody (kindly provided by Haptogen, Aberdeen, 
UK) (a humanised recombinant antibody fragment), in printing buffer (PBS-30% 
glycerol (AnalR grad, Merck)) was pooled over each assay area and the slide 
incubated in a humidity chamber for 2 hours.   
o The slide was then placed into a blocking solution of 0.1mg.ml-1 skimmed milk 
powder (Marvel), agitated to wash remaining anti-atrazine in printing buffer from 
the slide surface, and incubated in a humidity chamber for 2 hours.  
o Each assay area was washed five times with 1ml of 10mM PBS pH 7.4 with 
0.1% TWEEN-20 and then five times with 1ml of deionised water, by pipetting 
the water onto the assay area at an acute angle downwards.  The slide was 
then dried under a nitrogen line.   
 20μl of 0.02mg.ml-1 goat anti-human IgG (H+L) labelled with Alexa Fluor® 633 
(Molecular Probes, Paisley, UK) in 10mM PBS pH 7.4 was then pooled over the test 
assay area.  20μl of 10mM PBS pH 7.4 was pooled over the control assay area, and 
the slide incubated in a humidity chamber for 2 hours.  
 The chip was then placed into the imaging system and an image taken with a 60 
second exposure. 
 
 
4.4.2 GroEL immunoassay 
 
When amine coated slides were used, the assay areas of the slides were activated by a 15 
minute incubation in a freshly prepared solution of 2.5 x 10-5M BS3 (Pierce, Rockford, IL, 
USA) in pH 9.0 sodium carbonate-bicarbonate.  The BS3 solution was then washed off in 
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deionised water and the slide dried under a nitrogen gas stream.  Epoxy slides were used 
directly as supplied with no preparation step. 
 
 
 
4.5 Initial assays using Alexa Fluor® 633 labelled reagents in the optical breadboard  
 
The aim of this section was to show that an immunoassay could be carried out in a 
microarray format in a microfluidic channel structure.  The first experiment was designed to 
demonstrate an immunoassay based on immobilising material on the surface of a microfluidic 
channel, using an Alexa Fluor® 633 labelled secondary antibody, to show that an assay could 
be carried out with appropriate reagents for image readout with the breadboard system.  This 
was followed by an experiment in which the assay was carried out in a microarray spot 
format, in order to establish a protocol for an immunoassay in a microarray format, and to 
show that the imaging system was suitable for producing images to readout this type of 
immunoassay. 
 
4.5.1 Initial assay using Alexa Fluor® 633 labelled reagents in the optical breadboard – 
materials and methods 
 
In a previous experiment (see Appendix A), a polystyrene surface was used to physically 
immobilise proteins to a material surface to carry out an immunoassay.  In this experiment, 
rather than using a physical adsorption method, a covalent protein immobilisation method 
was selected.  A covalent immobilisation was chosen because, at this stage in the project, 
silicon waveguide wafers or chips were being considered as potential materials for the optical 
waveguides and microfluidic structures in the flight instrument.  These materials were not 
expected to be suitable for the physical adsorption of proteins since their surfaces are 
relatively hydrophilic.  Since the chemical properties of silicone oxide and silicon nitride are 
similar to glass, it was expected that standard surface chemistry reactions could be used to 
functionalise the surface with amine or epoxy surface chemistries.  The surface reactions 
were investigated in a later experiment (see section 4.10).  In this initial experiment 
commercially available amine-coated slides (Genetix, Loughborough, UK) were used, as they 
have a similar surface chemistry to an amine functionalised silicon wafer. 
 
The slides were first activated with BS3 linker (Pierce, Rockford, IL, USA).  20μl of a freshly 
prepared solution of 2.5 x 10-5M BS3 in pH 9.0 sodium carbonate-bicarbonate buffer was 
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pooled over each assay area as defined by laser cut microfluidic structures (cut from ARCare 
AR8939 adhesive tape - see Appendix A and Figure A.4), and incubated in a humidity 
chamber for 30 minutes.  Each assay area was then washed five times with 1ml of deionised 
water, by pipetting the water onto the assay area at an acute angle downwards.  The slide 
was then dried under a nitrogen gas line. 
 
In this experiment, the entire assay area of the microfluidic structure was coated with 
antibody, rather than using the microarray spot format.  This change was made because 
there were a number of modifications in the protocol compared to the previous immunoassay 
in a microarray format, including a different immobilisation chemistry and the use of a slightly 
less specific anti-human antibody.  It was considered that since all of these methodological 
changes would have to be successful in order for the immunoassay to work, carrying out the 
assay in a microarray spot format may further complicate the interpretation of the results of 
this experiment.  The aim of the experiment therefore was to determine whether the surface 
chemistry and antibody changes were compatible with reading out an immunoassay on the 
breadboard system.  The method was as follows: 
 
 20μl of 0.03mg.ml-1 anti-atrazine antibody (kindly provided by Haptogen, Aberdeen, 
UK) in PBS-30% glycerol (AnalR grad, Merck) (a humanised recombinant antibody 
fragment) was pooled over each assay area and incubated in a humidity chamber for 
2 hours.   
 The slide was then placed into a blocking solution of 0.1mg.ml-1 skimmed milk powder 
(Marvel), agitated to wash remaining anti-atrazine, in PBS from the slide surface and 
incubated in a humidity chamber for 2 hours.  
 Each assay area was washed five times with 1ml of 10mM PBS pH 7.4 with 0.1% 
TWEEN-20 and then five times with 1ml of deionised water, by pipetting the water 
onto the assay area at an acute angle downwards.  The slide was then dried under a 
nitrogen line.   
 20μl of 0.02mg.ml-1 goat anti-human IgG (H+L) labelled with Alexa Fluor® 633 
(Molecular Probes, Paisley, UK) in 10mM PBS pH 7.4 was then pooled over the test 
assay area.  20μl of 10mM PBS pH 7.4 was pooled over the control assay area, and 
the slide incubated in a humidity chamber for 2 hours.  
 The chip was then placed into the imaging system and an image taken with a 60 
second exposure. 
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4.5.2 Initial assay using Alexa Fluor® 633 labelled reagents in the optical breadboard – 
results and discussion 
 
 
Figure 4.5: 60 second exposures of the assay area (~ 1 x 2mm) of a microfluidic channel on which a binding 
immunoassay was carried out.  In both images, the top area is a complete immunoassay, the bottom area is a 
control area in which the secondary antibody was not included in the assay protocol.  Left: laser illumination 
directed onto the complete assay area.  Right: laser illumination directed onto the control area. 
 
Figure 4.5 shows that while the experiment in which the complete assay was performed (top) 
gives a strong fluorescent signal when the laser is directed at that area, the control assay 
with no Alexa Flour® 633 labelled secondary antibody present does not give any 
fluorescence.  Neither assay area produces any fluorescence when the laser is not directed 
at it, because the laser illuminates only a small area of the surface.  This suggested that all 
stages of the assay, including the covalent immobilisation of anti-atrazine antibody on the 
slide surface, were functioning as expected, and that it was possible to obtain images of 
bound Alexa Flour® 633 labelled secondary antibody.  The anti-human (H+L) secondary 
antibody labelled with Alexa Fluor® 633 may have a lower binding affinity than the anti-
human kappa light chain antibody (which was used as a secondary antibody to bind to the 
anti-atrazine scAb in section 3.1.2.3), because it is raised against a less specific target 
(personal communication, Haptogen, Aberdeen).  While this may be the case, this 
experiment confirmed that the anti-human (H+L) antibody would bind to the anti-atrazine 
scAb strongly enough for it to be detected with the breadboard imaging system, and 
therefore that the binding immunoassay appeared to be working under the conditions of this 
experiment.  However, it should be noted that if the anti-human (H+L) antibody does have a 
lower binding affinity for the recombinant anti-atrazine scAb than anti-human kappa light 
chain antibodies, it may not be possible to achieve very low limits of detection with this 
assay.  Since the immunoassay had been shown to work under the conditions used, an 
experiment to carry out an immunoassay with the same reagents and conditions in a 
microarray spot format was attempted. 
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4.5.3 Preliminary immunoassay in microarray format – materials and methods 
 
The assay area was activated with BS3 linker as described in section 4.4.  The protocol for 
the assay was as follows: 
 
 An array of 5 rows in a controlled pattern of spots was then printed with the Spotting 
Robot using of 0.03mg.ml-1 anti-atrazine antibody (kindly provided by Haptogen, 
Aberdeen, UK) in PBS-30% glycerol. 
 The slide was then placed into a solution of 0.1mg.ml-1 skimmed milk powder (Marvel), 
agitated to wash remaining anti-atrazine in PBS-30% glycerol from the slide surface.  
The slide was then incubated in a humidity chamber for 2 hours.  
 Each assay area was washed five times with 1ml of 10mM PBS pH 7.4 with 0.1% 
TWEEN-20 and then five times with 1ml of deionised water, by pipetting the solutions 
onto the assay area at an acute angle downwards.  The slide was then dried under a 
nitrogen line.   
 20μl of 0.02mg.ml-1 labelled anti-human IgG (H+L) labelled with Alexa Fluor® 633 in 
10mM PBS pH 7.4 was then pooled over the test assay area.  The slide was then 
incubated in a humidity chamber for 2 hours.   
 The assay area was then washed five times with 1ml of 10mM PBS pH 7.4 containing 
0.1% TWEEN-20 and then five times with 1ml of deionised water, by pipetting the 
solutions onto the assay area at an acute angle downwards.   
 The chip was then placed into the imaging system and an image taken with a 60 
second exposure (see Figure 4.6). 
 
4.5.4 Preliminary immunoassay in microarray format – results and discussion 
 
 
Figure 4.6: An immunoassay in which 110μm diameter spots of anti-artrazine scAb were deposited onto an activated amine surface and 
exposed to Alexa Flour
®
 633 labelled secondary antibody.  This 60 second image was taken on the optical breadboard. 
 
Figure 4.6 shows a 60 second exposure image of the chip after the assay was carried out, 
and shows fluorescence in the positions where the anti-atrazine scAb was spotted onto the 
surface, but not from other parts of the blocked assay area.  The low level of fluorescence 
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between the spots indicates that the blocking and washing protocols were reasonably 
effective in preventing non-specific binding.  This result was a clear demonstration that all 
stages of the assay system were fundamentally working.  Another important development 
was that even though the configuration did not allow maximum light collection efficiency from 
the array, Figure 4.6 showed that the breadboard imaging system could be used to readout 
immunoassays of this type with a convenient exposure time. 
 
However, it is apparent that the assay area has a non-uniform illumination, such that the 
spots in the centre of the image appear to be brighter than those at the outside.  This was 
interpreted as a result of the laser spot having an uneven intensity, and being smaller than 
the assay area, thus giving an uneven intensity distribution across the assay area.  In order 
to resolve this problem, a 10x beam expander (Intelite Inc., Genoa, USA) was incorporated 
into the imaging system.  This spread the point source of the laser over the area of a 1cm 
diameter circle, providing much more uniform illumination of the assay area (note, however, 
that this does not affect the energy distribution profile).  Spreading the laser illumination over 
a larger area reduces the intensity of the illumination at any given point, potentially making a 
longer exposure time necessary. 
 
The same chip imaged in Figure 4.6 was re-imaged with the beam expander in the system.  
Figure 4.7 below shows the result of this experiment.  It is clear by visual inspection of the 
image that the addition of the beam expander has resulted in a much more even illumination 
of the surface and correspondingly more even intensity of the array spots.  Also, the central 
spots also appear less bright than in Figure 4.6, as expected due to the reduced illumination 
intensity. 
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Figure 4.7:  An immunoassay in which 110μm diameter spots of anti-atrazine scAb were deposited onto an 
activated amine surface and exposed to Alexa Flour
®
 633 labelled secondary antibody.  This 60-second exposure 
image was taken on the breadboard imaging system in darkness with the beam expander present. 
 
All of the spots present in Figure 4.7 and Figure 4.6 appear to consist of a brighter square area 
with a „halo‟ of less bright fluorescence around them.  This „halo‟ effect is much clearer in 
Figure 4.7 than in Figure 4.6, due to the uneven illumination in Figure 4.6.  In order to try to 
prevent this halo effect from appearing, a series of experiments were carried out with 
variations on the blocking and washing protocols used in the immunoassay.  These are 
reported in the following section. 
4.6 Optimisation of blocking and washing protocols 
 
In the previous experiment (see section 4.5.4), the immunoassay in a microarray format was 
proved successful, but the spots appear to have a „halo‟ around them.  In order to try to 
remove this halo effect, a number of approaches to the blocking and washing stages were 
devised.  Three assay areas per chip were prepared using each of these approaches, to 
compare the effects and reproducibility of each method. 
4.6.1 Optimisation of blocking and washing protocols – materials and methods 
 
The approaches used in this experiment to find a suitable blocking and washing protocol 
included the use of alternative washing methods, different blocking solutions and sonication.  
The halo effect observed was thought to be occur between completion of pin printing and 
incubation in the blocking solution, so this is the stage at which the blocking and washing 
protocol was altered.  A 0.2M TRIS buffer pH 9.0 was used in some blocking protocols since 
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TRIS buffers contain free amine groups, and would inactivate any remaining epoxy groups on 
the slide surface prior to the protein blocking stage.  Ultrasonication was used in some 
protocols to try to remove the spotting buffer containing glycerol from the slide surface more 
effectively than by manual agitation. 
 
In each of these experiments the following protocol was followed: 
 
 An array of 5 rows in a controlled pattern of spots was printed onto BS3-activated  
amine coated slides (Genetic, Loughborough, UK) with the Spotting Robot using 20μl of 
0.03mg.ml-1 anti-atrazine scAb in PBS-30% glycerol. 
 
 Blocking step (one of the following was used for each experiment): 
 
o Assay areas were washed five times with 1ml blocking solution of 0.1mg.ml-1 
skimmed milk powder, then 20μl blocking solution was pooled over the assay 
area and incubated in a humidity chamber for 2 hours. (Table  4.1 top row left). 
o Assay areas were washed five times with 1ml 0.2M TRIS buffer pH9.0, then 20μl 
blocking solution of 0.1mg.ml-1 skimmed milk powder was pooled over the assay 
area and incubated in a humidity chamber for 2 hours (Table  4.1 top row centre). 
o Assay areas were washed five times with 1ml of 0.2M TRIS buffer pH9.0, then 
the slide was sonicated at 15000Hz for 1 minute in 0.2M TRIS buffer with 
additional manual agitation. The slide was then placed in a beaker of blocking 
buffer for 2 hours (Table  4.1 row 2). 
o The slide was washed for 1 minute in a beaker of blocking solution of 0.1mg.ml-1 
skimmed milk powder with manual agitation, then the slide was placed in a 
beaker of blocking buffer for 2 hours.  (Table  4.1 row 3). 
o The slide was sonicated at 15000Hz for 1 minute in blocking buffer with 
additional manual agitation for 1 minute, then the slide was then placed in a 
beaker of blocking buffer for 2 hours. (Table  4.1 row 4). 
o The slide was washed in a beaker of PBS-0.1% TWEEN 20 high-speed magnetic 
stirring for 1 minute, then each assay area washed three times with 1ml of 
deionised water, then the slide was then placed in a beaker of blocking solution 
of 0.1mg.ml-1 skimmed milk powder for 2 hours (Table  4.1 row 5). 
 
 Each assay area was then washed five times with 1ml of 10mM PBS pH 7.4 with 0.1% 
TWEEN-20 and then five times with 1ml of deionised water, by pipetting the water onto 
the assay area at an acute angle downwards.  The slide was then dried under a 
nitrogen line.   
 
 20μl of 0.02mg.ml-1 labelled goat anti-human IgG (H+L) (Molecular Probes / Invitrogen, 
Paisley, UK) labelled with Alexa Fluor® 633 in 10mM PBS pH 7.4 was then pooled over 
the test assay area, and the slide incubated in a humidity chamber for 2 hours.   
 
 The chip was then placed into the breadboard imaging system, and an image taken with 
a 60 second exposure (see Figure 4.6). 
 
4.6.2 Optimisation of blocking and washing protocols – results and discussion 
 
The results of this study are shown in Table  4.1.
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Table 4.1: Results of a number of different blocking and washing experiments on amine coated slides. 
 
5 x 1ml Blocking Buffer, 5x 1ml dH20 incubate 10μl  
 
5 x 1ml 0.2M TRIS pH 9.0, 5x 1ml dH20 incubate 10μl 
 
60 second sonication with manual 
agitation in blocking buffer, incubate 
10μl blocking  
 
60 second sonication with manual 
agitation in blocking buffer, incubate 
10μl blocking 2 
 
60 second sonication with manual 
agitation in blocking buffer, incubate 
10μl blocking 3 
 
60 second sonication with manual 
agitation in 0.2M TRIS pH 9.0, 
incubate 10μl blocking 1 
 
60 second sonication with manual 
agitation in 0.2M TRIS pH 9.0, 
incubate 10μl blocking 2 
 
60 second sonication with manual 
agitation in 0.2M TRIS pH 9.0, 
incubate 10μl blocking 3 
 
60 second sonication in blocking 
buffer, beaker blocking incubation 1 
 
60 second sonication in blocking 
buffer, beaker blocking incubation 2 
 
60 second sonication in blocking 
buffer, beaker blocking incubation 3 
 
60 second washing in PBS-0.1% 
TWEEN 20 under magnetic stirring, 
incubation in beaker of blocking 1  
 
60 second washing in PBS-0.1% 
TWEEN 20 under magnetic stirring, 
incubation in beaker of blocking 2 
 
60 second washing in PBS-0.1% 
TWEEN 20 under magnetic stirring, 
incubation in beaker of blocking 3   
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The first row of Table  4.1 shows the results of two experiments in which the slide was 
washed by pipetting 1ml of either blocking buffer or in 0.2M TRIS pH 9.0 over the assay area 
at an acute angle five times and then blocked by placing 10µl of blocking buffer over the 
assay area and incubating for two hours in a humidity chamber.  In the image on the left the 
blocking buffer used for washing and blocking was 0.1% w/v skimmed milk powder in 10mM 
HEPES pH 7.4.  The image on the right shows a slide that was washed in 0.2M TRIS pH 9.0 
before blocking with 0.1% w/v skimmed milk powder in 10mM HEPES pH 7.4.  While 
microarray spots are visible in both of these images, the spots are clearer when 0.1% w/v 
skimmed milk powder in 10mM HEPES pH 7.4 was used as a washing buffer rather than 
0.2M TRIS pH 9.0. 
 
The second row of Table  4.1 shows triplicate results of an experiment in which the slides 
were washed by sonication for 60 seconds in a beaker of blocking buffer (0.1% w/v skimmed 
milk powder in 10mM HEPES pH 7.4) while being manually agitated in the beaker, and then 
blocked by incubation in 10µl of blocking buffer.  In this case, no microarray spots are visible 
in any of the images.  A similar result was obtained in the third and fourth rows of Table  4.1, 
in which slides were washed by sonication for 60 seconds in a beaker of in 0.2M TRIS pH 9.0 
and then blocked by incubation in either 10µl of blocking buffer, or a beaker of blocking 
buffer, respectively.  The images in rows two to four indicate that sonication may disturb the 
microarray spots on the surface of the slide, causing the anti-atrazine antibody in the printing 
solution to spread and immobilise over the entire surface.  The labelled anti-human (H_L) 
antibody would then bind to the whole of the assay area resulting in the observed high 
background signal.  It was therefore decided not to include a sonication step in any future 
experiments. 
 
The fifth row of Table  4.1 shows triplicate results of an experiment in which the slides were 
washed in a beaker of 10mM PBS buffer pH 7.4 containing 0.1% TWEEN 20 surfactant 
before blocking by incubation in a beaker of blocking buffer.  Microarray spots are visible in 
these images, but they have a similar level of background fluorescence as the image in 
Figure 4.7, and also have the same „halo‟ effect around the spots observed in Figure 4.7 
(although this is difficult to observe in the images in Table  4.1, it is clear when the images 
are larger as in Figure 4.7). This method therefore does not offer any clear advantages over 
the previous protocol. 
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In summary, a number of conclusions were drawn from this series of experiments: 
 
 The inclusion of a sonication step resulted in an extremely high level of non-specific 
binding signal around the spots.  This could be because while removing the printing 
buffer containing antibody from around the spot area, the sonication was spreading 
the printing buffer over the surface and causing the anti-atrazine scAb to be 
immobilised across the entire assay area. 
 
 The use of TRIS buffer in the blocking protocol to neutralise any remaining active 
epoxy groups on the slide surface appeared to either have no effect or increase the 
background level.  Protocols including this step were eliminated as potential methods 
to overcome the problem of non-specific binding. 
 
 Manual agitation alone improved the blocking results in some cases but not 
reproducibly. 
 
Given that none of the above experiments appeared to have resolved either the background 
fluorescence or presence of „halo‟ effects around the spots, the slide surface chemistry was 
changed in the next series of experiments in order to circumvent some of these issues. 
 
4.7 Development of immunoassay on epoxy coated slides  
 
Since a number of the issues causing high background fluorescence in the assay images 
appeared to be difficult to resolve by modification of the blocking step using amine-coated 
slides, the pragmatic approach of attempting the assay on epoxy-coated slides was adopted.  
Both amine (Cras et al., 1999) and epoxy (Guilleaume et al., 2005) functionalised surfaces 
have been used for protein immobilisations in literature, and this change would have little 
effect on the existing experimental protocol other than to remove the BS3 activation step.  
The literature also indicated that epoxy coated slides are more commonly used for protein 
microarray work than amine-coated slides (Guilleaume et al., 2005).  Slide functionalisation 
methods are discussed in more detail in section 4.10. 
 
The epoxy coated slides (Genetix, product code K2652, New Milton, UK) were used directly 
as supplied, as no surface activation step was necessary.  For the initial experiments with 
epoxy coated slides the blocking and washing method selected was washing with five times 
with 1ml of RO water and incubating in a beaker of blocking solution. 
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4.7.1 Validation of epoxy coated slides – materials and methods 
 
Initially, an experiment was carried out to confirm that the assay performed similarly on 
epoxy-coated slides as for the amine slides, by repeating the same immunoassay protocol 
described in section 4.5.4 with minor modifications to adapt the protocol for epoxy coated 
slides.  This included increasing the imaging time from 60 seconds to 300 seconds, as this 
was found to improve the image quality for immunoassay on epoxy-coated slides. 
 
 An array of spots of 0.03mg.ml-1 anti-atrazine in 10mM PBS pH 7.4 containing 30% 
glycerol was printed directly onto the epoxy-coated slide, then the slide was incubated 
for 2 hours in a humidity chamber.   
 The slide was then blocked by immersion in a beaker of blocking solution of 0.1mg.ml-
1 skimmed milk powder for 2 hours. 
 Each assay area was washed five times with 1ml RO water, by pipetting the liquid 
over the surface at an acute angle.   
 20μl of anti-human Alexa Fluor® 633 labelled secondary antibody was pooled over the 
assay areas and the slide incubated in a humidity chamber for 2 hours.   
 The assay areas were then washed three times with 1ml of 10mM PBS pH 7.4 
containing 0.1% TWEEN 20, then twice with 1ml RO water and dried for 1 minute 
under a nitrogen line. 
 The slide was placed into the breadboard imaging system and an image taken using a 
300 second exposure time.   
4.7.2 Validation of epoxy coated slides – results and discussion 
 
 
Figure 4.8: An immunoassay in which a 4 x 20 array of 110μm diameter spots of anti-atrazine scAb were 
deposited onto an epoxy coated slide (Genetix) and exposed to Alexa Flour® 633 labelled secondary antibody.  
This 300-second exposure image was taken on the optical rig in darkness with the beam expander present. 
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Figure 4.8 shows an example of a microarray produced in this experiment (one sample of 
three).  It is clear that all of the spots appear to be present and emitting similar levels of 
fluorescence.  It is also immediately clear that the „halo‟ effect observed in Figure 4.7 is not 
present here.  This result was a clear demonstration that the assay system was 
fundamentally working, confirming that the assay protocol could be transferred to epoxy 
coated slides with improved results in terms of non-specific binding.  However, there are 
some undesirable features present such as „half-spots‟ and drying effects.  In order to 
achieve the goals of optimising the immunoassay protocol and developing a relevant assay 
for a biomarker target, a number of protocol variations were carried out during the 
development of a new immunoassay system. 
4.8 Selection of an assay system directly relevant to Martian samples 
 
In order to make the immunoassay development work more relevant to the final instrument, 
the decision was taken to change the both the target molecule and the assay format.  The 
new assay system selected was based on the detection of GroEL (chaperonin-60), a 
molecular chaperone involved in protein synthesis and ubiquitous to many forms of terrestrial 
life (see section 2.2.6.1).  A commercially available GroEL protein (Cat. No. C7688, Sigma-
Aldrich, Poole, UK.) and anti-GroEL antibody (Cat. No. G6532, Sigma Aldrich, Poole, UK) 
were selected for this assay because they were available in a convenient form (freeze-dried 
protein and IgG antiserum fraction, respectively), and had also been used in earlier work by 
collaborators (Steel, A., personal communication). 
 
In the proposed SMILE Life Marker Chip, one of the key elements of the assay system was 
the in-situ labelling of biomarker targets with fluorescent dyes to allow direct detection of 
biomarkers in the sample (Sims et al., 2005).  As far as the author is aware, such labelling 
reactions have not been attempted in this format before.  Since neither the anti-GroEL 
antibody nor the GroEL protein were available pre-labelled with Alexa Flour® 633, a small 
scale in-situ labelling method was developed.  The addition of this in-situ labelling step made 
the assay protocol being used more relevant to the proposed final format for the flight 
instrument, and provided a way to readout GroEL immunoassays in a microarray format with 
the optical breadboard system in the absence of commercially available reagents.  
4.9 Initial in-situ labelling protocol for GroEL protein 
 
As mentioned in section 4.2.1, the Alexa Fluor® 633 dye used was selected in part because it 
is available with a succimidyl ester functional group.  The succimidyl group will react with 
amine groups causing the dye to covalently attach to the amine, and this can be utilised in 
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protein labelling since proteins contain many free amine groups at their surface (Document 
No. MP00143 (Amine-reactive probes), Molecular Probes).  This section describes how 
Alexa Fluor® 633 succimidyl ester was used to label GroEL protein.   
 
4.9.1 Initial in-situ labelling protocol for GroEL protein – materials and method 
 
The GroEL protein was aliquotted into a number of vials each containing 20μl of 1 mg.ml-1 
GroEL as supplied by the manufacturer, in TRIS buffer.  Since, as described above TRIS 
buffer contains free amine groups which react with succimidyl ester groups, and this would 
have a quenching effect on any labelling reaction.  To avoid this problem without the need for 
a large excess of reactive dye, prior to use the GroEL aliquots were made up to 500μl by 
addition of HEPES buffer (pH 7.4, 10mM), then the 500μl volume was passed through a 
Microcon 10,000 molecular weight cut-off filter (Fisher Scientific, Loughborough, UK) by 
centrifuging at 13,000 RPM for 30 minutes.  The 60,000Da GroEL held back by the 
membrane was reconstituted into HEPES buffer (pH 7.4, 10mM), by adding 100μl of the 
buffer to the filter, inverting the filter and centrifuging the product out into a clean vial for 1 
minute at 6,500 RPM.  The final concentration of GroEL in HEPES buffer was 0.2 mg.ml-1, 
assuming that no GroEL was lost during the filtration step. 
 
In preparing this labelling reaction, Alexa Flour® 633 succimidyl ester was dissolved in 
anhydrous methanol (Sigma-Aldrich, Poole, UK) to a concentration of 1 mg.ml-1.  The 
succimidyl ester groups will hydrolyse in water (Document No. MP10168 (Alexa Fluor® 
Succimidyl Esters), Molecular Probes) and have a half-life of 30 minutes.  Anhydrous 
methanol was selected as a suitable solvent as it was sufficiently polar to dissolve the dye, 
but does not contain water and so would not significantly affect the reactivity of the 
succimidyl groups.  The dye was then diluted to a concentration of 0.2mg.ml-1 in anhydrous 
methanol, and 100μl of this dye solution was added to a number of 1.5ml Eppendorf vials.  
The open aliquots and remaining stock solution of 1mg.ml-1 Alexa Flour® 633 in anhydrous 
methanol were then placed into a sealed vessel containing excess self-indicating silica gel 
desiccant (to prevent the dye absorbing water from the ambient atmosphere), and the vessel 
placed into an oven at 37°C overnight to drive off the methanol and leave only reactive dye in 
the aliquots.  This left a mass of 0.02mg of reactive Alexa Flour® 633 dried in the vials.  
 
The ratio of dye to protein was calculated such that there was a fifty times molar excess of 
dye compared to protein molecules in the reaction mixture.  This was thought to be sufficient 
as a typical labelling reaction of this type attaches 20-40 dye molecules per protein molecule 
for a typical protein such as BSA.  100μl of 0.2 mg.ml-1 protein was added to the Eppendorf 
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vials of Alexa Flour® 633, and the dye dissolved and mixed thoroughly by pipetting and 
agitation.  This reaction mixture was left in a sealed vial at ambient temperature for 30 
minutes.  Effective dye labelling was verified by passing the dye reaction mixture through a 
10,000 MWCO filter after completion of the labelling reaction (see Figure 4.9 below).  Since 
the protein would be held back by the filter while any unreacted dye would pass through it, a 
blue colour in the separated high molecular weight fraction would indicate that dye was 
attached to the protein i.e. the reaction was successful. 
 
4.9.2 Initial in-situ labelling protocol for GroEL Protein – results and discussion 
 
 
Figure 4.9: Photograph of labelled GroEL protein under different conditions: Left: Complete reaction mixture.  
Centre: Fraction of reaction mixture retained after filtration though a 10,000 MWCO filter and reconstituted in 
10mM HEPES pH 7.4. Right: Filtrate of complete reaction mixture. 
 
Figure 4.9 showed that the majority of the dye was held back by the filter after the reaction 
had taken place, indicating a high degree of successful labelling.  However, some dye 
passed through the filter confirming that the amount of dye initially in the reaction mixture 
was an excess, as intended.  This experiment established that the labelling process 
appeared to be successful, and that the anti-GroEL antibody could bind to the labelled GroEL 
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protein, and the labelling reaction was scaled down to the level of a single batch in 
subsequent experiments. 
 
The next goal of this section of work was to confirm that the GroEL immunoassay system 
could be applied to epoxy-functionalised slides in a microarray format.  The previous 
experiments had demonstrated that a number of requirements for a working GroEL 
immunoassay in this format were established.  Figure 4.9 had confirmed that the GroEL 
labelling reaction was working, since Alexa Fluor® 633 would only be retained by the 
molecular weight cut-off filter if it was attached to the GroEL protein. The experiment in 
section 4.7 had shown that an immunoassay protocol was working on epoxy-coated slides, 
and could be read out with the breadboard imaging system.  Therefore, the main unknown 
factors involved in performing a GroEL immunoassay were whether the anti-GroEL antibody 
would bind to GroEL labelled with a large amount of Alexa Fluor® 633, and what binding 
affinity the antibody would have if it did bind.  To minimise the potential effect of a low 
antibody binding affinity, a high concentration of labelled GroEL was used in the first GroEL 
immunoassay in a microarray format, to ensure that binding would be detected if it occurred.   
 
In the LMC flight instrument design the base material of the optical waveguides is proposed 
to be a silicon wafer, with a surface of either silicon oxide or silicon nitride.  Silicon oxide and 
silicon nitride waveguides are not commercially available with an epoxy surface chemistry, 
and would need to be functionalised in-house.  This meant that one of the key goals of the 
LMC development was to demonstrate immunoassays on in-house epoxy functionalised 
silicon surfaces.  In order to progress towards such a demonstration, the decision was taken 
to develop the GroEL immunoassay on both commercial and in-house epoxy-coated 
surfaces in parallel.  The next key requirement was to establish a procedure for the in-house 
epoxy functionalisation of surfaces, and the following section describes the epoxy 
functionalisation protocol that was adopted.   
 
4.10 (3-glycidoxypropyl)trimethoxysilane (GOPS) functionalisation protocol 
 
A standard method to covalently immobilise proteins on a glass or silica surface is to modify 
the surface with a functionalised silane containing an epoxy group.  The silane group reacts 
with free hydroxyl groups on the surface and under ideal conditions produces a monolayer 
surface coating with a high density of reactive epoxy groups available for immobilisation of 
proteins (Kambhampati, 2004, Cras et al., 1999, Van Der Voort & Vansant, 1996).  Protein 
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molecules are immobilised by the formation of a covalent bond between the epoxy group on 
the surface and free amine groups on the protein (Kambhampati, 2004) 
 
A number of epoxy functionalisation protocols were reviewed (Cras et al., 2006, Guilleaume 
et al., 2005, Han et al., 1999, Lamure et al., 1994), and for convenience the simplest 
approach identified in the literature was adopted (Cras et al., 2006).  Briefly the protocol 
involves an overnight incubation in an anhydrous organic solvent containing an appropriate 
epoxy-functionalised silane at room temperature and under an inert gas, either argon or 
helium.  The inert gas prevents water from entering the system via the ambient atmosphere. 
Other adaptations of this basic protocol were present in the literature, including higher 
temperature incubations, refluxing, agitation and sonication, but for this work it was 
considered that if a simple approach was successful, a more complex protocol was not 
necessary.  
 
4.10.1 (3-glycidoxypropyl)trimethoxysilane (GOPS) functionalisation protocol – materials and 
methods 
 
 (3-glycidoxypropyl)trimethoxysilane (GOPS) (Cat. No. 440167, Sigma Aldrich, Poole, UK) 
was selected as an appropriate silane reagent because it has been used extensively in the 
literature and is commercially available.  It is used diluted to an appropriate concentration in 
anhydrous toluene. 
 
The critical factors in the success of any silane functionalisation are the cleaning of the 
surface to be functionalised and all equipment used in the experiment (to remove organic 
contamination which could inhibit the functionalisation reaction), and removal of water from 
the reaction chamber (Cras et al., 1999).  Water must be removed to prevent polymerisation 
of the silane, which would result in a thicker and non-uniform deposition, which, in the context 
of the Life Marker Chip, could extend beyond the evanescent field (Cras et al., 1999).  To 
achieve the required level of cleanliness, all glassware used in the procedure (a 500ml 
reaction vessel with three Quickfit access ports, three Quickfit glass stoppers to seal the 
reaction vessel, two 20ml Hamilton syringes, and one 2ml Hamilton syringe) and a metal 
spatula were thoroughly washed with detergent and rinsed with RO water.  All of this 
equipment was placed in an oven (OMT oven, Sanyo, Loughborough, UK) at 200°C for four 
hours to remove adsorbed water. 
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The glass chips were cleaned during the oven drying of other equipment.  In the first run 
glass microscope slides were used, and these were cut into the same dimensions as the 
silicon chips to be supplied by collaborators.  This was because the functionalisation 
chemistry would be expected to be the same and the availability of silicon chips was limited.  
A 500ml plastic beaker was thoroughly cleaned with detergent and rinsed with RO water.  
Working in a laminar flow cabinet to reduce particulate contamination from the atmosphere, 
four 20 x 20mm glass microscope slide chips were placed inside the beaker with plastic 
wafer tweezers, and moved to space them evenly around the base.  The first washing step 
was ultrasonication in a detergent, to remove any organic contamination from the surface of 
the glass chips.  Approximately 200ml of a 1% w/v Dri-Decon solution in RO water was 
added to the beaker slowly, to cover the chips with minimal disturbance.  The beaker was 
then covered in aluminium foil and placed in an ultrasonic water bath (275W, 15000Hz) for 
10 minutes.   
 
After ultrasonication, the next stage of cleaning was a water washing step to remove all 
organic material cleaned from the chip surface, and the bulk of the surfactant cleaner, from 
the beaker.  A water vacuum pump was used to remove the Dri-Decon solution from the 
plastic beaker.  The beaker was then re-filled with approximately 200ml of RO water, gently 
agitated for approximately 30 seconds, and then the RO water removed through the water 
pump.  This was repeated two more times to a total of three washes with RO water.    The 
next stage was to remove both water and residual surfactant from the chip and beaker 
simultaneously. 
 
Approximately 100ml of anhydrous methanol (Sigma-Aldrich, Poole, UK) was added to the 
plastic beaker, agitated for approximately 30 seconds and removed through the water pump.  
A second volume of approximately 100ml of anhydrous methanol was added, and then the 
beaker was covered in aluminium foil and placed in an ultrasonic water bath for 10 minutes in 
1-2cm of water.  The methanol was then removed through the water pump, and the beaker 
re-filled with approximately 100ml of anhydrous methanol, gently agitated for approximately 
30 seconds and the methanol removed through the water pump.  This was repeated two 
more times to a total of three washes with anhydrous methanol.  The final methanol wash 
solution was not removed until the reaction chamber was assembled – i.e. the glassware was 
ready for the slides / chips to be placed into the reaction vessel. 
 
The glassware was removed from the drying oven and allowed to cool in air sufficiently that it 
could be handled, and placed in the laminar flow cabinet for assembly.  An argon gas line 
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was placed into the reaction vessel through one of the access plugs, and gas released such 
that a small flow of argon was filling the vessel and gently overflowing from it.  This was 
validated by carefully feeling the flow from the remaining reaction chamber exits.  An argon 
atmosphere prevents water from the ambient atmosphere entering the reaction vessel.  
 
The chips were then removed from the final anhydrous methanol wash and dried under a 
nitrogen gas flow.  The dried chips were then gently placed onto the side of the reaction 
vessel using clean plastic wafer tweezers, and the reaction vessel gently moved or shaken to 
slide them in to the bottom of the vessel. 
 
The anhydrous toluene solvent (Cat. No. Sigma-Aldrich, Poole, UK) was then added to the 
reaction vessel.  A 20ml Hamilton syringe was assembled from the dried clean glassware.  In 
order to remove any humidity from the ambient atmosphere from the Hamilton syringe, it was 
filled with argon gas from the reaction vessel and the argon ejected into the ambient 
atmosphere.  This was repeated nine times to a total of ten cycles of argon through the 
syringe.   
 
The toluene was supplied under an inert gas, so removal of toluene from the supplied vessel 
required adding a volume of gas to the stock bottle to replace the volume to be removed.  To 
achieve this, the Hamilton syringe was filled with 20ml argon gas, inserted into the anhydrous 
toluene vessel, and the gas injected.  The Hamilton syringe was then filled with 20ml toluene, 
removed from the toluene vessel and the 20ml toluene injected into the reaction vessel. 
 
The GOPS was then added to the toluene in the reaction vessel.  The 2ml Hamilton syringe 
was assembled and purged with argon from the reaction vessel ten times as for the 20ml 
Hamilton syringe.  The syringe was then filled with 2ml argon and inserted into the GOPS 
(Sigma-Aldrich, Poole, UK) bottle.  The 2ml argon was injected into the GOPS, and the 
syringe filled with 2ml of GOPS.  The syringe was then removed from the GOPS bottle and 
the 2ml GOPS injected into the toluene in the reaction vessel.  The final concentration of 
GOPS in toluene was therefore 0.40M.  
 
The argon gas line was removed from the reaction vessel, and the remaining reaction vessel 
ports sealed with their Quickfit stoppers.  The reaction vessel was then agitated gently to mix 
the GOPS and toluene with minimal disturbance of the glass chips.  The reaction vessel was 
incubated for 24 hours at room temperature, with gently agitation every few hours to mix the 
solutions.  Care was taken to ensure that the chips did not lie on top of each other at any 
point during incubation, as this could result in uneven GOPS coating. 
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After the 24 hour incubation, the reaction vessel was opened and an argon line placed into 
the reaction vessel as before.  A clean 20ml Hamilton syringe was assembled and purged 
with 20ml argon from the reaction vessel ten times to remove air and moisture from the 
atmosphere.  The toluene / GOPS solution was removed from the reaction vessel and 
disposed of.   
 
The chips were then washed in toluene to remove any excess un-reacted GOPS on the chip 
surface.  A second clean 10ml Hamilton syringe was filled and purged with 20ml argon 10 
times, then filled with 20ml argon.  20ml anhydrous toluene was removed vessel as 
described previously and injected into the reaction vessel.  The reaction vessel was agitated 
to wash the chips in toluene.  The Hamilton syringe used to remove the reacted GOPS / 
toluene mixture was then used to remove the toluene from the reaction vessel.  This was 
repeated two further times to a total of 3 washes in anhydrous toluene.   
 
The glass chips were carefully removed from the reaction vessel, and placed into a clean 
500ml plastic beaker.  Excess toluene on the chip surface was then removed by covering the 
chips with approximately 50ml anhydrous methanol, agitating the beaker for 30 seconds, and 
removing the methanol with a water vacuum pump.  This was repeated two further times to a 
total of three washes in anhydrous methanol.  Finally, the methanol was removed by a series 
of washes in RO water.  As for the anhydrous methanol washes, the chips were immersed in 
approximately 50ml of RO water, agitated for 30 seconds and the water removed with a 
water vacuum pump, and this process repeated two further times to a total of three washes in 
RO water.  The chips were then removed from the plastic beaker, dried under nitrogen, and 
stored in a sealed container with excess self indicating silica gel desiccant at room 
temperature until used. 
 
One glass chip was removed at each stage of the protocol to verify the effect of that step on 
the surface by contact angle measurements.  It was expected that the cleaning steps would 
remove organic contamination from the chip surface and thus reduce the contact angle, while 
the GOPS incubation, if successful, would increase the contact angle to ~60° (Cras et al., 
2006).  Three contact angle measurements were made on each of the chips on a KVS CAM 
100 contact angle system (KSV Instruments, Helsinki, Finland). 
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4.10.2 Silane (GOPS) functionalisation of glass – results and discussion 
Table 4.2: Results of contact angle measurements at different stages of GOPS functionalisation.  One chip was 
removed from the process at each stage, and three measurements made on each chip at different locations. 
Stage of protocol Contact angle 
Untreated glass slides <5° 
After detergent wash <5° 
After anhydrous methanol wash 12±2° 
After GOPS incubation and washing 61.5±2° 
Untreated commercial GOPS slide 49.7±1° 
 
Table 4.2 shows the results of the contact angle measurements.  These indicate that prior to 
the GOPS immobilisation the microscope slide was very hydrophilic, having a contact angle 
of <5°.  This increased slightly to 12° after the methanol wash, and after incubation in the 
0.4M GOPS solution in toluene the contact angle increased to 61.5°, which is in agreement 
with the range of contact angle measurements for similar methods in the literature (Cras et 
al., 1999).  The commercial GOPS coated slides were found to have a contact angle of 
49.7°, possibly due to differences in the GOPS protocol used. 
4.11 Silane (GOPS) functionalisation of silicon 
 
For the Life Marker Chip demonstrator and flight instrument, the optical waveguides are 
proposed to be made from silicon, and coated with a cladding layer of either silicon oxide or 
silicon nitride.  The immunoassay reagents in the microarray must therefore be immobilised 
onto one of these surfaces.  Since the GOPS functionalisation protocol had been shown to 
be successful on glass, which was expected to have a similar surface chemistry to both 
silicon oxide and silicon nitride, the next experiment was to test GOPS coating protocol 
described in section 4.10 on silicon nitride and silicon oxide chips (kindly provided by Lionix, 
Leiden, Netherlands) (see section 2.3.6). In both silicon based and glass surfaces, silane 
groups are believed to react with exposed silanol groups on the surface (Van Der Voort and 
Vansant, 1996), so no fundamental changes were required in the functionalisation protocol.   
4.11.1 Silane (GOPS) functionalisation of silicon - materials and methods  
 
The silicon chips were found to have an unexpectedly high contact angle before cleaning 
which was assumed to be due to organic material contaminating the surface.  To remove 
this, prior to the Dri-Decon and methanol washes the chips were incubated in 1M NaOH for 
30 minutes.  Otherwise, the protocol was unchanged from that in section 4.10. 
 
4.11.2  Silane (GOPS) functionalisation of silicon – results and discussion  
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The chip surfaces have been assessed by several methods to determine the quality of the 
GOPS coating.  These methods include visual inspection, contact angle measurement and 
atomic force microscopy.  Visual inspection under good lighting allows the surface to be 
assessed for roughness or large particulates on the surface and drying stains.  No 
particulates or uneven surface features were observed by visual inspection. 
 
Changes in contact angle indicate a chemical alteration of the surface.  Glass has a very low 
contact angle of <5°, and the silicon surfaces used also have a low contact angle.  Silicon 
nitride and silicon oxide have contact angles of approximately 35° (A. Prack, Lionix, The 
Netherlands, personal communication) while GOPS modified surfaces have a contact angle 
of 60° - 70° (Cras et al., 1999).  The contact angles found after cleaning the surfaces and 
after GOPS functionalisation are shown in Error! Reference source not found.. 
 
It is clear from Error! Reference source not found. that both the silicon nitride and silicon 
oxide surfaces have a similar contact angle to that expected after cleaning, and that both 
materials have a contact angle very close to 60° after the functionalisation.  This was a good 
indication that the protocol successfully coated the surface with an epoxy surface chemistry, 
as intended.  Having demonstrated this, the next stage was to develop the assay on epoxy 
functionalised surfaces, and this was carried out in the following section. 
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Table 4.3: Contact angle measurement of silicon nitride and silicon oxide surfaces before and after GOPS 
functionalisation.  Typical images and the average values ± one standard deviation from three measurements 
are shown. 
 Cleaned chip surface GOPS coated surface 
Silicon 
Nitride 
 
Contact angle 37.6 ±2.9° 
 
Contact angle 58.2 ±2.7° 
Silicon 
Oxide 
 
Contact angle 31.4 ±2.0° 
 
Contact angle 59.6 ±2.0° 
4.12 Use of in-situ labelled GroEL in microarray assays on in-house GOPS 
functionalised surfaces 
 
As described in section 4.9.2, establishing a procedure for the in-house epoxy 
functionalisation of surfaces was a requirement for the parallel development of the GroEL 
immunoassay on commercial and in-house surfaces.  In this section, a series of experiments 
were carried out in which the in-situ GroEL labelling protocol was used to develop a GroEL 
immunoassay on both commercial epoxy coated microscope slides and glass slides treated 
with the in-house GOPS functionalisation protocol.  A successful immunoassay on the 
surface functionalised in-house would demonstrate that GOPS functionalisation was a 
suitable method to prepare silicon or glass surfaces for immunoassays in a microarray 
format.  In addition, this immunoassay utilises custom reagents and a target directly relevant 
to the Life Marker Chip, and would therefore show that the techniques could be applied for 
the detection of other suitable biomarkers.  Optimisation of the same immunoassay on 
commercially available GOPS treated slides would show that the more conveniently available 
commercial slides were suitable for use during the development of the assays.  The initial 
assay showed that GroEL protein was not being removed from the slide surfaces during the 
assay, possibly due to non-specific binding.  This effect was much greater on the commercial 
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GOPS coated slides.  To overcome this, the protocol for in-situ labelling of GroEL was 
modified and a number of changes were made to the immunoassay protocol to try to reduce 
this effect. 
 
4.12.1 Initial assay using in-situ labelled GroEL in microarray assays – materials and 
methods 
 
At this point in the project, in-situ labelling of GroEL had been carried out and verified by 
filtration and an assay on a commercial GOPS coated slide, and in-house surface 
functionalisation of glass and silicon surfaces had been optimised and confirmed by contact 
angle measurement.  The next stage of development was to combine these protocols by 
using the GroEL assay system on the in-house GOPS coated slide, since this is how the 
assays would be prepared and carried out in the flight instrument.  In addition, an assay 
using the previous anti-atrazine assay was carried out on both in-house and commercial 
GOPS microscope slides as a control for the immunoassay protocol (since this protocol was 
known to be successful on amine-coated slides). 
 
The protocol used for these experiments were as follows:  
 
 A 5 x 5 array of either 1/10 v/v anti-GroEL IgG fraction (Sigma-Aldrich, Poole, UK) or 
0.3mg.ml-1 anti-atrazine scAb in PBS containing 30% v/v glycerol was spotted onto 
either commercial or in-house GOPS coated glass slides, and incubated in a humidity 
chamber for 2 hours. 
 The slide was washed and incubated for 4 hours in 0.1mg.ml-1 skimmed milk powder 
in HEPES 10mM, pH 7.4 buffer, to remove excess spotting buffer and block the 
remaining slide surface. 
 Each assay area was washed five times by pipetting 1ml RO water over it at an acute 
angle. 
 The appropriate Alexa Fluor® 633 labelled analyte was pooled over the assay area 
and incubated for 1 hour (one of the following). 
o 0.2mg.ml-1 Alexa Fluor® 633 labelled anti-human IgG (H+L) antibody in HEPES 
10mM, pH 7.4 was pooled over anti-atrazine scAb arrays. 
o 0.1mg.ml-1 Alexa Fluor 633® labelled GroEL protein total reaction mixture, in 
10mM PBS pH 7.4 was pooled over anti-GroEL arrays. 
 Each assay area was washed five times with 1ml of HEPES 10mM, pH 7.4 with 0.1% 
v/v Tween 20, and then five times with 1ml RO water, by pipetting the solution over 
the assay area at an acute angle. 
 The slide was dried under a nitrogen gas line for 1 minute. 
 The chip was placed into the breadboard imaging system, and each assay area was 
imaged with a 300 second exposure. 
Paul Kerr Wilson                        Development of the Life Marker Chip Microarray Readout Breadboard System 
Development of Life Marker Chip Technology for in-situ Life Detection on Mars                            Page 159 of 206 
4.12.2 Initial assay using in-situ labelled GroEL in microarray assays – results and discussion 
Table 4.4: Images showing the results of the experiments described in section 4.12.1.  Top Left: Commercial 
GOPS slide scAb assay. Top Right: Commercial GroEL Assay.  Bottom Left: In-House GOPS slide scAb assay.  
Bottom Right: In-House GOPS slide GroEL assay. 
  
  
Table 4.5: Results and observations from initial assays on commercial and in-house GOPS coated slides. 
 ScAb 
Spotting 
Anti-scAb IgG 
labelled with 
Alexa Fluor 
633 
Anti-GroEL 
Spotting 
GroEL “in situ” 
labelled with 
Alexa Fluor 
GOPS – 
commercial 
coated glass 
microscope 
slides 
Antibody 
“successfully” 
spotted 
 
 
“High” binding 
 
Low  
background 
Spotting 
not verified  
 
 
Binding not 
verified 
 
Very high  
background 
 
GOPS – in-
house coated 
glass 
microscope 
slides 
Antibody 
partially 
“successfully” 
spotted 
 
 
“High” binding 
 
Partial arrays 
only 
 
Low  
background 
Antibody 
“successfully” 
spotted 
“High” binding 
 
High 
background 
compared to 
scAb assay 
 
Table 4.4 contains the images obtained from each of these experiments using a 300 second 
exposure on the optical breadboard.  Table 4.5 summarises the conclusions that can be 
drawn from these images, both in terms of the microarray spotting process on each surface 
and the assay itself, including factors such as non-specific binding.   
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The important points are that the anti-atrazine scAb assay used in the previous experiments 
was at least partially successful on both the commercial and in-house epoxy functionalised 
surfaces.  This indicated that the in-house GOPS coating procedure had produced active 
epoxy groups on the glass surface enabling covalent immobilisation of the anti-atrazine scAb 
onto the surface, and the assay protocol did not create large amount of non-specific binding 
on either GOPS surface.  However, only partial arrays of spots were visible, so further 
optimisation was still required.   
 
The GroEL assay appeared to be successful on the GOPS surface prepared in-house, but 
produced a high background when carried out on the commercial GOPS slide.  This 
indicated that there were some differences in the properties of the commercial and in-house 
surface chemistries, possibly due to differences in the immobilisation protocol.  The high level 
of background could be caused by un-reacted Alexa Fluor® 633 dye in the GroEL reaction 
mixture binding non-specifically to one surface more than the other.  There was also a higher 
level on non-specific binding observed for GroEL assay on in-house GOPS surfaces than the 
anti-atrazine scAb assay on the same surface. 
 
Although this initial GroEL assay was not very successful on commercial GOPS slides, there 
was a practical advantage in using commercially available surfaces to pursue the GroEL 
assay on, since the GOPS functionalisation procedure was quite time consuming so a higher 
throughput of assay experiments could be achieved by purchasing commercial slides.  As 
this experiment established that the basic surface chemistry of the in-house GOPS 
functionalisation was similar to the commercially prepared GOPS surfaces, GroEL assays on 
commercial GOPS slides were used to try to eliminate the high level of non-specific binding, 
by varying the blocking and washing protocols. 
 
4.12.3  Modification of in-situ labelling protocol to include ethanolamine as a quenching 
reagent for un-reacted dye – materials and methods  
 
Initially, the assay protocol was modified by the addition of a ten times molar excess of 
ethanolamine (relative to the initial dye concentration) to the reaction mixture prior to applying 
the reaction mixture to the assay area.  Ethanolamine (Sigma-Aldrich, Poole, UK) was diluted 
to 1 / 500 to a concentration of 30mM in 10mM PBS pH7.4 and 5μl of this solution was 
added to the reaction mixture to inactivate any remaining succimidyl groups on un-reacted 
dye molecules.  The complete experimental protocol was as follows: 
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 A 5 x5 array of 1/10 anti-GroEL IgG fraction (30 to 100 µg/ml) in 30% v/v glycerol in 
PBS was spotted onto a commercial GOPS coated slide, and the slide placed into a 
humidity chamber and incubated for 2 hours. 
 The slides were washed and incubated in 0.1g.ml-1 skimmed milk powder in HEPES 
10mM, pH 7.4 buffer, to block the remaining slide surface. 
 Each assay area was then washed five times with 1ml RO water, by pipetting the 
water over the slide surface at an acute angle. 
 20μl of 0.1mg.ml-1 Alexa Fluor 633® labelled GroEL total reaction mixture (in 10mM 
PBS pH 7.4) containing 30mM ethanolamine was pooled over each assay area and 
incubated for 1 hour in a humidity chamber. 
 Each assay area was washed five times with 1ml of HEPES 10mM, pH 7.4 with 0.1% 
w/v Tween 20, followed by five washes with 1ml RO water, pipetted across the assay 
area at an acute angle. 
 The slide was dried under nitrogen for 1 minute 
 The chip was placed into the optical rig and each assay area was imaged with a 300 
second exposure in darkness. 
4.12.4 Modification of in-situ labelling protocol to include ethanolamine as a quenching 
reagent for un-reacted dye – results and discussion 
 
Two replicate results of this experiment are shown in Figure 4.10 and Figure 4.11 below. 
 
 
Figure 4.10: 300 second exposure image of an assay area in which a 5 x 5 array of anti-GroEL was printed and 
exposed to Alexa Flour
®
 633 labelled GroEL protein after addition of ethanolamine. 
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Figure 4.11: 300 second exposure image of an assay area in which a 5 x 5 array of anti-GroEL was printed and 
exposed to Alexa Flour
®
 633 labelled GroEL protein after addition of ethanolamine. 
 
This experiment produced an interesting result.  There is a strong non-specific signal 
present, in the form of spots that are approximately equal in size and evenly spaced.  Also, in 
between the spots faint fracture lines can be seen.  There were two likely explanations for 
these observations.  The most probable is that when the slide is dried after washing away the 
labelled protein reaction mixture, the remaining reaction mixture is de-wetting from the 
surface as it dries, leaving circular deposits of material containing dye.  This is supported by 
the observations that the circular features are all similar in size and equally distributed, and 
that small fracture lines are present in between the features, which are effects characteristic 
of the de-wetting of liquid films from homogeneous surfaces (Sharma & Khanna, 1998).  The 
presence of inactivated dye in the reaction mixture could be contributing to this effect, since it 
was not observed in previous experiments where commercially prepared products that do not 
contain unreacted dye were used (see section 4.12.2).  Other possible explanations were 
that un-reacted dye was binding to areas of the surface that were not fully blocked, or that 
the circular objects being observed were particles.  However both of these alternative 
explanations are made less likely by the even size and distribution of the features and the 
presence of fracture lines between them.   
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4.12.5   Assay including test with inactivated dye filtrate – materials and methods 
 
In order to test the theory that the deposition of the circular features in Figure 4.11 might be 
caused by the presence of inactivated dye in the reaction mixture, an experiment was carried 
out in which two different conditions were used.  After the GroEL labelling reaction had been 
completed, ethanolamine (Sigma-Aldrich, Poole, UK) diluted to 1 / 500 in 10mM PBS pH7.4 
to a concentration of 30mM, was added to the reaction mixture to inactivate any remaining 
succimidyl groups on un-reacted dye molecules.  In one slide, this complete reaction mixture 
was applied directly onto the slide.  In a second slide, the reaction mixture was filtered again 
through a 10,000 MWCO filter (Fisher Scientific UK, Loughborough, UK) to remove the 
labelled GroEL protein, and the filtrate (containing only un-reacted dye and buffer) was 
applied to the microarray spots.  
4.12.6 Assay including a test with inactivated dye filtrate – results and discussion 
 
 
Figure 4.12: A 60 second exposure image of an assay area in which a 5 x 5 array of anti-GroEL was printed 
and exposed to Alexa Flour
®
 633 labelled GroEL protein after addition of ethanolamine. 
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Figure 4.13: A 60 second exposure image of an assay area in which a 5 x 5 array of anti-GroEL was printed an 
exposed to filtrate produced from the GroEL reaction mixture after the addition of ethanolamine. 
 
The fact that the filtrate containing no protein did not produce the non-specific binding signal 
that was observed when labelled protein was present indicated that the labelled protein, and 
not un-reacted Alexa Flour® 633 dye, must be non-specifically binding to something on the 
slide surface.  The most likely cause of this was thought to be a problem with the blocking 
step, so in the next experiment the blocking method was revised by replacing the five washes 
with 1ml of deionised water after blocking with a more thorough one minute wash in a beaker 
of deionised water with manual agitation.  This experiment will be described and discussed in 
section 4.13. 
 
In this section a number of experiments were carried out attempting to develop a GroEL 
immunoassay on microscope slides functionalised with GOPS either commercially or in-
house.  The initial experiment showed that the scAb assay was successful on both surfaces 
to a limited extent, and that the GroEL assay was partly successful only on the in-house 
GOPS treated slide.  In order to optimise the protocol, a series of experiments using the 
GroEL assay or components of it on GOPS coated slides was carried out.  This lead to the 
development of a protocol which could be used to further characterise the performance of 
antibody assays in a microarray format.  This final protocol is described in the following 
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section, in which assays using a range of concentrations of labelled GroEL protein were 
carried out and used to produce a calibration curve for the immunoassay in a microarray 
format.  
 
4.13  Calibration curve for an immunoassay in a microarray format 
 
 
The problem of labelled GroEL non-specifically binding to the epoxy slide surface appeared 
to be resolved by replacing the five 1ml washes in deionised water after the blocking step 
with a one minute manual agitation in a beaker of deionised water.  This method 
considerably reduced the level of non-specific binding, and was used to produce a calibration 
curve by carrying out immunoassays with different concentrations of GroEL labelled in-situ 
with Alexa Fluor® 633.   
 
4.13.1 Calibration curve for an immunoassay in a microarray format - materials and methods 
 
Since the non-specific binding issue had been considerably improved by modifying the 
washing procedure as described in section 4.12.6, the next stage of development was to 
produce a calibration curve to demonstrate reproducibility of the immunoassay, and 
determine the binding affinity of the antibody and detection limit of the assay.  The complete 
final protocol was as follows: 
 
 A 5 x 5 array of spots of 1/10 anti-GroEL IgG in PBS-30% glycerol was printed onto 
commercially available epoxy functionalised slides, and the slide incubated in a 
humidity chamber for 2 hours. 
 The slide was then place into a beaker of blocking buffer (0.1g.ml-1 Skimmed milk 
powder in 10mM HEPES pH7.4), agitated for 30 seconds and then immersed in the 
blocking buffer for 4 hours. 
 The slide was then removed from the blocking buffer and vigorously agitated in a 
beaker of RO water to remove excess blocking buffer, and dried under nitrogen. 
 20μl of Alexa Flour® 633 labelled GroEL protein at different concentrations was 
„pooled‟ over each assay area, and the slide incubated for 1 hour in the humidity 
chamber. 
 Each assay area was washed five times with 1ml of 10mM HEPES pH7.4 containing 
0.1% TWEEN 20, then five times with 1ml of RO water and dried under nitrogen. 
 The slide was then placed into the optical breadboard, and an image of each assay 
area was taken with a 300 second exposure time. 
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4.13.2 Calibration curve for an immunoassay in a microarray format – results and discussion  
Table 4.6: Images used to form a calibration curve for the GroEL Assay system. 
 Assay Area 1 Assay Area 2 Assay Area 3 
0.002 
mg.ml-1 
   
0.02 
mg.ml-1 
   
0.1 
mg.ml-1 
   
0.2 
mg.ml-1 
   
1 
mg.ml-1 
   
 
The images in Table 4.6 show the results of carrying out the GroEL assay at a number of 
different concentrations of GroEL.  It is immediately clear that these images show a 
considerable reduction in the level of background fluorescence than the image in the top-right 
box of Table 4.4, which was taken using the previous protocol.  However, there are still areas 
where background fluorescence is present, mainly in the form of circular features which are 
likely to be caused by the presence of particulates in the assay solutions, and various pattern 
features across the area of the image which appear to be a drying effect.  The images in 
Table 4.6 were of a sufficient quality to analyse and produce date to include in the calibration 
curve in all cases except the central image of the 1mg.ml-1 assay, in which almost all of the 
spots were obscured by an area of non-specific binding.  In all other images, spots partially 
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or wholly obscured by a feature considered to be caused by non-specific binding were not 
included in the analysis. This illustrates that while an analysis could be carried out on these 
images, further work needs to be done to prevent the appearance of these features.   
 
In order to carry out a quantitative assessment of the spots rather than a qualitative 
assessment of the images, image analysis software was required.  There are many image 
analysis programs available for microarray images.  In this project, ScanAlyze (v2.35, 
Stanford University) was selected as a convenient program to use after a brief trial of a 
number of alternatives, as it is freely available to download for academic use, and offers a 
more user-friendly interface than other similar software.  In order to analyse the FITS images 
generated by the CCD camera in ScanAlyze, they had to be exported into TIF format.  This 
was done using the Starlight Express software (version 3.5) associated with the CCD camera 
in the breadboard imaging system.  The TIF images were then analysed using ScanAlyze.  
This software is designed for analysing microarrays using two different dyes but was used 
here to analyse images with a single dye as follows: 
   
 The TIF image of each array were loaded into both image analysis areas in the 
ScanAlyze software.   
 A 6 x 5 grid was then created and adapted so that the spot sizes and spacing 
approximately matched those on the images, and one column of spots was on a blank 
area of the slide and used to provide a background measurement.  This grid was used 
as a starting point to analyse all images.  At this point spots obscured by non-specific 
binding features were removed from the analysis. 
 The grid was then placed over the array, and the „align‟ feature used several times to 
achieve the optimum spot alignment.   
 The data was then saved and imported into Microsoft Excel, where the value for 
„channel 1 pixel intensity‟ was subtracted from the average value of the „channel 1 
pixel intensity‟ from the background spots.  This value was used as the binding signal 
in the calibration curve in Figure 4.14. 
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Figure 4.14: GroEL calibration results including a fitted curve. 
 
The Microsoft Excel Solver Add-In feature was used to determine the best-fitting sigmoid 
curve for this data.  A sigmoid function was selected because this is the typical shape of a 
binding antibody assay curve.  This allowed the antibody dissociation constant (KD) (which is 
inversely proportional to the antibody binding affinity) to be measured and indicated the 
range of concentrations at which labelled GroEL protein can be detected with this system. 
 
The KD value for the antibody was found to be 1.9x10
-5M, approximately two orders of 
magnitude higher than the typical range of KD values for antibody-antigen binding (which is 
10-7 to 10-11) (Garcia et al., 1999), indicating that the antibody binding affinity was lower than 
expected.  This was assumed to be due to the high level of labelling of the GroEL protein 
with Alexa Flour® 633, as the presence of the dye may have altered the protein enough to 
reduce the antibody‟s affinity for it.  Since the anti-GroEL antibody used was an IgG fraction, 
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it may contain a number of different epitopes of antibody which bind to different regions of the 
GroEL protein, so a low KD value could indicate that dye molecules could have been 
attached on or near the binding site of one or more epitopes, but others are still able to bind 
to the protein.  It is possible that the labelling reaction could be adjusted to reduce the level of 
labelling to counter this, or that antibodies could be raised against labelled proteins such that 
they have a greater affinity for the labelled protein, and this will be investigated in future work.  
Nonetheless, this finding highlighted that it may be necessary to use antibodies raised 
against labelled targets for some assays in the flight instrument, where an in-situ labelling / 
direct detection assay is proposed. 
 
4.14 Summary and conclusions from instrument platform development experiments 
 
 
The first stage of development of the instrumentation platform was to carry out preliminary 
experiments to validate the equipment and early readout methods (see Appendix A).  Once 
this was completed, a breadboard system representative of the design of the Life Marker 
Chip instrument was assembled.  Tests were carried out with dried down dye material to 
confirm that this breadboard system was suitable for the readout of immunoassays carried 
out in a microarray format. 
 
Having confirmed the suitability of the breadboard imaging system, an immunoassay based 
on conveniently available reagents (anti-atrazine scAb and commercially available Alexa 
Fluor® 633 labelled anti-human IgG) similar to those used in Chapter 3 were used to 
establish a basic protocol for carrying out an immunoassay in a microarray format on 
commercially available amine-coated slides.  The immunoassay protocol did produce 
microarray spots that could be imaged on the breadboard system, but a number of features 
indicative of non-specific binding of material to the surface and “halo” effects around the 
microarray spots were present.  A number of different blocking and washing protocols were 
explored to try to resolve this, however a satisfactory solution was not found.  In an attempt 
to circumvent these problems, commercially available epoxy-functionalised slides were used 
in place of the amine-coated slides.  When the immunoassay was carried out on epoxy-
coated slides, the „halos‟ around the microarray spots were no longer present and the non-
specific binding problems were reduced for the anti-atrazine scAb immunoassay.   
 
At this point, two changes were made to make the immunoassay more relevant to the final 
Life Marker Chip instrument.  First, a procedure for in-house silane modification of glass and 
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silica to produce epoxy-functionalised surfaces was adopted from the literature.  This 
procedure was found to give reproducible contact angle measurements when carried out on 
glass, silicon oxide and silicon nitride samples.  These procedures are well established, 
however confirming a successful protocol within the Life Marker Chip consortium is an 
important step in de-risking the instrument development.  Secondly, a new immunoassay for 
the detection of a biomarker target molecule of astrobiological interest (GroEL / chaperonin-
60), which may be included in the flight instrument Life Marker Chip, was developed.  This 
involved establishing a protocol for in-situ Alexa Fluor® labelling of GroEL protein which could 
be adapted for the flight instrument and labelling of any amine-containing biomarker target, 
another key step in the development of the Life Marker Chip. 
 
The GroEL immunoassay was carried out in a microarray format on both commercially 
available and in-house epoxy-coated microscope slides.  Although the initial experiment 
indicated that the in-house epoxy surface showed less non-specific binding than the 
commercial epoxy coating, the more conveniently available commercial slides were used for 
further development of the assay.  The development work involved a series of experiments to 
optimise blocking and washing protocols, which yielded a protocol that, although not fully 
optimised in terms of preventing non-specific binding, was consistent enough that most of the 
immunoassay images taken could be used to analyse microarray spot intensity.  This 
protocol was used to produce a calibration curve for an immunoassay in a microarray format 
carried out in an open microfluidic channel structure.  Although this calibration is not directly 
representative of the final format, since a closed microfluidic channel will restrict the volume 
of solution available and therefore the amount of material available to bind to the microarray 
spots, it is still an important development.  An important point highlighted by the results of this 
experiment is that the binding affinity of the antibody as calculated from the calibration curve 
appeared to be higher than typical values, which may be due to the Alexa Fluor® 633 
labelling of the GroEL affecting the binding affinity of the anti-GroEL antibody.  This raises 
the point that antibodies raised against labelled biomarkers may be more suitable for the Life 
Marker Chip than antibodies against the unmodified target molecules. 
 
Although the development of the Life Marker Chip instrumentation is ongoing and future work 
will be discussed in section 6.2, Chapter 4 has described the developments made during the 
timescale of this PhD work.  The following chapter describes a number of experiments that 
were carried out in order to determine if, and how, the Martian environment and sample 
processing techniques may affect immunoassays and thereby how the design of the Life 
Marker Chip and sample processing system could reduce or prevent any effects. 
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Chapter 5: Effect of Martian regolith salts and sample extraction solvents on 
antibody-based assays  
5.1 Introduction 
As described in section 2.3, Martian regolith samples, especially those of interest for 
astrobiology, may contain different salts of which the most interesting ones for the Life 
Marker Chip (LMC) are particularly iron (II) and iron (III) sulphates, magnesium sulphate 
and calcium sulphate (Parnell et al., 2004, Harland, 2005, Amaral, Martinez-Frias & 
Vázquez, 2005, Clarke et al., 2005, Squyres et al., 2005, Marion et al., 2006, Peterson & 
Wang, 2006).  Iron (III) sulphate is a lower priority target, since while it is formed in water 
the primary sites of interest for Life detection are areas that have been exposed to 
aqueous environments for extended periods of time, and are more likely to contain iron (II) 
sulphate produced by paragenesis (Squyres et al., 2005, Marion et al., 2006) (see section 
2.4.1.2).  Iron (III) sulphate (jarosite) has therefore not been tested for compatibility with 
biological buffers at the time of writing, but is intended for future work. 
 
The SMILE LMC sample processing system will extract polar and a-polar biomarkers from 
the sample using solvents, which for biomolecules from extant Life may involve the use of 
agents such as guanidine-HCl to extract proteins. For a-polar biomarkers the sample 
processing and extraction may include highly a-polar organic solvents such as 
dichloromethane and n-hexane with or without other more polar organic solvents e.g. 
methanol, propanol. 
 
At present it is unknown whether, or how much of, these salts and organic solvents will 
pass through the sample processing system and into the LMC assays.  Thus a series of 
preliminary experiments have been carried out to determine what effect these might have 
on antibody assays, using an existing anti-atrazine binding ELISA based on a recombinant 
scAb antibody as a model system.  As described in section 3.2, this anti-atrazine scAb 
antibody was used because it is an antibody against a small organic molecule similar to 
some of the proposed targets, and could be used in the flight as a positive control marker 
since it is unlikely that atrazine will be present on Mars.  The antibody was also 
conveniently available in the laboratory.  This antibody is a recombinant antibody, so it is 
representative of some antibodies that may be used in the flight instrument (Sims et al., 
2005).  The detailed protocol for this assay is described in Section 3.2. 
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The experiments carried out in this section include assays with the anti-atrazine scAb in 
buffers containing the representative Martian salts iron (II) sulphate, magnesium sulphate 
and calcium sulphate at different percentages of their solubility limit.  During the 
preliminary experiment, precipitation and oxidation of iron (II) to iron (III) was observed, so 
a second experiment was performed to define the conditions under which this occurred.  In 
a further experiment, an attempt was made to prevent this precipitation by the addition of 
an anti-oxidant (ascorbate). An assay to determine the effect of different concentrations of 
guanidine-HCl varying from 8M (the most commonly used concentration for extraction) to 
1M diluted in buffer was also carried out.  Initial experiments to determine the need to 
remove organic solvents from the sample after processing were also done by performing 
assays with the anti-atrazine scAb in a number of organic solvents (hexane, hexane-
methanol mixture and methanol-buffer mixtures).   
5.2 Effect of representative Martian regolith salts on antibody assays 
 
In order to determine the effect of representative Martian regolith salts on antibody assays, 
commercially available pure salts were dissolved in standard biological buffers to identify 
any effect of each salt individually.  The assay was carried out exactly as described in 
section 3.1.1.4, but instead of using standard buffers for the antibody incubation step, 
buffers containing dissolved salts at different concentrations (depending on the solubility 
limit of the salt) were used.  In this way, the salt was only present during the critical stage 
of antibody binding to its target antigen, and would not affect other aspects of the 
experiment.  This is representative of the proposed assay system for the LMC, in which 
samples will flow in to a pre-fabricated microfluidic channel containing dried-down 
reagents and pass directly over the immobilised antibodies (Sims et al., 2005).  In this 
proposed assay system no other stages in the assay would be carried out in buffers 
containing Martian salts. 
In the LMC itself, the buffer used for the immunoassays may be mixed with an organic 
solvent.  However, this was not considered in these initial tests with Martian regolith salts, 
in order to determine the effects of each salt, and each organic solvent, individually before 
moving on to study more complex buffer combinations. 
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5.2.1 Effect of calcium sulphate (CaSO4) on anti-atrazine binding ELISA – materials and 
methods 
A literature survey indicated that the solubility limit of CaSO4 (pure) in water at 25°C is 
0.205g.100ml-1 (2.05mg.ml-1) (CRC Manual, 2007).   0.4g of CaSO4 (Sigma-Aldrich, Poole, 
UK) was dissolved in 100ml of 10mM HEPES buffer pH 7.4 and vigorously shaking for 10 
minutes.  0.4g of CaSO4 in 100ml of HEPES exceeded the solubility limit of CaSO4 at 
20°C, as determined by the presence of visible precipitate in the solution after 24 hours 
incubation.  Precipitates were left to settle, and removed by decanting the solution into a 
fresh container.  HEPES buffer was used for this experiment in preference to PBS, which 
had been used in the radiation testing work (see section 3.1.1.4), to avoid precipitation of 
calcium phosphate.  In the future a similar experiment with a real sample of gypsum 
(CaSO4.2H2O), a calcium sulphate mineral, from the Houghton impact crater, is planned.  
This is discussed in section 4.2. 
5.2.2 Effect of calcium sulphate (CaSO4) on anti-atrazine binding ELISA – results and 
discussion 
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Figure 5.1: Comparison of anti-atrazine scAb binding ELISA run in PBS, HEPES and HEPES saturated with 
CaSO4.  The average lines show the average for duplicate wells for the assay in each buffer, with symbols in 
the corresponding colour showing the data points for each well.  
Figure 5.1: confirms that changing the assay buffer from 10mm PBS pH7.4 to 10mM 
HEPES pH7.4 had no significant effect on the assay.  Figure 5.1: also shows that the 
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presence of calcium sulphate at its solubility limit has no negative effect on the antibody 
assay.  Indeed, the antibody binding signal observed was slightly higher with calcium 
sulphate present.  This demonstrates that calcium sulphate passing through into the assay 
chamber of the Life Marker Chip would not appear to present a problem for this particular 
assay.  As this anti-atrazine antibody is representative of the type of antibody-antigen 
system for other LMC targets, it is reasonable to assume that the presence of calcium 
sulphate will not affect other immunoassays.  However this will need to be tested and has 
been identified as future work in section 6.2.  
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5.2.3 Effect of magnesium sulphate (MgSO4) on anti-atrazine ELISA  – materials and 
methods 
Magnesium sulphate (MgSO4) (Epsom salt) was found in a literature survey to have a 
solubility limit in water of 35.7g.100ml-1 at 25°C (CRC handbook, 2007).  Since this 
solubility is very high, it was decided to test the effect of MgSO4 at 10, 50 and 100% of this 
solubility limit (i.e. 3.56, 17.3 and 35.6g.100ml-1) on the antibody assay.  These solutions 
were prepared by adding 3.56, 17.3 or 35.6g of MgSO4 (Sigma-Aldrich, Poole, UK)
 to 
100ml of 10mM HEPES buffer pH 7.4 and shaking for 10 minutes.  WARNING - This 
solution preparation was observed to be highly exothermic, sufficiently so that the 
35.6g.100ml-1 solution damaged the glassware it was prepared.  In the future 
representative real MgSO4 samples e.g. epsomite could be tested with this system. 
5.2.4 Effect of magnesium sulphate (MgSO4) on anti-atrazine binding ELISA  – results 
and discussion 
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Figure 5.2: Comparison of Anti-Atrazine scAb binding ELISA run in HEPES containing MgSO4 at 3.6 and 
17.3mg.ml-1.  Data points for each well are shown in the corresponding colour for each assay.  Some of the 
lower data points drop below 0 binding signal due to an anomalously high background signal during this 
experiment.  The experiment will be repeated to resolve this problem. 
Figure 5.2 shows that while the presence of magnesium sulphate at 3.6 and 17.6mg.ml-1 
causes a reduction in antibody binding of approximately 50%, significant activity remains.  
This shows that the high solubility of magnesium sulphate and therefore high salt content 
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of the buffers does have an adverse effect on antibody-antigen interaction, but significant 
binding activity remains even at 50% of the solubility limit.  Assuming that other antibody-
antigen systems are similarly affected, this reduction in binding is something that must be 
considered in the development of the LMC sample processing system.  If this reduced 
binding is found to have a significant effect on the lower limit of detection of the LMC, a 
demineralisation step to remove mineral ions from the sample will have to be considered. 
5.2.5 Effect of iron II sulphate (FeSO4) on anti-atrazine binding ELISA – materials and 
methods 
As discussed in section 3.3.1, while iron (III) sulphate (jarosite) is present on the Martian 
surface in much greater quantities that iron (II) sulphate, iron (II) sulphate is present in 
areas paragenesies has occurred, i.e. where the presence of water for extended periods of 
time caused iron (III) sulphate to be reduced to iron (II) sulphate.  Sites where this has 
occurred are of greater relevance to the Life Marker Chip since they indicate and 
environment in which Life may have evolved, and so the effect of iron (II) sulphate  sample 
on the immunoassay, and the consequences of this for the sample processing system, 
was investigated in this work while iron (III) sulphate remains and important regolith 
component to be tested in future experiments (see section 4.2).   
Iron (II) sulphate (FeSO4) (also known as ferrous sulphate) was found to have a solubility 
limit in water of 29.56g.100ml-1 at 25°C (CRC Manual, 2007).  Since this solubility is very 
high, it was decided to test the effect of FeSO4 at 10, 50 and 100% of this solubility limit 
i.e. 2.66, 13.3 and 26.6g.100ml-1 on the antibody assay.  These solutions were prepared 
by adding 2.66, 13.3 and 26.6g of FeSO4 (Sigma-Aldrich, Poole, UK)
 to 100ml of 10mM 
HEPES buffer, pH 7.4 and shaking for 10 minutes. 
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5.2.6 Effect of iron II sulphate (FeSO4) on anti-atrazine binding ELISA – results and 
discussion 
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Figure 5.3: Comparison of Anti-Atrazine scAb binding ELISA run in HEPES containing FeSO4 at 2.6, 13.3 
and 26.6mg.ml-1 
Figure 5.3 shows the results of the assay with FeSO4 present at different concentrations, 
and indicates that no significant antibody binding has been observed.  However this does 
not illustrate other issues with this experiment.  The results in Figure 5.3  were derived by 
subtracting the signal of microtitre plate wells containing antibody from wells containing 
only FeSO4 in HEPES buffer.  In this experiment, all of the microtitre plate wells to which 
FeSO4 was added, including those with no antibody, gave a very high signal.  In addition, 
the HEPES buffers containing FeSO4 were observed to contain red precipitates after 
completion of the assay, indicative of the presence of iron (III) compounds.  It is possible 
that the products of this reaction affected the protein blocking of these wells, resulting in 
non-specific binding of the anti-atrazine scAb and a high signal in all wells.  Due to this 
very high background signal it was not possible to determine whether the antibody-antigen 
was affected by the presence of iron(II) sulphate.  
 
We conclude from this that iron (II) sulphate was oxidised to iron (III) in the HEPES buffer, 
and that this oxidation generated insoluble iron (III) precipitates.  Since this is incompatible 
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with the microfluidics in the sample processing system and the LMC, an alternative buffer 
in which these precipitates are not formed must be identified.  Further experiments (see 
section 5.3) were carried out to investigate the timescale of this precipitation and ways to 
prevent it.   
 
5.3 Investigation of buffer compatibility with Martian regolith salts 
 
5.3.1 Preliminary experiment to determine compatibility of biological buffers with iron (II) 
sulphate – materials and methods 
A preliminary experiment to identify an alternative buffer was carried out in order to 
validate the precipitation observation in section 5.2.6, and find out if this occurred with a 
number of buffer types.  Approximately similar amounts of iron (II) sulphate (a low fraction 
of the solubility limit) were added to ~400ml of RO water, and uncontrolled concentrations 
and pH (of similar weight/volume ratio solutions) of different buffers used in biological 
assays (HEPES, TRIS, and MOPS).  After the buffers were prepared they were 
photographed with a digital camera (Figure 5.4 and Figure 5.5).   
5.3.2 Preliminary experiment to determine compatibility of biological buffers with iron (II) 
sulphate – results and discussion 
Immediately after the iron (II) sulphate was added water the solution was clear.  After 10 
minutes incubation in water, HEPES and MOPS buffer solutions became a yellow-orange 
colour and contained precipitates.  This indicates that oxidation of iron (II) to iron (III) has 
occurred, since iron (II) compounds are green in colour while iron (III) compounds are 
orange / red.   When iron (II) sulphate was added to TRIS buffer, large amounts of a dark 
green precipitate were formed immediately and the solution became ‘milky’ in texture.  
These solutions were left for one hour more, and greater redness was observed in the 
TRIS solution and the RO water, suggesting that further oxidation of iron (II) had occurred.  
The HEPES and MOPS buffer solutions appeared to be similar in colour after one hour 
suggesting that they had reached equilibrium. 
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Figure 5.4: Photograph of iron (II) sulphate in different solutions.  From left to right, a fresh solution in water, 
10 minutes incubation in water, HEPES, MOPS and TRIS buffers.  The buffer solutions were uncontrolled in 
terms of their concentration and pH, but were similar weight / volume ratios.  
 
Figure 5.5: Photograph of iron (II) sulphate in different solutions.  From left to right, 1 hour incubation of a 
solution in water, 1 hour 10 minutes incubation in water, HEPES, MOPS and TRIS buffers (the same 
solutions shown in Figure 5.4 after incubation at room temperature for 1 hour).  The buffer solutions were 
uncontrolled in terms of their concentration and pH, but were similar weight / volume ratios. 
This result clearly eliminates TRIS as a candidate for a biological buffer, since the 
precipitation reaction was immediate.  The other buffers all behaved in a similar way and 
the reaction appeared to occur more slowly, indicating that it may be possible to inhibit it 
with an antioxidant e.g. ascorbic acid.  Since ascorbic acid was already being considered 
for incorporation into the buffer salts to prevent or reduce radiation damage (see section 
2.1.3.6), it was the first choice of antioxidant for preventing precipitation of buffer salts by 
oxidation reactions. 
5.3.3 Controlled experiment to characterise precipitation in different buffers – materials 
and methods 
A further experiment was carried out to monitor the effects observed in section 5.3.2 in a 
more controlled experiment and to determine whether the presence of an antioxidant 
(ascorbic acid) would prevent or reduce oxidation of iron (II) and the formation of 
precipitates in different buffers.  The buffers HEPES, MOPS and TRIS were prepared at a 
concentration of 10mM (the concentration used in the previous assays).  RO water was 
used as a control, to verify that effects observed were due to the presence of the buffer 
salts.  Iron (II) sulphate was dissolved in 50ml of each buffer at a concentration of 26.6 
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mg.ml-1, 10% of its solubility limit in water at 25°C.  The buffers were then photographed 
immediately after addition of the iron (II) sulphate and after 1 hour. 
5.3.4 Controlled experiment to characterise precipitation in different buffers – results and 
discussion 
 
Figure 5.6: Photograph showing different buffers immediately after the addition of 26.6mg.ml-1 iron (II) 
sulphate.  From left to right the solutions are RO water, 10mM HEPES, 10mM TRIS, and 10mM MOPS all at 
pH 7.4. 
 
Figure 5.7: Photograph showing different buffers 1 hour after the addition of 26.6mg.ml-1 iron (II) sulphate.  
From left to right the solutions are RO water, 10mM HEPES, 10mM TRIS, and 10mM MOPS all pH 7.4. 
The visible presence of iron (III) in the RO water in this experiment is likely to be because 
the concentration of iron (II) sulphate added to the solutions in this experiment was much 
greater than that used in Figure 5.4, so the red precipitate is visible in Figure 5.6.  It is 
immediately clear from the colour change in the solutions in Figure 5.6 that the iron (II) is 
oxidised to iron (III) immediately in both RO water and 10mM TRIS buffer.  The 10mM 
HEPES buffer also appears to have a slight red colour, indicating that some oxidation of 
iron (II) also occurred in HEPES buffer.    Very little oxidation was observed in the MOPS 
buffer.  The results were very similar after a 1-hour incubation (Figure 5.7), except that in 
the TRIS buffer the iron (III) precipitate appears to have accumulated in the centre of the 
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solution.  This accumulation of precipitate did not occur in RO water, indicating that the 
precipitate was formed by reaction of the iron (II) with the TRIS buffer salt.  The clear 
conclusion from this and the assay carried out with the HEPES buffer is that pure TRIS 
and pure HEPES are clearly not appropriate for use in the Life Marker Chip since the 
formation of precipitates is incompatible with a microfluidic channel system.  
 
5.3.5 Controlled experiment with buffer salts and antioxidant (ascorbic acid) – materials 
and methods 
The experiment described in section 5.3.3 was then repeated, but this time with the 
addition of ascorbic acid, which was dissolved in the buffer prior to addition of the iron (II) 
sulphate.  Ascorbic acid was added to each solution at a concentration of 20.6mg.ml-1, a 
2.5 times molar excess of ascorbic acid for the concentration of iron (II) sulphate added.  
No other changed were made to the protocol. 
5.3.6 Controlled experiment with buffer salts and antioxidant (ascorbic acid) – results and 
discussion 
 
Figure 5.8: Buffer solutions after the addition of ascorbic acid at a concentration 20.6mg.ml-1.  From left to 
right the buffers are: RO water, 10mM HEPES, 10mM MOPS, 10mM TRIS all pH 7.4. 
The buffer solutions were transferred into clean beakers to remove the un-dissolved 
ascorbic acid.  Iron (II) sulphate was then added to these solutions at a concentration of 
26.6mg.ml-1.  
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Figure 5.9: Buffer solutions containing ascorbic acid immediately after the addition of iron (II) sulphate at a 
concentration of 26.6mg.ml-1.  From left to right the buffers are: RO water, 10mM HEPES, 10mM MOPS, 
10mM TRIS. 
 
Figure 5.10:  Buffer solutions containing ascorbic acid 1 hour after the addition of iron (II) sulphate at a 
concentration of 26.6mg.ml-1.  From left to right the buffers are: RO water, 10mM HEPES, 10mM MOPS, 
10mM TRIS all pH 7.4. 
Figure 5.9 and Figure 5.10 show that, in contrast to the previous experiment, the buffers 
containing ascorbic acid are all a blue/ green colour characteristic of the presence of iron 
(II) ions.  This blue/green colour this indicates that formation of red / orange iron (III) 
precipitates as in section 5.3.4 did not occur, either immediately or after one hour.  This is 
a clear demonstration that the addition of an antioxidant to the buffer is an effective way to 
prevent the formation of iron (III) precipitates and ensure that iron (II) containing samples 
will not be problematic for the microfluidic system.  Since ascorbic acid does not dissolve 
in the buffers used at a high enough concentration to give a large molar excess of 
antioxidant, even at an iron (II) sulphate concentration of 26.6mg.ml-1 (only 10% of its 
solubility limit of in water), other antioxidants with a higher solubility may be considered in 
future experiments.  Nonetheless, this experiment has demonstrated a method by which 
oxidation reactions which may prove damaging to the Life Marker Chip can be prevented. 
 
No experiments to determine whether the buffers containing 20.6mg.ml-1 ascorbic acid and 
26.6 mg.ml-1 iron (II) sulphate were compatible with immunoassays were carried out in this 
thesis.  However, Grieb et al. (2002) demonstrated an antibody assay with antibody in 
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buffer containing 200mM ascorbic acid, showing that the presence of ascorbic acid does 
not prevent antibody-antigen interaction.  The presence of iron (II) ions in the buffer may 
have an effect on the assay, but there are two possible solutions to this.  One is the 
addition of an ion chelator e.g. EDTA to the buffer to prevent the Fe2+ ion interacting with 
the antibody, and the second would be the addition of a demineralisation step to the LMC 
sample processing system, which would prevent iron (II) salts reaching the antibody assay 
buffer in the flight instrument. 
 
Although much further work is required to fully develop a buffer system that is fully tested 
and known to be compatible with the evaporite minerals most likely to be present on the 
Martian surface (see section 4.2), the experiments reported here summarise the work 
carried out to date.  One of the key outcomes of this work was that it highlighted the 
possibility of dissolved evaporite minerals reaction with buffer salts to form insoluble 
precipitates that would be incompatible with a microfluidic channel based Life Marker Chip 
instrument, which had not previously been considered.  Another key result was the finding 
that the inclusion of an antioxidant (ascorbate) that is compatible with immunoassays 
prevented the formation of these precipitates.  Ascorbate is used routinely in some 
biological assay applications and antibody preparations (e.g. Grieb et al., 2002), so would 
not be expected to have an adverse effect on the Life Marker Chip immunoassays.  Thus 
although a buffer format that would be expected to be compatible with the Martian samples 
has not been fully tested in this work, it is believed that a solution had been found to the 
precipitation of buffer salt reaction products.  The next stage in development was to 
determine the tolerance of immunoassays to the presence of organic solvents that may be 
considered in the development of the sample processing system, and this work is 
described in the following sections. 
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5.4 Sample extraction reagents and organic solvents 
As described in section 2.4.4.5, the sample processing system for the SMILE LMC is 
currently based on the use of a solid phase extraction column, in which a single solvent is 
used to remove organics from the column and into the LMC assay area.  Depending upon 
the detailed design of this system, dissolved Martian regolith salts and reagents for use in 
the sample processing and extraction system may pass through into the LMC assay 
reaction chamber.  In polar biomarker extraction, guanidine-HCl is a common extraction 
reagent that may be used to extract biological target molecules from the regolith samples 
(see for example Schweitzer et al., 2005).  The a-polar biomarker extraction line, by the 
nature of the hydrophobic target molecules of interest, must use hydrophobic solvents e.g. 
n-hexane to extract the targets from the sample, and may transfer these into a solution 
more compatible with antibody-antigen interaction by use of an intermediate organic 
solvent such as methanol (Schweitzer et al., 2005, Buch et al.,2003). 
Little previous work has been done to date to determine the effects of these reagents or 
organic solvents on the binding properties of antibodies.  Aga & Thurman (1993) carried 
out ELISAs after solid phase extraction though a C18 column with different solvents, and 
found an ELISA assay to be tolerant to up to 20% v/v methanol in water.  However the 
tolerance of ELISAs to methanol was found to be highly variable (from 5-50%v/v) 
depending on the antibody-antigen pair (Aga & Thurman, 1993).   
 
A series of experiments were devised and carried out to determine whether or how much 
of these solvents would be tolerated by an antibody-antigen interaction, using the anti-
atrazine scAb binding ELISA described in section 3.1.1.4 as a representative system.  This 
is broadly comparable with the proposed assay format in the flight instrument since one of 
the antibody-antigen pair is immobilised on a surface and the binding reaction occurs in 
solution over this functionalised surface.  In all experiments in organic solvents, the 
antibody-antigen binding step was carried out in the solvent of interest, while the rest of 
the protocol remained unaltered as described in section 3.1.1.4. 
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5.4.1 Effect of guanidine-HCl on antibody-antigen interaction – materials and methods 
Guanidine HCl can be used to extract proteins, amino acids and DNA from soil or regolith 
samples.  It is normally used as a denaturant for proteins and therefore denaturation of the 
scAb antibody, i.e. loss of activity, is expected at higher concentrations, for example the 
8M typically used in extraction protocols (Schweitzer et al., 2005).  In this experiment, anti-
atrazine scAb was used only at a concentration of 0.3μg.ml-1 rather than the serial dilution 
(2-fold dilutions from 0.3 – 5.9x 10-4μg.ml-1) used in previous experiments.  This was 
because it is known that guanidine-HCl is a protein denaturant and would almost certainly 
reduce the antigen-binding ability of the antibody fragment significantly, especially at lower 
concentrations of antibody (since at lower concentrations any slight denaturation effect 
may be beyond the lower limit of detection of the assay).  In order to achieve maximum 
similarity to the proposed final instrument, plastic Eppendorf vials were loaded with 1μl of 
0.3mg.ml-1anti-atrazine scab and placed into a sealed vessel containing excess silica 
hydride desiccant, and the vessel placed in an oven at 37°C overnight to remove all water 
present.  The binding ELISA assay protocol was then carried out as described in section 
3.1.1.4, except that the addition of the anti-atrazine scAb was carried out as follows.  
Immediately prior to the addition of anti-atrazine scAb to the plate wells, 1ml of guanidine 
HCl (Sigma-Aldrich, Poole, UK) was added to the vials containing dried anti-atrazine scAb 
at concentrations of 8M (as supplied) and 6M, 4M, 2M and 1M diluted in 10mM HEPES 
pH7.4.  100μl of this solution was then added to the appropriate wells on the ELISA plate 
and incubated for 2 hours at 20°C, and the remaining protocol was carried out according to 
section 3.1.1.4.  
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5.4.2 Effect of guanidine-HCl on antibody-antigen interaction – results and discussion 
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Figure 5.11: Effect of the presence of different dilutions of guanidine-HCl on anti-atrazine scAb in a binding 
ELISA format.  Guanidine HCl was used at concentrations of 8M (directly from the stock solution) and diluted 
to 6M, 4M, 2M and 1M in 10mM HEPES buffer pH 7.4.  The control antibody was reconstituted in 10mM 
HEPES pH 7.4. The line connects the average binding signal from the duplicate wells at each concentration, 
and filled triangles and squares represent replicates of the guanidine HCl serial dilutions. 
Figure 5.11 shows that guanidine HCl at 1M appeared to increase the amount of bound 
antibody.  This may be due to the diluted guanidine-HCl partially denaturing the scAb, and 
thereby increasing the binding affinity of the labelled secondary antibody, without 
adversely affecting the scAbs atrazine binding site (so the scAb still binds to its BSA-
atrazine antigen).  At concentrations 2M and above, no significant antibody binding is 
observed as expected (because guanidine-HCL denatures proteins). 
 
This experiment has demonstrated that this ELISA, (and potentially immunoassays for 
other LMC targets) will not function in the presence of over 2M guanidine-HCl.  This 
imposes a requirement on the LMC sample processing system to limit the amount of 
guanidine-HCL that passes through into the assay chamber to a maximum concentration 
of 2M, either by diluting the extracted solution (which given the low concentrations of target 
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analytes is unfavourable) or transferring the extracted biomarkers into a different solution 
before releasing it into the assay chamber. 
5.4.3 Effect of sample extraction organic solvents on antibody assays – materials and 
methods 
Sample extraction procedures use a variety of organic solvents to remove potential target 
molecules from their matrices.  Antibodies are known to have variable tolerance to the 
presence of organic solvents (Aga & Thurman, 1993).  Factors contributing to this can 
include poor solubility and changes in the secondary structure of the antibody due to the  
hydrophobic nature of the solvent (Aga & Thurman, 1993). 
Dried antibody samples were prepared by pipetting 1μl of 0.3mg.ml-1 anti-atrazine scAb 
into Eppendorf vials, and placing the vials in a sealed container with excess silica gel 
dessicant in an oven at 37°C overnight.  These antibody samples were reconstituted in the 
desired solvent and used in the assay.  A binding ELISA was then carried out according to 
the protocol in section 3.1.1.4.  During incubation steps involving antibody in organic 
solvents, the plates were sealed with AlumaSeal™ adhesive aluminium foil sheets (Sigma-
Aldrich, Poole, UK) to prevent evaporation of the solvent. 
Two solvents have been tested to date.  Methanol is used to elute some molecules of 
intermediate polarity from solid phase extraction columns as described in section 2.4.1.3, 
either in pure form or combined with other solvents, so was considered a useful solvent to 
test.  Methanol was diluted in 10mM HEPES buffer pH 7.4 in volume fractions of 10, 25 
and 50%, to represent different ratios of water-methanol that may be used to elute 
organics from the solid phase extraction column.  Hexane is used to remove highly a-polar 
molecules from the solid phase extraction column and was tested as an example of a 
highly a-polar solvent.  100% hexane, hexane containing 12.5% volume fraction of 
Methanol (close to the solubility limit of methanol in hexane) and 100% methanol were 
tested in a separate experiment. 
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5.4.4 Effect of sample extraction organic solvents on antibody assays – results and 
discussion 
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Figure 5.12: Effect of the presence of different concentrations of methanol in HEPES Buffer on the binding 
properties of anti-atrazine scAb recombinant antibody fragment. 
Figure 5.12 shows that with up to 25% volume fraction of methanol in HEPES buffer 
antibody binding still occurs, and in fact a higher signal was observed.  Similarly to 
guanidine-HCl, this increase in binding could be due to the different polarity of the 
methanol causing partial denaturation of the scAb, making it easier for the labelled 
secondary antibody to bind.  Such an effect could increasing the binding signal without 
affecting the binding site allowing the scAb to attach to the BSA-atrazine target.  At 50% 
volume fraction of methanol in HEPES buffer, however, no signal is observed.  This loss of 
signal could be caused by the organic solvent causing structural damage to the antibody, 
or a consequence of the antibody being insoluble in the methanol / HEPES buffer solution.  
This result is in broad agreement with the findings of Aga & Thurman (1993). 
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Figure 5.13: Effect of the presence of hexane, methanol and a hexane / methanol mixture on the binding 
properties of anti-atrazine scAb recombinant antibody fragment. 
Figure 5.13 shows that no antibody binding was observed when the scAb incubation stage 
of the ELISA was carried out in 100% methanol, 100% hexane or hexane containing 
12.5% volume fraction methanol.   The most likely explanation for this is that the antibody 
is insoluble in the hexane, 100% methanol and hexane / methanol mixture.  Further tests 
need to be done to establish what the contribution of each of these factors is to the loss of 
antibody binding signal.  However, this result is a clear indication that pure hydrophobic 
solvents are unlikely to be compatible with the antibody assay in the flight instrument, so 
methods to dilute or remove the organic solvents from the extraction system while 
retaining the target molecules of interest in the sample will have to be considered. 
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5.5 Summary and discussion of the effects of Martian regolith salts and sample 
extraction solvents on antibody-based assays 
 
The focus of this section has been to determine the effect of likely Martian samples on 
antibody assays, since the Life Marker Chip proposes to utilise antibody assays for the 
detection of biomarkers on Mars.  The sample processing system for the LMC has not 
been fully defined at this stage, therefore some of these experiments were carried out to 
determine requirements for the sample processing system as well as determining the 
effect of different conditions on the assays. 
 
The first area that was considered was the effect of Martian regolith salts.  Since the target 
areas of most interest to the ExoMars mission are areas that may have supported Life on 
Mars, the mission will intend to place a rover on an area of the surface that may once have 
been covered by liquid water (Vago et al., 2003).  These areas are likely to contain large 
deposits of evaporite minerals including calcium sulphate, iron (II) and iron (III) sulphates 
and magnesium sulphate (see section 2.1.4.2).  Assays were carried out using antibody in 
buffers containing these minerals at different fractions of their solubility limit.  It was found 
that calcium sulphate had little effect on the assay, and magnesium sulphate reduced the 
binding signal by approximately 50%.  The addition of iron (II) sulphate to buffers resulted 
in precipitation of an insoluble iron (III) compound and a very high background signal in the 
assay.  A further set of experiments was carried out in which it was found that the 
formation of precipitates in the presence of iron (II) sulphate could be prevented by the 
addition of ascorbate (an antioxidant), but this new buffer was not tested in an assay 
format.  However ascorbate is used in some biological assays and has no adverse effects 
(Grieb et al., 2002), so this solution is expected to overcome the non-specific binding 
caused by the addition of iron (II) sulphate to buffers.  This will be confirmed in future work 
(see section 4.2).  Since an antioxidant was already being considered for addition into the 
LMC buffers to prevent oxidation by radiation damage, this does not significantly affect the 
design of the LMC.   
 
The second area considered in this section was the possibility that reagents including 
organic solvents used in the sample extraction system may reach the assay area of the 
Life Marker Chip.  Since the chemistry and solvents to be used in the LMC sample 
processing system have not yet been defined, experiments were carried out in which a 
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representative antibody (anti-atrazine scAb) was used in different concentrations of 
guanidine-HCl (a common sample extraction reagent for proteins) methanol / HEPES 
buffer mixtures, representing a polar organic solvent, n-hexane as an example a-polar 
solvent, and a methanol / n-hexane mixture to represent a mixture of organic solvents.  
Guanidine-HCl increased the antibody binding signal at a concentration of 1M, but at 2M 
and above the binding signal was very low.  Since guanidine-HCl is a protein denaturant, 
this is likely to be due to denaturation of the antibody or the BSA-atrazine conjugate, or 
both.  This result indicated that guanidine HCl can only be present in the antibody assay at 
concentrations of 1M and below, and the possibility of denaturing target proteins of interest 
in the sample limits it’s usefulness in this application. 
 
It was found the antibody assay had an enhanced signal when 25% v/v methanol was 
present in the buffer, but at 50% and higher concentrations of methanol no antibody 
binding signal was observed.  No antibody binding was observed when the antibody was 
used in pure n-hexane or n-hexane containing 12.5% v/v methanol.  These experiments 
indicate that methanol could be used in the sample processing system and diluted in buffer 
prior to reaching the antibody assay area of the LMC.  However, if n-hexane or organic 
solvent mixtures are used, the biomarkers to be detected must be transferred into a 
different carrier solution before an antibody assay can be carried out. 
 
This series of experiments has defined some of the limits of using an antibody assay 
based detection system for applications in the Martian environment, and provided a 
number of key design inputs for the sample processing system which is currently under 
development.  Some of the results are positive, for example enhanced binding signal when 
low concentrations of methanol are present, and others have raised unexpected points for 
consideration such as the reaction of iron (II) sulphate with HEPES buffer.  This area 
requires further investigation as the design of the sample processing system is developed. 
The organic solvents or mixtures present in the solution used for antibody-antigen binding 
is critical, and further work to confirm that the solution used in this assay step is compatible 
with all of the salts that may be present in the Martian regolith samples to be analysed is 
essential. 
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6 Discussion and Future Work 
 
6.1 Discussion of developments in Life Marker Chip technology for in-situ Life 
detection on Mars made during this work 
 
Since the three sections of practical work were carried out and reported as a series of 
experiments in which the results of each experiment and implications for subsequent 
work were discussed throughout Chapter 3, this final discussion presents a brief 
summary of the developments made and the status of each area of work at the 
conclusion of this PhD work. 
 
The Life Marker Chip is an important instrument proposed for the Pasteur payload for 
the European Space Agency’s flagship Life detection mission, ExoMars, since it has the 
ability to detect large number of molecular targets of interest that are beyond the 
detection capabilities of other instruments.  However, at the time that work in this thesis 
began, a number of key areas of work critical to the development of the Life Marker 
Chip had not been carried out. 
 
Firstly, the proposal to utilise the specific molecular recognition properties of antibodies 
and the sensitivity enabled by fluorescent dyes had to be confirmed as compatible with 
the radiation and sterilisation environments encountered during a space mission.  The 
current state of knowledge initially was primarily the work of others using gamma 
radiation, which indicated that transporting or sterilising proteins in solution would not be 
successful due to degradation by the radiolytic products of water.  However, protein in a 
dried state had been shown to be more resistant to damage.  No work had been done 
exposing fluorescent dyes or antibodies to gamma, proton or helium ion radiation.  In 
producing the literature review for this thesis a draft publication has been written and is 
awaiting submission to the journal Astrobiology, pending receipt of updated figures for 
the measured radiation environment during flight to Mars from the NASA MARIE team. 
 
To address this, a protocol was developed which allowed dried samples of fluorescent 
dyes and antibodies to be exposed to fluences of protons and helium ions at level 
comparable to a mission to Mars and large excesses.  Although some loss of activity 
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was observed in some experiments, none of the conditions used completely inactivated 
either the antibody used or representative fluorescent dyes.  Fluorescent dyes were 
also shown to survive both heat sterilisation and gamma radiation exposure up to the 
levels used in sterilisation protocols in the dried state, although in water the dyes did not 
retain fluorescent properties when exposed to sterilisation doses.  These results 
contributed towards the continuation of funding for the development of the Life Marker 
Chip by the European Space Agency, some results for the particle radiation tests have 
been published (Thompson et al., 2006) and further publications are planned for other 
results including the exposure of fluorescent dyes to gamma radiation. 
 
The second area of interest was the development of the instrumentation platform on 
which the Life Marker Chip would be based.  Reviewing the literature indicates that the 
proposed design utilised a number of technologies that were already at an advanced 
stage of development in other fields, but have not be used in combination in previous 
work.  In this thesis many of the components required for the assay system to be used 
in the final Life Marker Chip design have been demonstrated, including epoxy 
functionalisation of glass and silicon surfaces, printing protein and antibody microarray 
within microfluidic channel structures, covalent attachment of proteins and antibodies to 
these surfaces, optimising an assay protocol for carrying out an immunoassay in a 
microarray format in an open microfluidic channel, in-situ labelling and detection of a 
relevant target protein, and developing a breadboard system and imaging protocol that 
allows imaging of fluorescently labelled protein bound to antibody microarrays.  This 
work has advanced the level of knowledge in this area by demonstrating deposition of 
protein and antibody microarrays in microfluidic structures for the first time, using spot 
assay areas much smaller than demonstrated in previous work, and successfully 
carrying out immunoassays using these microarrays.  It has also provided strong 
support for the continuing development of the Life Marker Chip design by demonstrating 
capability within the consortium to carry out each of the assembly stages required to 
build the complete instrument.   
 
The third and final aspect of the Life Marker Chip instrument considered in this work 
was the effect of real sample matrices and sample processing reagents and solvents on 
the proposed antibody assay detection system.  While calcium sulphate and 
magnesium sulphate did reduce the antibody binding signal in the representative assay, 
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they did not present critical problems for the assay even at their solubility limits in water.  
However, iron (II) sulphate did present a problem for the antibody assay and a 
microfluidic design, specifically by forming precipitates of an iron (III) salt in both HEPES 
and TRIS buffers.  The resulting HEPES buffer appeared to cause a very high binding 
signal in the antibody assay, indicating that they affected either the dissolved antibody 
or the protein conjugate in the plate wells, or both, in a way which caused a high degree 
of non-specific binding.  However, on visual inspection the buffer MOPS did not appear 
to be affected in this way, and in HEPES, TRIS and MOPS buffers the addition of 
ascorbic acid as an antioxidant appeared to prevent the formation of precipitates.  While 
ascorbic acid many not prove to be the best antioxidant for the flight instrument for the 
flight instrument because it does not have high enough solubility to provide a large 
excess over iron (II) sulphate (even at 10% of iron (II) sulphate’s solubility limit), this 
work has demonstrated that the inclusion of an antioxidant in the final assay buffer is a 
suitable approach to preventing oxidation reactions and the formation of precipitates. 
 
The use of Guanidine-HCl as an extraction reagent may increase the yield of protein 
from samples, but it is not compatible with an antibody assay system at concentrations 
of more than 1M.  Since typical extraction protocols use guanidine-HCl at 8M or 6M, it 
would either have to be diluted or removed from the solution before it reached the 
antibody assay reaction chamber.  Diluting the sample is likely to be impractical due to 
the likely low concentrations of target analytes, but reagents could be removed during a 
solid phase extraction step.  Solid phase extraction was already being considered in the 
design for the sample processing system since it allows both concentration of the 
sample and exchange of buffer solutions between the extraction and assay stages. 
 
The experiments with organic solvents demonstrated that completely organic solvents 
such as methanol, hexane or methanol-hexane mixtures are not compatible with 
antibody assays as expected.  This suggests that if these solvents are to be used in the 
sample processing system the targets extracted from them must be transferred into an 
aqueous solvent prior to being passed over the antibody assay area, for example by a 
solid phase extraction.  This is not a critical problem for the Life Marker Chip since, as 
mentioned above, a solid phase extraction step was already being considered for the 
sample processing system.  Experiments with buffer-methanol mixtures suggested that 
solutions containing up to 25% methanol could be used in the antibody assay reaction.  
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This may allow buffer-methanol mixtures to be used to increase the solubility of organic 
target molecules in the solution used for the antibody assay without adversely affecting 
the assay.  Buffer-methanol mixtures could therefore be used to remove targets from a 
solid phase extraction column after they had been extracted from the sample by other 
reagents or solvents that are incompatible with antibody assays.  All of the work on 
Mars related media is believed to be novel especially for this application, and will be 
considered for publication when further experiments have been carried out to increase 
the range of conditions tested. 
 
In summary, this thesis includes work that has advanced the current state of scientific 
knowledge in three key areas for the development of the Life Marker Chip; the effect of 
the radiation environment on biological assay components, development of the 
instrument platform and effect of Mars-related media and sample processing reagents 
on biological assays. This knowledge has contributed to both the continuation of 
developing the Life Marker Chip instrument by validating the use of biological reagents 
in space, and the design and development of the instrument platform and sample 
processing system.  A number of publications have been produced or are being 
prepared that include data from work carried out in this project, in addition to 
contributions to the technical documentation required by the European Space Agency 
for the Technology Readiness Level Upgrade Study.  This work is ongoing and will be 
expanded upon in future work, which will be discussed in the following section. 
 
6.2 Future Work 
 
While significant progress has been made during the work described in this thesis, 
further work is required in all three of the key areas in order to ensure the successful 
development of a breadboard and flight model of the Life Marker Chip by 2011, the 
target date set by the European Space Agency for delivery of the LMC instrument.  
Since the Life Marker Chip Technology Readiness Level Upgrade Study continues 
beyond the timescale of this PhD work, the information reported here may not represent 
the final state of development in any particular area. 
 
In radiation testing, the key experiment that was not carried out during this work is the 
exposure of dried antibody samples to Gamma radiation, at a series of doses including 
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mission and sterilisation levels.  Unfortunately due to time constraints and availability of 
equipment and personnel this could not be carried out in time for the submission of this 
thesis, but it remains a key test and is to be carried out at the earliest opportunity.  
Since the conclusion of the practical work reported in this thesis, a further series of 
proton radiation tests has begun.  This involves the exposure of a number of types of 
sample to 2, 5 and 10 times the mission fluence of protons, using 60MeV protons.  The 
samples exposed include antibody and fluorescent dye freeze-dried into glass-fibre 
pads, and silicon oxide and silicon nitride chips epoxy functionalised with GOPS and 
printed with a microarray containing 5 different reagents.  At the time of writing these 
samples and other Life Marker Chip components including gasket materials have been 
exposed to these proton radiation fluences and are currently in quarantine until residual 
radioactivity drops to a safe background level.  Other radiation tests that are planned 
are further exposures of both antibodies and fluorescent dyes to lower energy level 
protons and neutrons, both of which may be generated as secondary radiation from 
spacecraft shielding.  This is to be carried out either using the Dynamitron at the 
University of Birmingham or facilities at the National Physics Laboratory.   
 
For the instrument platform, the first priority is to develop an assay in a closed 
microfluidic channel. The assay may have a slightly different calibration curve than the 
open channel due to there being a restricted volume of sample solution.  Early 
experiments attempting to achieve this were not successful due to problems with non-
specific binding to one of the materials used to form the microfluidic channel, but this 
problem is not anticipated to be difficult to solve.  In addition, assay using some of the 
protocols developed in different sections of this work together rather than independently 
are a key step, for example demonstrating a successful GroEl assay on a silicon oxide 
surface that had been modified with the GOPS functionalisation protocol is a logical 
development.  Work is planned in which a consortium partner will supply silicon devices 
with microfluidic devices and optical waveguides integrated in to them, and these will be 
used to integrate some of the techniques demonstrated in this thesis. 
 
The range of Mars media and sample processing reagents tested with antibody assays 
and buffer salts needs to be expanded as soon as possible, to establish a suitable 
buffer for the assay at an early stage.  This will initially involve further testing of different 
buffers with the Martian regolith salts with an without the addition of ascorbic acid, to 
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identify a buffer that is suitable for all likely sampling environments, and then to test this 
buffer in antibody assays with difference concentrations of each representative regolith 
salt.  This may then be expanded in to mixing this final buffer with methanol to integrate 
it with the sample processing system.  Work is already planned by other members of the 
SMILE consortium to develop the design of the sample processing system, and select 
an appropriate sample processing method based on the results generated in the initial 
work in this thesis.  If this development identifies any other potentially suitable organic 
solvents or extraction reagents these will be tested for compatibility with the antibody 
assay. 
 
The ultimate goal for this work is to develop a flight instrument Life Marker Chip and 
sample processing system for the Pasteur payload on board the ExoMars mission 
rover, and validate the use of this instrument and sample processing unit in the Mars 
environment.  This is to be achieved by 2011, with a mission launch date in 2013.  This 
thesis contains early development work towards this in three key areas, by providing 
evidence supporting the potential application of biological materials in Mars missions, 
validating the instrument design approach and confirming a number of immunoassay 
and imaging protocols, providing input into the design and development of the Live 
Marker Chip sample processing system, and indicates the areas of high importance for 
the next stage of development of the SMILE Life Marker Chip. 
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A Appendix A: Initial development of microarray spotting equipment and 
immunoassay readout protocols 
A.1 Configuring a robotic system for microarray spotting 
 
The most successful technology for the automated creation of microarrays is contact pin 
printing, using robotically controlled micro-machined pins to deposit controlled nanolitre 
volumes of liquid onto a surface (Affara, 2003, Macbeath & Schreiber, 2000).  This 
approach was adopted for this work because it was desirable to use standard microarray 
spotting equipment and a robot capable of carrying out the printing was available at 
Cranfield University and could be adapted to this function with only minor modifications.  
Other potential approaches to microarray production include ink-jet printing, but since a 
suitable ink-jet printer was not readily available in the short term this was not considered 
further in this work. 
 
In order to create a protein microarray by pin printing, a robotically controlled printing 
system is required to achieve accurate and precise deposition of microarray spots.  At 
Cranfield University, a suitable robotic system, a SPI GmbH XYZ robot (SPI GmbH, 
Oppenheim, Germany), shown in Figure A.1, was available for this project.  The movement 
within the SPI GmbH robot is precisely controlled by THK LM Guide Actuators, specifically 
by two 520mm rails controlling movement in the Y direction, a 420mm rail controlling 
movement in the X direction and a 200mm rail controlling movement in the Z direction.  
These actuators are designed to give reproducible sub-micron positional accuracy 
(http://www.lmsystem.com: Accessed 11 January 2005). 
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       Figure A.1: View of the SPI GmbH robot, showing the guide actuators and other key features. 
 
Movement of the robot along the 3 axes was controlled by the Advanced Robotic Control 
(ARC) software (version 3.2), which was developed by SPI GmbH and supplied with the 
robot.  This software allows users to create a program consisting of a series of movements 
and functions in order to make the robot perform a particular task automatically and 
reproducibly, therefore ensuring that the printing process is highly reproducible.  The details 
of this macro programming process will not be included here, but are described in the ARC 
Manual (ARC (Advanced Robot Control) Manual 3.2 (2003) SPI GmbH Technologies, 
Oppenheim, Germany.) 
 
In order to be adapted to the production of microarray spots it was necessary to adapt the 
SPI GmbH technologies robot by the addition of a printing pin, and specific printhead for 
use with that spotting pin.  In order to meet the mass and volume constraints of the 
ExoMars Mission, it was desirable that the microarray spots be as small as possible 
provided that the optical imaging could provide a suitable image of the microarray.  This 
had the consequence that pins producing spots at the smaller size of the range of 
commercially available equipment, approximately 100µm, were desirable.  Taking this, the 
cost and availability of components, and the feasibility of attaching components to the SPI 
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robot into consideration,  ArrayITTM StealthTM 32 pin print head and Stealth Micro-spotting 
Pin SMP3 class of spotting pins (Telechem International, Sunnydale, CA, USA) were 
selected as the most suitable printing equipment for this project.   SMP3 spotting pins were 
supplied in 3 sizes, with slightly different spot sizes and reservoir capacity.  The SMP3B 
pin, which prints spots approximately 110µm in diameter, was chosen for the initial work, 
since this was close to the desired 100µm spot size.  The smaller SMP3 pin did not have a 
large enough reservoir for printing large arrays and the larger SMP3XB pin produces spots 
of 130μm diameter, which was slightly larger than the SMP3B spots. The print head was 
attached onto the robot arm with a customised mounting block, as shown in Figure A.2. 
 
 back :). 
Custom 
mounting 
block 
Spotting Pin 
Location 
ArrayIT Pin 
Holder  
 
Figure A.2:  SPI GmbH Technologies robot after addition of the Stealth™ print matrix  
 
A camera microscope was mounted on the spotting robot and focussed on the spotting 
pin,, such that it showed both the pin and an area of the surface underneath the pin.  This 
camera microscope was fitted with a ring of white LEDs around the objective lens to 
provide better illumination of the pin and surface (see Figure A.1).  The camera microscope 
images was displayed in real-time in the spotting robot software (described below).  This 
real time imaging was critical when using the robot for spotting microarrays, as the light 
source was required to allow manual alignment of the spotting pin with reference co-
ordinates each time.  
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SMP3B Stealth Pins have a machined “slot-like” reservoir in their tips with a capacity of 
0.6μl, and nominally deposit 600pl in each spot, so they can print up to 510 spots of 110µm   
diameter per loading (www.arrayit.com).  They are designed to capillary fill when immersed 
in a reservoir of solution, for example in this work was a microtitre plate well, and then, 
provided the properties of the pin surface and printing solution are suitable, a small volume 
of liquid is held over the end of the pin by surface tension.  Normally this is achieved by 
using the same controlled printing buffer for all print runs. A typical printing buffer consists 
of a standard biological buffer e.g. PBS or HEPES mixed with 30% volume glycerol to 
prevent evaporation of the spotting buffer during any reaction with the printing surface e.g. 
for covalent attachment of a protein or antibody to a functionalised surface.  Printing buffers 
may also contain stabilising agents and other preservatives, but none were used during this 
work.   When the spotting pin is brought into contact with a solid surface, assuming the 
properties of the pin surface, spotting buffer and printing surface are suitable, the liquid 
volume suspended from the bottom of the spotting pin is deposited onto the surface and 
replaced by liquid from a reservoir as the pin is raised away from the solid surface.  This is 
shown in Figure A.3.  There are a number of conditions under which this does not happen, 
and these will be described later in this chapter. 
 
 
Figure A.3: Function of Stealth
TM
 print pins (taken from www.arrayit.com) 
 
A.2 Initial contact pin printing protocol demonstrations - overview 
 
This section describes a series of experiments which were carried out in order to validate 
the contact pin printing process and methods of confirming successful pin printing and 
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readout of different reagents, such that these procedures were established prior to using 
the pin printing system to prepare protein or antibody microarrays for immunoassays.   
 
After modification of the spotting robot for microarray pin printing, the next objective was to 
demonstrate successful pin printing of microarray spots using a solution that would make it 
easy to visualise the spots.  For convenience, the solution used in the first experiment was 
a conveniently available fluorescent dye (Rhodamine G) in deionised water containing 1% 
surfactant.  This dye was selected because it was conveniently available and is visible both 
by eye and fluorescently.  The initial dye concentration was not controlled since this was 
not a quantitative test; the solution used was an uncontrolled high concentration of dye 
which make the solution a dark red colour. 
 
A method of imaging fluorescent microarray spots was also a key objective of this section 
of work.  In order to ensure that fluorescent spots could be imaged on the fluorescent 
microscope at Cranfield University, a BSA-fluorescein conjugate was selected as an 
inexpensive reagent suitable for fluorescent imaging involving protein interactions.  This 
protein was initially pin printed from a standard buffer solution resulting in a high 
concentration of protein dried down on the surface, largely to test the imaging of the 
fluorescent protein, and then immobilised onto a hydrophobic surface by physical 
adsorption and washed thoroughly to show that a very thin layer of fluorescent material 
could be detected. 
 
These experiments confirmed that the pin printing process and readout method was 
suitable for preliminary assays in a microarray format.  The experiments are described in 
detail below. 
 
A.2.1 Initial contact pin printing – materials and methods 
 
As an initial demonstration of the spotting procedure, the robot was programmed to deposit 
an array of spots consisting of five rows each containing twenty spots. Each spot in a row 
was separated by 100μm (centre to centre), and each row was separated by 500μm 
(centre to centre).  An uncontrolled highly concentrated solution of rhodamine G in RO 
water containing 1% surfactant (a domestic washing-up liquid) was used as a printing 
solution, since rhodamine G could be seen by eye, would behave similarly to other 
fluorescent dyes and could be visualised fluorescently if required. The concentration of the 
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solution was not critical at this stage, since the main objective of this initial experiment was 
to demonstrate printing of a dye solution. 
 
As discussed in section 2.3.1, the final SMILE instrument is to be based on microfluidic 
devices.  For this initial printing demonstration, The microfluidic devices used were 
fabricated by a laser cutting a biocompatible double-sided tape (Product code AR8939, 
ArCare, Adhesives Research, Dunmow UK).  This tape was selected because it is 
designed to be compatible with biological assays and would allow the easy assembly of 
prototype microfluidic devices in future experiments, and provided a reference location 
where the microarray spots were printed in this experiment.  The laser cut microfluidic 
structure was mounted on a glass microscope slide, and this slide was placed under the 
spotting robot for pin-printing (see Figure A.4).  The pattern printed was a 20 x 5 array of 
spots with a horizontal spacing of 200µm and a vertical spacing of 250µm.  Images of the 
spots were then taken under an optical microscope (Zeiss, Oppenheim, Germany), using a 
Peltier cooled CCD digital camera (Zeiss, Oppenheim, Germany).  
 
Figure A.4: Microfluidic structure on a standard microscope slide for test printing of microarray spots 
 
A.2.2 Initial contact pin printing - results and discussion 
 
Figure A.5 shows examples of the spots produced in this experiment.  The end of the 
SMP3B pin is designed to produce approximately circular spots with a diameter of 110μm.  
A sample section of an array of spots produced using this solution is shown in Figure A.5 A.  
The dark area towards the bottom of the picture is the edge of the assay area of the 
microfluidic channel that the spots were deposited in to.  Figure A.5 shows that the spots 
produced in this experiment are essentially circular, with some small variation in the size 
and shape of the shots.  It is also clear particularly from Figure A.5 B that there are a series 
of rings within the spot, which is typical of a drying effect that might be expected from an 
aqueous solution (e.g. Deegan et al.,1997).  This result indicates that pin-printing from 
water-based solutions may not produce uniform spots.  Standard microarray printing 
methods deposit proteins on functionalised surfaces to allow covalent immobilisation and 
Assay areas 
Microfluidic channels 
Waste Reservoirs  
Areas for assay 
reagent storage  
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use buffers containing 10% to 30% glycerol, to prevent evaporation of the solution during 
this reaction.  Drying effects such as those seen in Figure A.5 are therefore unlikely to 
occur in the flight instrument. 
 
Figure A.5: Highly concentrated of rhodamine Dye in PBS microarray printed onto a glass surface within a 
microfluidic channel.  Image taken on a ZEISS CCD camera at A) 10x magnification B) 40x Magnification 
(images not to scale). 
 
The final assay system proposed for SMILE was to utilise fluorescently labelled antibodies 
or capture reagents in a microarray format within a microfluidic channel such as that shown 
in Figure A.4 (Sims et al., 2005).  This experiment established a basic printing protocol and 
imaging system for printing microarray spots using fluorescent dyes in water-based 
solutions.  This is a first step towards developing an antibody assay in a microarray spot 
format within a microfluidic structure.  The next step was to extend this printing protocol to 
the deposition of proteins in buffer solutions, and to establish a message for fluorescent 
imaging of the spots.  Establishing a fluorescent imaging method would provide input into 
the design of a bespoke imaging system which would allow a breadboard version of the 
flight instrument to the assembled.  
 
 
A.2.3 Development of protocols for printing proteins in solution and fluorescent imaging – 
materials and methods 
 
The next step in the assay development was to verify that proteins in solution could be 
used with the microarray pin printing system and to confirm a fluorescent readout method.  
Since a protocol for drying down reagents in solution have been demonstrated in section 
A.2.2, a similar system was used in this experiment to print a fluorescently labelled protein 
in buffer solution.  A 1mg.ml-1 concentration solution of BSA-fluorescein (Sigma-Aldrich, 
Poole, UK) in 10mM PBS pH 7.4 (PBS tablets, Sigma-Aldrich, Poole, UK), was printed onto 
A B 
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glass microscope slides and allowed to dry down.  The pattern printed was a 20 x 5 array of 
spots with a horizontal spacing of 200µm and a vertical spacing of 250µm, as for the 
previous experiment (see section A.2.1). The spot array was then imaged under an optical 
fluorescent microscope (Zeiss, Oppenheim, Germany) using a Peltier cooled CCD digital 
camera (Zeiss, Oppenheim, Germany).   
A.2.4 Development of protocols for printing proteins in solution and fluorescent - results 
and discussion  
 
 
Figure A.6: 1mg.ml
-1
 BSA-Fluorescein microarray spots printed onto a glass microscope slide.  Image taken 
with a Zeiss CCD camera with a 10000ms exposure at 10x magnification (image not to scale) 
 
Figure A.6 shows the spots of BSA-Fluorescein conjugate produced in this experiment.  
The spots are all present, indicating that printing in the standard PBS buffer was 
successful..  The spacing of the spots appears to be less in Figure A.6 than in Figure A.5, 
but this may be due to the spotted solution spreading further over the surface in this 
experiment, creating larger spots.  By visual inspection, the spots in Figure A.6 appear all 
to be similar both in terms of size and structure i.e. they all have a ring feature around their 
edges and linear structures within the central area of the spot.   
 
Image analysis, scale bar 
 
In addition to what appears to be a drying effect around the outside of the spots (Deegan et 
al.,1997), as was observed with the rhodamine B spots above, there appears to be 
structure within the spots.  These features are assumed to be crystals of phosphate buffer 
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salts produced as the water in the spotting solution evaporated.  As discussed in section 
2.3.1, and A.2.5, in the final microarray spotting format the reagent in the spots would be 
attached to the printing surface in a monolayer and any remaining printing solution would 
not be allowed to dry out, so these drying effects would not be expected.   
 
In order to confirm that buffer salt precipitates could be removed by washing, and 
determine whether it was possible to visualise a monolayer of immobilised material on the 
slide surface, the protocol was modified in the next experiment. 
 
A.2.5 Immobilisation of BSA-fluorescein by physical absorption in order to create an 
approximation of a monolayer of florescent microarray spots – materials and 
methods  
 
In the previous experiment it has been shown that spots of fluorescently labelled protein 
could be imaged using a fluorescent microscope.  In the final SMILE instrument the 
fluorescent material on the microarray spots would be present in a monolayer, since it 
would arise from a layer of bound antibody.  In section A.2.4, the fluorescent image was 
created from a relatively large amount of dried down protein material.  In order to determine 
whether a monolayer of fluorescently labelled material could be visualised, an array of 
1mg.ml-1 BSA – Fluorescein conjugate (Sigma-Aldrich, Poole, UK) in 10mM PBS pH 7.4 
was printed onto a polystyrene surface (a plastic petri dish), using the same printing 
program as in section A.2.4.  In contrast to a glass microscope slide, polystyrene would 
allow the protein to bind to the surface by physical adsorption rather than drying down.  
This would be a stronger bond and vigorous washing would remove excess material from 
the surface leaving only a monolayer.   After printing the array was incubated in a humidity 
chamber for 2 hours and then thoroughly washed by agitation in a beaker of RO water and 
left to dry for 2 hours, to try to remove any dried down BSA-fluorescein and therefore 
produce a monolayer of adsorbed protein on the surface.  This array was then imaged on a 
fluorescent optical microscope with a cooled CCD camera (Zeiss, Oppenheim, Germany). 
 
A.2.6 Creating a monolayer of florescent microarray spots – results 
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Figure A.7: 1mg.ml-1 BSA-Fluorescein microarray spots printed onto a polystyrene substrate and washed 
thoroughly with deionised water.  Image taken with a Zeiss CCD camera with a 10000ms exposure at 10x 
magnification. 
 
Figure A.7 shows a 10,000ms exposure image of the array of washed BSA-fluorescein 
spots on the polystyrene Petri dish, taken with the Zeiss optical fluorescent microscope.  All 
of the spots appear to be present and have a broadly uniform appearance.  In Figure A.7, 
in contrast to Figure A.5 and Figure A.6, the spots appear to be square.  This is likely to be 
because the end of the sporting pin is square, and in contrast to the hydrophilic glass 
microscope slide, the hydrophobic surface of the polystyrene Petri dish prevented the liquid 
forming circular spots.  The intensity of the spots appears to be significantly lower than in 
the previous experiment (Figure A.6).  Both images were taken under the same conditions 
and with the same exposure time, so the reason for this is likely to be that the washing 
procedure did remove a large amount dried down material, leaving only a very small 
amount of material, approximating a monolayer, of physically adsorbed protein on the 
surface.   
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There are some particulates and inclusions present within and outside the spots.  However, 
the crystalline structures within the spots observed in the previous experiment are no 
longer present, indicating that washing the microscope slide in RO water immediately after 
incubation in a humidity chamber either prevented crystallisation of buffer salts on the 
surface or away any crystals that were formed. In either case it prevented crystals 
remaining on the surface after washing.  The remaining particulates in the spots could be 
removed by passing all the solutions though a 0.2μm particle filter.   
 
The columns of spots appear to be slightly offset from one another.  This was thought to be 
due to slight movement of the relatively low mass polystyrene material during the printing 
process, as when the robot changed speed or direction suddenly this could cause 
movement of the polystyrene.  
 
Having now reached the point of developing a confirmed microarray printing and readout 
system through preliminary experiments, these techniques were used and adapted to 
develop an antibody based assay in this microarray format. 
 
A.3 Demonstration of binding immunoassay in microarray format with fluorescent 
readout 
 
Since an image of a very thin layer of fluorescently labelled material on a surface had been 
produced, an experiment to use this to carry out a binding immunoassay experiment in a 
microarray format was carried out with the BSA-atrazine system described previously (see 
section 3.1.1.4).  In order to use this assay system with a fluorescent readout, a 
fluorescein-labelled anti-human kappa light chain secondary antibody (Sigma-Aldrich, 
Poole, UK) was used to replace the HRP labelled anti-human kappa light chain secondary 
antibody used in section 3.1.1.4. 
A.3.1 Initial microarray format binding immunoassay materials and methods 
 
The protocol used for this assay was as follows: 
 
 An array of 1μg.ml-1 BSA-atrazine conjugate (Haptogen, Aberdeen, UK) in 10mM 
PBS pH 7.4 was spotted onto a polystyrene Petri dish 
 The polystyrene Petri dish was then placed in a humidity chamber, consisting of a 
sealed plastic container lined with a moist paper towel, for 2 hours.   
 The polystyrene Petri dish was immersed in a beaker of blocking solution (0.1g.ml-1 
skimmed milk powder (Marvel) in 10mM PBS pH 7.4) for 2 hours. 
Paul Kerr Wilson                                                                                                  Initial validation of microarray printing and readout systems             
Development of Life Marker Chip Technology for in-situ Life Detection on Mars                            Page A-12  
 The polystyrene Petri dish was then removed from the blocking solution and the 
assay area washed twice with 1ml of 10mM PBS pH 7.4 and once with RO water, by 
pipetting these solutions over the assay area at an acute downwards angle.   
 20μl of 0.2μg.ml-1 fluorescein-labelled anti-human kappa light chain in 10mM PBS 
pH 7.4 was pooled over the array areas of the slide and incubated for 2 hours in the 
humidity chamber.   
 The assay area was then washed three times with 1ml of 10mM PBS-0.1% TWEEN 
20 and once with RO water as described above, then dried with a nitrogen gas 
stream from a compressed nitrogen gas source for 1 minute, and stored until 
analysis. 
 
A.3.2 Initial microarray format binding immunoassay results and discussion 
 
Figure A.8 shows the results of this experiment in the form of a 10,000ms exposure image 
taken under the Zeiss florescent microscope. It is clear that the array spots are visible, 
which indicates that all of the key steps in the assay are working – printing, adsorption of 
the dye, binding of the anti-atrazine scAb and binding of the secondary antibody.  The 
background is also relatively low, indicating that the blocking and washing system is 
effective.  However, the spots all appear to be non-uniform in fluorescent intensity, and in 
fact many features are present in all of the spots.  This indicates that there was a problem 
with the printing process, possibly contamination on the spotting pin which could have been 
introduced the pin had been allowed to dry after printing the protein solution.  There is also 
some evidence of particulates and some non-specific binding around the lower spots in this 
image. This could have been introduced by the printing process, or spreading of the pin 
printing solution to areas outside the microarray spots during incubation in the humidity 
chamber. 
 
This experiment showed that an immunoassay can be carried out in a microarray format 
with a fluorescent readout.  While there are still some problems with non-specific binding 
and particulates, this proof of concept experiment has shown that the approach was valid 
and generated enough data to design a test rig which would be more representative of the 
flight model of the SMILE instrument.  Also, at this time in the project additional funding was 
available which allowed the test rig equipment to be purchased and used to further develop 
the microarray immunoassay.  The design and assembly of this test rig is described in 
section 3.1.2. 
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Figure A.8: immunoassay carried out on spots of atrazine-BSA physically adsorbed onto glass microscope 
slides 
 
 
